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Abstract of the Dissertation 
 
Rhodococcus opacus PD630 Genetic Tool Development to Enable the Conversion of Biomass 
By 
Drew Michael DeLorenzo 
Doctor of Philosophy in Energy, Environmental and Chemical Engineering 
Washington University in St. Louis, 2019 
Professor Tae Seok Moon, Chair 
 
The discovery of fossil fuels facilitated a new era in human history and allowed many firsts, 
such as the mass production of goods, the ability to travel and communicate long distances, the 
formation of population dense cities, and unprecedented improvements in quality of life. 
Alternative sources of energy and chemicals are needed, however, as hydrocarbon reserves 
continue to deplete and the effects of burning fossils on the planet become better understood. 
Lignocellulosic biomass is the most abundant raw material in the world and a viable alternative to 
petroleum-derived products. The pre-treatment of lignocellulose (e.g., thermocatalytic 
depolymerization, enzymatic hydrolysis, pyrolysis, etc.) generates a range of products, including 
readily available sugars for microbial fermentation. One of the typically unused fractions of 
biomass is the structural component, referred to as lignin, that makes up 15 to 30% of the material 
and when depolymerized generates a heterogeneous mixture of toxic aromatic compounds. 
Generally, lignin is separated from the carbohydrate fraction and burned, but its utilization has 
been identified as a key factor in biorefinery profitability. One possible option for lignin 
valorization is to find a microbe that not only ferments lignocellulose-derived sugars into a 
valuable commodity, but also the lignin-derived aromatics.  
xiv 
 
Rhodococcus opacus PD630 (hereafter R. opacus) is a non-model, gram-positive bacterium 
that possesses desirable traits for biomass conversion, including consumption capabilities for both 
lignocellulose-derived sugars and aromatic compounds, significant accumulation of the biodiesel 
precursor triacylglycerol, a relatively rapid growth rate, and genetic tractability. Few genetic 
elements and molecular biology techniques, however, have been directly characterized in R. 
opacus, limiting its application for lignocellulose bioconversion. The goal of this dissertation is to 
greatly expand the genetic toolbox available in R. opacus in order to provide insight into its 
aromatic catabolism and to promote its use as a microbial chassis for the conversion of biomass-
derived products into biofuels or other value-added products. The contributions developed as part 
of this dissertation include 1) the development of strong constitutive promoters for the 
overexpression of heterologous genes, 2) the development of chemical and metabolite sensors for 
tunable gene expression, 3) the characterization of native and endogenous plasmid backbones and 
resistance markers, 4) a heterologous T7 RNA polymerase expression platform for gene 
expression, 5) the demonstration of genetic logic circuits for programable gene expression, 6) a 
recombinase-based recombineering platform for gene knockouts and insertions, 7) a CRISPR 
interference (CRISPRi) platform for targeted gene repression, 8) the identification of stable 
reference genes for RT-qPCR applications, 9) insight into aromatic degradation through the β-
ketoadipate pathway via gene knockouts, and 10) insight into the role of aromatic transporters via 
gene knockouts. Taken together, this work greatly advances the ability to engineer R. opacus for 
any desired application, in addition to providing understanding into its catabolism of aromatic 
compounds.  
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Chapter 1: Introduction 
 
1.1 Need for renewable sources of energy and chemicals 
 Humanity has faced and overcome innumerable challenges throughout its collective 
history. The greatest challenge of the 21st century and beyond, however, will be responding to 
anthropogenic climate change. Since the discovery of fossil fuels and the subsequent onset of the 
industrial revolution in the mid-1700s, the relationship between humans and the biosphere has 
been significantly altered. The use of fossil fuels as energy-rich power sources facilitated a new 
era in which humans moved to population-dense cities, traveled and communicated rapidly across 
great distances, mass-produced goods, enhanced agricultural output, and improved their quality of 
life. This paradigm shift in human existence came at an unforeseen cost, however, as the burning 
of fossilized carbon sources led to the large-scale release of greenhouse gases, particularly carbon 
dioxide (CO2). Compared to pre-industrial levels, the current global atmospheric CO2 
concentration has increased over 30%, or 100 parts per million (ppm), and is now stably 
maintained at over 400 ppm, with 75% of that change occurring since 1960.1 Furthermore, the 
current atmospheric concentrations of carbon dioxide, methane, and nitrous oxide are at their 
highest levels in the last 800,000 years.2 Emissions will be further exacerbated as the human 
population is projected to continue growing to 9.5 billion by 2050 and the standard of living in 
developing countries continues to improve.3 
Increased levels of greenhouse gases have already led to many negative consequences 
across the globe and will continue to present an unparalleled challenge for years to come. The most 
direct outcome of an amplified concentration of greenhouse gases is global warming. Certain 
gases, such as CO2 and methane, cause the atmosphere to behave similarly to a greenhouse, 
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wherein visible radiation from the sun can penetrate through the gaseous layer, but the resulting 
radiated thermal energy from the planet is prevented from escaping. This trapped thermal energy 
in turn leads to an increase in system temperature. As a result of this enhanced greenhouse effect, 
the three decades from 1983 to 2012 were the warmest 30-year period of the last 1400 years in the 
Northern Hemisphere.2 The observed terrestrial warming would be even more significant if the 
oceans had not absorbed more than 90% of the additional thermal energy accumulated since 1971.2 
Over the past 250 years, the earth’s atmosphere has warmed approximately 1 °C, ocean pH has 
increased by 26% due to the additional dissolved CO2, Arctic sea ice is decreasing at a decadal 
rate of approximately 4%, and global mean sea level has risen about 0.2 meters.2 If the overall 
planet temperature increases by over 2 °C, wide-scale global consequences including, but not 
limited to, even more substantial sea level rise from the melting of glaciers, decreased agricultural 
and fishery output, further ocean acidification, extreme weather (e.g., drought or heat waves), and 
higher rates of natural disasters (e.g., wildfires, hurricanes, monsoons) will all occur.2 Based on 
leading emission scenarios calculated by the International Panel on Climate Change (IPCC), if 
global warming is to be limited to less than 2 °C over the next century, CO2 levels must remain 
below 450 ppm. Achieving this would require bringing net CO2 emissions down to 0 by 2100.
2 As 
such, an alternative supply of fossil fueled-derived energy and chemicals is sorely needed. 
1.2 Sources of renewable energy and chemicals 
 Sustainable energy can be derived from multiple sources (e.g., solar, wind, geothermal, 
hydroelectric, or biomass), eliminating the need for fossil fuels to power electricity generation. A 
single technology, however, is not capable of fully displacing hydrocarbon deposits, meaning that 
a portfolio of energy sources will be required.4 Furthermore, almost all sources of renewable 
energy are geographically or temporally limited, further necessitating the development of multiple 
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complementing technologies.5 For example, solar panels can only generate electricity during the 
day, turbines are dependent on variable winds, and hydroelectric dams require a significant body 
of water. The stochastic availability of renewable energy sources can also lead to disruptions in 
the electrical grid, as conventional energy plants cannot quickly ramp their production up or down 
to meet demand.5 To avoid blackouts, an excess of fossil fuel-derived energy is produced as a 
buffer against variable renewable energy sources, partially negating the desired effect of 
employing these sources. To make these forms of renewable energy available to the entire 
population, significant gains in long-range electricity transmission and energy storage (i.e., 
batteries) are required to deploy energy across electrical grids when needed.5 In spite of these 
challenges, renewable energy made up 19.2% of global final energy consumption as of 2014 and 
is expected to continue to rise.4  
An alternative to long-range electricity transmission or batteries is storing energy 
chemically through the production of energy-dense liquid fuels, such as biodiesel and bioethanol. 
Potential options include: electrochemically generating liquid fuels from CO2 using a catalyst and 
a sustainable source of electricity, recycling waste oils (ex. cooking oil) into “drop-in” fuels for 
difficult to replace products (e.g., jet-fuel), and converting biomass, whether derived from food or 
energy crops, agricultural residues, or algae, into liquid fuels.2-3, 6-7 Biomass is already the fourth-
largest source of global energy, accounting for 10%–14% of the final energy consumption over 
the past decade, although this energy is typically extracted through the direct burning of material 
for heat.8 Biomass, unlike other renewable energy sources, can also be used as a carbon feedstock 
to generate replacements for petroleum-derived products.  
First-generation biofuels, or those generated from potential food products (e.g., starch, 
sugar, animal fats, and vegetable oil), are an increasingly-popular improvement over directly 
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burning biomass, with production reaching 106 billion liters worldwide in 2012 (82.6 billion liters 
of ethanol and 23.6 billion liters of biodiesel).7 These types of fuels are not new; the inventor of 
the diesel engine himself advocated for farmers generating their own biofuel in areas without a 
source of petroleum.9 There is concern, however, that as the human population continues to climb, 
using potential food goods for fuel could lead to shortages as the combined global demand for food 
and fuel outweighs the supply of arable land.10-11 Furthermore, while first-generation biofuels may 
mitigate CO2 emissions associated with fossil fuels, they still pose economic and environmental 
problems, such as the energy consumed related to irrigation, fertilizer production, crop cultivation, 
and transportation.9-10, 12 Second-generation biofuels, or those produced from non-food biomass or 
lignocellulose, can alleviate many of the concerns garnered by first-generation biofuels.13  
1.3 Lignocellulosic biomass as a sustainable carbon feedstock 
 Lignocellulose is the most abundant raw material in the world. Three primary sources exist 
for use as second-generation fuels and chemicals, including virgin biomass (e.g., common trees, 
shrubs, and grasses), agricultural and forestry wastes and residues (e.g., corn stover and sugarcane 
bagasse), and dedicated energy crops (e.g., poplar and switchgrass).13-14 Lignocellulosic biomass, 
regardless of source, is comprised of three main fractions. Two of these fractions, cellulose and 
hemicellulose, are polymers predominantly composed of carbohydrates that can be hydrolyzed 
into easily fermentable sugars, predominantly glucose and xylose, and make up to 70-85% of the 
biomass dry-weight.15 The third fraction, representing 15-30% of the biomass dry-weight, is the 
structural component, referred to as lignin, that imparts a “woody” characteristic to the plant, 
prevents polysaccharide degradation, and waterproofs the cell wall and vascular system.16 Lignin’s 
structural rigidity and recalcitrance to degradation derives from it being a complex, cross-linked, 
and highly heterogeneous aromatic macromolecule.17-18  
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Up to a billion tons of lignocellulosic biomass is potentially available in the United States, 
deriving predominately from agricultural and forestry waste. If all of this biomass were utilized, 
current petroleum consumption could be reduced by at least 30%.19 Additional study needs to 
conducted, however, to determine how much of these feedstocks should be used for energy and 
chemical production, as agricultural and forestry wastes are often used for other tasks, such as the 
maintenance of soil nutrient quality (e.g., re-tilling of corn stover into the soil).3, 8 Furthermore, 
many industrial biomass by-products are currently already used for other needs and there may not 
be enough left over for energy production.3, 8 This is the case in Germany, where all biomass waste 
is already fully utilized.3, 8 Energy crops that perennially produce large quantities of biomass are a 
viable supplement to industrial, agricultural, and forestry wastes, as they can typically grow in 
nutrient-poor soil, have a lower water demand than food crops, and can be beneficial to the 
environment.14 Approximately 13.6 million hectare of land that is not suitable for food production 
is available for switchgrass cultivation in the United States.20 Regardless of source, biorefineries 
can convert biomass into a range of products by employing a number of distinct catalytic, 
thermochemical, and biological conversion processes to take advantage of the carbon and energy 
stored in this renewable material.21-22 
 Lignocellulose, unfortunately, does require more complex and costly processing to 
produce biofuels or products compared to first-generation feedstocks. Lignin provides a particular 
challenge as it resists degradation and generates toxic aromatic compounds when 
depolymerized.23-25 Generally, the lignin fraction of biomass is separated from the carbohydrate 
fractions and is either discarded or burned to recover low-grade heat.26 The economic viability of 
second-generation biorefineries, however, depends on the complete utilization and upgrading of 
lignin. According to the National Renewable Energy Laboratory (NREL), selling the lignin 
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fraction at the same price as the original feedstock for conversion into higher value by-products 
could reduce the minimum sugar transfer price by 12.5%.27 This is significant considering that the 
production of sugar from corn stover makes up 69% of the suggested minimum ethanol sale price 
of $2.15, greatly eating into potential profits.28 The global production of industrial-waste lignin is 
estimated at approximately 70 million tons per year and projections suggest that, by 2025, a single 
second-generation bio-alcohol refinery could generate approximately 20-25 million pounds per 
year of lignin as a by-product.29-30 While the utilization of the carbohydrate fraction of biomass 
has increased by several orders of magnitude, with cellulosic bioethanol production projected to 
ramp up to 14 billion gallons per year by 2022, the question still remains what to do with the lignin 
fraction.31-32 
1.4 Taking advantage of lignin 
 Lignin is the second most abundant polymer on the planet and can be separated from the 
carbohydrate fraction of lignocellulose in many ways (e.g., organic solvent, pulping, alkaline or 
acid treatment).33-34 The method utilized, however, affects the composition of the final extract, so 
downstream processes need to be considered when choosing a technique.33-34 As previously 
mentioned, lignin is an extremely heterogeneous polymer composed of aromatic subunits derived 
primarily from p-coumaryl, coniferyl, and sinapyl alcohols that have undergone pseudo-random 
enzymatic polymerization.23, 34-35 The composition of the extracted lignin also depends on the 
original biomass source, as the ratios of these three monolignol precursors varies between species, 
genotypes, and even across tissue types, in addition to being a function of environmental factors 
during growth.36 For example, softwood lignin consists mainly of coniferyl alcohols units (95%), 
while hardwood lignin predominantly contains coniferyl alcohol and sinapyl alcohol units in 
equivalent ratios.37 The monolignols form several types of chemical bonds, but the most common 
7 
 
are aryl ether bonds (e.g., -O-4, α-O-4, and 4-O-5).16 The extreme diversity and variability in the 
composition of lignin makes commercial degradation difficult and widespread utilization of lignin 
challenging; however, it is the largest renewable source of aromatic compounds globally and is 
critical to displacing petroleum derived fuels and chemicals.  
 There are many different uses for lignin than span the gamut of valuations. Currently the 
most common and lowest value use, is burning the lignin for low-grade heat.26 Burning biomass 
requires high initial temperatures (800 to 1200 oC) to start ignition, particularly when the material 
has not been pre-dried, but it is an economical way to generate heat.38 Alternative options for 
electricity generation are the gasification of lignin into synthesis gas (syngas), which can be burned 
directly or converted into synthetic natural gas (SNG), or the production of liquid bio-oil through 
fast pyrolysis.39-40 Gasification requires slightly lower temperatures than biomass burning, which 
reduces energy inputs and the production of undesirable nitrogen and sulfur oxides. Additionally, 
the final product can be used in efficient reciprocating engines or gas turbines for electricity 
generation.38 Fast pyrolysis utilizes a much lower temperature than both burning and gasification 
(350 to 600 oC) and the resulting liquid product is more easily transported.38 Bio-oil is typically 
not useful for anything other than burning though due to its extremely heterogeneous distribution 
of compounds that prevents effective chemical separations.41  
Lignin can also be used as a carbon feedstock to produce value-added compounds. The 
most common method to upgrade lignin is recovering lignosulfonates formed during sulfite 
pulping of lignocellulose, which can then be used as plasticizers in concrete, additives in animal 
feed, or converted into the high-value food additive vanillin.34, 42 There are several challenges 
associated with the production of lignosulfonates, the primary issue being that most industrially 
produced lignin is Kraft lignin, meaning that additional steps are required for sulfonation. 
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Additionally, lignosulfonates must be physically or chemically extracted and purified from the 
spent sulfite liquors collected during sulfite pulping, the degree of sulfonation is heterogeneous, 
and the molecular weights of the products can span orders of magnitude.43 Alternatively, 
thermochemical and catalytic technologies (e.g., oxidative cracking, hydrogenolysis, and 
solvolysis) that depolymerize the entirety of lignin into its constituent aromatics can be applied.44 
Catalytic technologies can depolymerize lignin more selectively due to targeting specific chemical 
bonds, in addition to reducing the occurrence of secondary reactions due to the lower required 
input energy.44 Enzymes and various microorganisms have also been investigated as a selective 
and low-cost method of lignin depolymerization.45-46 In general, biological systems require mild 
conditions that avoid costs associated with the use of high temperatures and high pressures. Only 
a few bacteria (e.g., Streptomyces spp., Rhodococcus spp., and Nocardia spp.) and brown/white-
rot fungi, however, have demonstrated an ability to depolymerize lignin, and their 
depolymerization rates are often considered too slow to be useful on an industrial scale.24, 47-49  
Regardless of the method employed, a lignin breakdown mixture with a narrower 
distribution of aromatic compounds is more cost-effective for chemical separations and product 
upgrading, which helps facilitate the widespread adoption of lignin valorization. The lignin 
breakdown products, however, still generally contain so many compounds that performing 
chemical separations for specific products leads to isolation of only a small fraction of the total 
mixture. One solution is to utilize a process that can convert all the aromatic compounds in a 
depolymerized lignin mixture into a single compound that can then be processed into other 
chemicals using traditional methods. A biological catalyst (i.e., a microbe) can use its array of 
catabolic enzymes to “funnel” a mixture of compounds through the organism’s metabolism into a 
single metabolite.50 Combining a process such as thermocatalytic depolymerization of lignin with 
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a biological catalyst that can reduce lignin breakdown products into a single high-value compound 
has been referred to as a hybrid conversion strategy.50-51 
1.5 Hybrid conversion of lignocellulose into value-added products 
A hybrid conversion approach combines the best attributes of a depolymerization 
technology, such as a thermocatalytic reaction, with biological conversion technologies.51 In a 
hybrid conversion approach, a process with advantageous reaction kinetics and selective product 
formation is applied for the initial lignin depolymerization. Microbial conversion is then applied 
downstream and funneling of the depolymerized lignin breakdown products to a single value-
added product then occurs with advantageous selectivity.52 Specially evolved organisms possess 
an array of upper degradation pathways than can convert a distribution of aromatics into common 
metabolic intermediates (e.g., protocatechuate and catechol), effectively acting as a “biological 
funnel”.50-51 These intermediates undergo further conversion to central metabolites (e.g., acetyl-
CoA) that can be utilized to produce target compounds with high selectivity and concentration. 
Hybrid conversion technologies have been previously implemented, but they have almost 
exclusively focused on cellulosic sugar utilization.53-54 Recent work has begun to shift the focus to 
lignin utilization, with initial efforts focusing on screening different biological catalysts (e.g., 
Pseudomonas putida and Rhodococcus spp.) with lignin model compounds to characterize their 
aromatic degradation pathways and bioconversion abilities.55-58 A number of organisms have now 
also been demonstrated to consume real lignin breakdown products, but which biological catalyst 
is best for conversion still remains an open question.59-66 
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1.6 Choosing Rhodococcus opacus PD630 as a biological catalyst 
The choice of a biological catalyst is important, as the chassis needs to not only possess  a 
sufficient number of catabolic pathways for the consumption of lignin-derived aromatics, and 
ideally hexose and pentose sugars, but also have a tolerance towards inhibitory compounds 
generated during biomass depolymerization. The pretreatment of lignocellulose generates an array 
of toxic compounds, such as aromatics from the lignin fraction or furfurals from the hemicellulose 
fraction, that conventional model microbes (e.g., Escherichia coli) are not able to effectively 
tolerate or consume.15, 67-68 Furthermore, if the conversion process is to be profitable, the biological 
catalyst must be able to produce a valuable product in large quantities, which requires a high initial 
feedstock load.  
The Actinomycetales bacterium Rhodococcus opacus PD630 (hereafter R. opacus) has 
many desirable traits for the microbial valorization of lignocellulose, most critically the ability to 
consume a wide variety of biomass-derived substrates. R. opacus has been screened on a broad 
range of compounds and demonstrated growth on oligosaccharides, alcohols (e.g., arabitol and 
mannitol), hexose sugars (e.g., glucose and galactose), carboxylates (i.e., organic acids), aromatics 
(e.g., phenol, guaiacol, and benzoate), and lignocellulose-derived by-products (e.g., furans).69-71 
Furthermore, R. opacus strains have been engineered to consume common biomass-derived 
pentose sugars (e.g., arabinose and xylose), in addition to the disaccharide cellobiose.72-75 R. 
opacus has been further confirmed to consume several forms of treated biomass, including 
switchgrass pyrolysis oil66, alkali-treated corn stover and poplar wood 48, 64, 76, and depolymerized 
kraft lignin77. Very recently, an engineered strain of R. opacus that secretes a heterologous laccase 
enzyme was demonstrated to depolymerize and grow on insoluble Kraft lignin in a consolidated 
bioprocess.78 Providing further insight into the metabolism of R. opacus, an annotated reference 
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genome is available and several transcriptomic and proteomic datasets have been generated when 
cells were grown on various feedstocks (e.g., glucose, aromatics, and kraft lignin).69, 78-79 
R. opacus not only possesses a diverse set of catabolic pathways, but it has also previously 
demonstrated a natural and adaptive tolerance towards inhibitory lignocellulose-derived products, 
including biomass pretreatment by-products (e.g., furans), organic acids, aromatics, and 
chlorinated and halogenated compounds.69-70, 80 The tolerance mechanisms in R. opacus are not 
fully understood, but are partially attributed to its numerous catabolic pathways that consume 
inhibitory compounds, such as aromatics via a high flux -ketoadipate pathway, which reduces the 
effective local concentration of these compounds.18, 81 Furthermore, its ability to modulate its 
lipidome in response to a phenolic compound suggests membrane permeability contributes to 
tolerance.82 R. opacus also demonstrates advantageous conversion rates as it can concurrently 
consume glucose via Entner–Doudoroff pathway, acetate via the glyoxylate shunt, and phenolic 
compounds via β-ketoadipate pathway, leading to improvements in productivity.72, 83 It has also 
demonstrated osmotic tolerance to very high initial loadings of sugars feedstocks (up to 419 g/L 
glucose), which facilitates higher final product titers.71, 84  
R. opacus can convert lignocellulose-derived feedstocks into a number of high-value 
products. R. opacus is primarily known for its ability to produce significant amounts of the 
biodiesel precursor triacylglycerol (TAG; up to 76% of its cellular dry weight when grown on 
gluconate).80 This oleaginous ability in R. opacus is attributed to its type 1 FASI lipid synthesis 
mechanism, which is rare in prokaryotes and is normally found only in animals and fungus.78 
Bacteria commonly use the type 2 FASII system. The type 1 FASI system facilitates more efficient 
lipid synthesis through the use of a single multicomponent and multifunctional enzyme, compared 
to many single function enzymes in the type 2 FASII system.78 The TAGs generated through this 
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efficient lipid synthesis pathway can then be extracted and readily converted into biodiesel through 
a transesterification reaction that generates three free fatty acids (FFAs) and a glycerol. The 
glycerol can be separated from the FFAs and fed back to the cell as a secondary carbon source.85-
86 The lipid metabolism has also been engineered in several ways to foster value-added product 
synthesis, including the overexpression of enzymes identified as reaction bottlenecks to increase 
lipid production and the re-routing of lipid species to produce wax esters, which have roles in the 
production of cosmetics, pharmaceuticals, and lubricants.78, 87 Intermediates in the aromatic 
degrading -ketoadipate pathway can also be diverted into high-value products, such as muconic 
acid or succinic acid.88-90 Finally, R. opacus natively produces carotenoids, which can be used as 
dietary supplements to benefit human health.91  
All of these natural and engineered abilities of R. opacus make it an ideal microbial 
biorefinery for the conversion of lignocellulosic material, particularly lignin, into fuels and 
chemicals. Many of the modifications performed in R. opacus, however, are commonly achieved 
using borrowed and generally uncharacterized genetic parts from related Actinobacteria.72-74, 87, 92  
Genetic parts (e.g., promoters, plasmid backbones, dynamic sensors, etc.) and molecular biology 
techniques (e.g., genome recombineering, targeted gene repression, gene expression 
quantification, genetic logic implementation, etc.) often taken for granted in model organisms such 
as E. coli are limited in R. opacus. The goal of this dissertation is to develop and apply a 
characterized genetic toolbox for advanced engineering in Rhodococcus opacus PD630 and to 
provide insight into its aromatic catabolism.  
1.7 Summary and organization of dissertation 
 The primary objective of this dissertation is to expand the genetic toolbox for Rhodococcus 
opacus PD630 as a microbial platform for the conversion of lignocellulose into value-added 
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compounds. A subset of the tools developed herein will be applied to enable more sophisticated 
gene expression (i.e., genetic logic) and to provide insight into aromatic consumption and pathway 
regulation. In Chapter 2, several chemical and metabolite sensors were developed and 
characterized in R. opacus to facilitate tunable gene expression. Furthermore, multiple fluorescent 
proteins from three distinct color categories, which allows the simultaneous utilization of up to 
three reporters, were screened for the best signal over the background. One of the developed 
sensors was repurposed as a cellular timer to enable gene expression at a desired time point during 
cell culture. Finally, the activity of five native R. opacus promoters from genes related to aromatic 
catabolism were examined in response to six model lignin compounds, providing novel insight 
into regulatory mechanisms. This work was published in ACS Synthetic Biology.93 In Chapter 3, 
additional genetic parts for strong, tunable gene expression were developed, including the 
development of novel IPTG-inducible promoters, four selective aromatic inducible promoters, and 
the first application of the T7 RNA polymerase expression system in Rhodococcus spp. Genetic 
parts from this chapter and Chapter 2 were then combined to demonstrate three different forms of 
genetic logic (AND, NAND, and IMPLY logic gates). This work was published in ACS Synthetic 
Biology. In Chapter 4, the genetic toolbox is further expanded to include a constitutive promoter 
library for variable gene expression, a new curable plasmid backbone for temporary gene 
expression, two newly characterized antibiotic resistance markers for selection, a system for 
targeted and tunable gene repression (e.g., CRISPR interference), three neutral sites in the genome 
for gene integration, and a platform to enable genome recombineering (i.e., gene knockouts and 
gene insertions). Furthermore, the copy number of 4 heterologous plasmids and 9 endogenous 
plasmids was determined through quantitative PCR (qPCR). This work was published in ACS 
Synthetic Biology.94 In Chapter 5, a set of stably expressed reference genes was identified in R. 
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opacus for use as benchmarks to normalize mRNA expression data collected through reverse 
transcription quantitative PCR (RT-qPCR). RT-qPCR is critical for quantifying the repression of 
native genes via CRISPRi when no easily measurable metric is observable (i.e., fluorescence). 
This work was published in Scientific Reports.95 In Chapter 6, three transporters and two catabolic 
pathways identified as being relevant to aromatic consumption via transcriptomic analysis were 
knocked out using parts developed in Chapter 4. The role of these genes was then characterized 
via growth assays. This work was published in Metabolic Engineering.71 Chapter 7 summarizes 
the conclusions of this dissertation and discusses possible future directions for research efforts in 
R. opacus.  
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Chapter 2: Development of chemical and metabolite 
sensors for Rhodococcus opacus PD630 
 
An abridged version of this chapter was published as DeLorenzo, D.M., Henson, W.R., Moon, 
T.S. Development of Chemical and Metabolite Sensors for Rhodococcus opacus PD630. ACS 
Synthetic Biology (2017). 6, 1973–1978. Reprinted with permission. 
 
Genetic elements for predictable, tunable, and quantifiable gene expression are a critical 
aspect for successfully engineering a host. In this chapter, multiple fluorescent reporter genes were 
screened to assist in quantifying gene expression in Rhodococcus opacus PD630. Furthermore, 
multiple genetic sensors that detect a variety of chemical and metabolite ligands were characterized 
in this host for tunable gene expression. These tools, such as the developed aromatic and 
ammonium sensors, could be utilized in the future to implement dynamic regulation. Additionally, 
one sensor was demonstrated to function as a delayed onset gene expression system or cellular 
timer. This chapter substantially adds to the R. opacus genetic toolbox and will enable future 
engineering efforts. I performed all experiments and wrote the manuscript. 
2.1 Abstract 
 
Rhodococcus opacus PD630 is a non-model, gram-positive bacterium that possesses 
desirable traits for biomass conversion, including consumption capabilities for lignocellulose-
based sugars and toxic lignin-derived aromatic compounds, significant triacylglycerol 
accumulation, relatively rapid growth rate, and genetic tractability. However, few genetic elements 
have been directly characterized in R. opacus, limiting its application for lignocellulose 
bioconversion. In this letter, we report the characterization and development of genetic tools for 
tunable gene expression in R. opacus, including: 1) six fluorescent reporters for quantifying 
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promoter output, 2) three chemically inducible promoters for variable gene expression, and 3) two 
classes of metabolite sensors derived from native R. opacus promoters that detect nitrogen levels 
or aromatic compounds. Using these tools, we also provide insights into native aromatic 
consumption pathways in R. opacus. Overall, this work expands the ability to control and 
characterize gene expression in R. opacus for future lignocellulose-based fuel and chemical 
production. 
2.2 Introduction 
Lignocellulosic biomass represents an abundant and renewable resource that could displace 
petroleum feedstocks, but it requires the development of more efficient conversion processes for 
commercialization.(1) One approach uses microbe-based biorefineries to produce value-added 
products from plant material. For economic viability, the entire biomass (cellulose, hemicellulose 
and lignin) must be consumed.(1-3) The utilization of lignin (~15-30% of plant matter by dry 
weight) remains a challenge as it is a complex, cross-linked, and highly heterogeneous aromatic 
macromolecule; lignin is mostly burned for low-value process heat or discarded.(1, 3, 4) When lignin 
is catalytically depolymerized, it produces a wide range of toxic aromatics.(5) These compounds 
are not directly useful due to the extensive separation costs required to purify any desirable 
products. To refine this complex product stream, depolymerized lignin can be fed to biological 
catalysts (i.e., microbes) that use enzymatic pathways to “biologically funnel” aromatics into core 
intermediates.(3, 6) These intermediates can then be selectively converted into valuable, high titer 
compounds.(7) Additionally, microbial production of compounds, typically derived from petroleum 
feedstocks, could significantly diminish greenhouse gas emissions.(8-10) 
The Actinomycetales bacterium Rhodococcus opacus PD630 (hereafter R. opacus) has many 
desirable traits for the microbial valorization of lignocellulosic biomass. The depolymerization of 
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lignocellulose, particularly lignin, generates a spectrum of growth inhibiting compounds.(1-3) R. 
opacus has previously demonstrated a high natural tolerance towards such products, including 
biomass pretreatment by-products (e.g., furfural and hydroxymethylfurfural [HMF]), 
polychlorinated biphenyls (PCBs), and aromatic and halogenated compounds.(11-13) This tolerance 
is partially attributed to numerous enzymatic consumption pathways that funnel aromatics into 
central metabolism via its high flux β-ketoadipate pathway.(4, 14) Intermediates in the β -ketoadipate 
pathway can be diverted into high-value products, such as adipic acid.(8-10) R. opacus can also 
concurrently consume glucose (via Entner–Doudoroff pathway), acetate (via glyoxylate shunt), 
and phenolic compounds (via β-ketoadipate pathway), improving productivity.(15, 16) Its high 
osmotic tolerance also allows for a high loading of sugars and high product titers.(17) R. opacus is 
primarily known for its ability to produce significant amounts of the biodiesel precursor 
triacylglycerol (TAG; up to ~78% of its cellular dry weight when grown on gluconate).(13) Both 
alkali lignin and biomass gasification wastewater have successfully been converted into TAG-
based biofuels using R. opacus.(18, 19) These traits make R. opacus an ideal microbial biorefinery 
for the conversion of lignocellulosic material, particularly lignin, into fuels and chemicals. 
Microbial tolerance to and utilization of lignocellulose degradation products can be further 
improved through rational engineering and adaptive evolution.(14, 20) Previous work has 
demonstrated the application of adaptive evolution to improve utilization of lignin monomers, such 
as phenol, in R. opacus.(14) Additionally, R. opacus has been engineered to consume other 
lignocellulose components, including xylose, arabinose, and cellobiose, but the modifications were 
achieved using borrowed and generally uncharacterized genetic elements from related 
Actinomycetales.(16, 21-23) Optimization of gene expression and dynamic regulation have both been 
demonstrated to significantly improve product titers, yields and productivity, but this process 
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requires well-characterized genetic tools to precisely control gene expression.(24-26) Promoters and 
dynamic sensors, often taken for granted in model organisms, are limited in R. opacus, but this 
work expands the available genetic toolbox for future engineering efforts. 
To aid in quantifying gene expression and promoter characterization, we first characterized 
several fluorescent reporters (CFP, RFP, mCherry, GFP+, sfGFP, and EYFP). Next, we 
characterized chemically inducible promoters (pBAD, pAcet, and pTet; induced by unmetabolized 
chemicals in R. opacus) from other bacterial species and optimized the dynamic range of the pTet 
promoter by tuning repressor protein expression. Finally, we developed two classes of metabolite 
sensors that detect either nitrogen levels or aromatic compounds. A subset of these tools was 
applied to provide insights into native, aromatic consumption pathways in R. opacus. Together, 
these genetic tools provide the groundwork for the further development of R. opacus as a new 
chassis for fuel and chemical production from lignocellulose. 
2.3 Results and discussion 
2.3.1 Fluorescent reporters 
 Developing next generation synthetic biology tools in R. opacus, such as promoters and 
systems of gene control, requires easily discernable reporters. Previous work has tested lacZ and 
GFP in R. opacus.(27) However, lacZ requires cell lysis and an enzymatic assay, which does not 
facilitate real time measurement. Additionally, while GFP has been used, it is unknown whether 
this reporter is ideal in R. opacus. To determine which reporters generate the highest fluorescence 
relative to the background fluorescence (empty vector control strain), six reporter proteins with 
three distinct wavelength ranges (CFP, RFP, mCherry, GFP+, sfGFP, and EYFP) were tested 
under the same constitutive promoter and ribosome binding site (RBS; Figure 2.1). mCherry 
demonstrated the highest level of fluorescence relative to the empty vector control (~452-fold), 
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and cells were visibly red (Supplementary Figure A.1). In summary, we have demonstrated the 
outputs of multiple fluorescent reporters that span a wide range of excitation and emission 
wavelengths for quantifying expression (Supplementary Table A.8). 
 
Figure 2.1. Fluorescent reporters in R. opacus. CFP, RFP, mCherry, GFP+, sfGFP, and EYFP 
were all expressed under the same promoter and ribosome binding site (RBS). Fold increase over 
background represents the absorbance normalized fluorescence of the reporter strain (Fluosample 
/ Abs600sample) divided by the absorbance normalized fluorescence of the control strain 
containing the empty vector (Fluocontrol / Abs600control) (see Methods). Values represent the 
average of three replicates grown in minimal media A, and error bars represent one standard 
deviation.  
 
2.3.2 Chemically inducible promoters 
 The ability to precisely regulate the quantity of gene product per cell is critical to synthetic 
control systems and metabolic engineering. Chemically inducible promoters allow an external, 
non-feedstock signal to modulate the level of transcription of the downstream gene. Presently, only 
one chemically inducible promoter has been previously described in R. opacus: the thiostrepton 
inducible TipA promoter.(28) Thiostrepton is an antibiotic that inhibits growth of R. opacus, and 
thus this promoter also requires a thiostrepton resistance marker. To further improve the selection 
of available genetic tools, we characterized three additional chemically inducible promoters in R. 
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opacus: an arabinose inducible promoter from E. coli (pBAD), an acetamide inducible promoter 
from Mycobacterium smegmatis (pAcet), and an anhydrotetracycline (aTc) inducible promoter 
from E. coli (pTet).  
The arabinose degradation operon in E. coli is controlled by the arabinose inducible pBAD 
promoter, which is regulated by the AraC transcription factor and cAMP-cAMP receptor protein 
(cAMP-CRP) complex.(29) pBAD has been extensively studied for several decades due to its 
complex repression and induction mechanisms, and AraC homologs exist across bacterial 
species.(29) To test the application of this promoter in R. opacus, the pBAD promoter was placed 
in front of EYFP on the pAL5000 backbone and induced with arabinose (0 to 250 mM).(30) We 
observed a ~59-fold increase in fluorescence (Figure 2.2A) and found that arabinose had no effect 
on cell growth (measured by final culture absorbance at 600 nm; |logarithmic regression 
coefficient| < 0.01; Supplementary Figure A.2). These results suggest that arabinose does not 
support or inhibit growth at these concentrations, which is consistent with previous reports.(22)  
 The acetamide degradation enzyme, AmiE, in M. smegmatis is controlled by the pAcet 
promoter, the regulators AmiA, AmiC, and AmiD, and the transporter AmiS.(31) pAcet has been 
previously demonstrated as a constitutive promoter in R. opacus.(23) To improve characterization 
of this promoter, the entire acetamide degradation operon was expressed on pAL5000 (amiA, 
amiC, amiD, and amiS), and the amiE gene was replaced with GFP+. When acetamide was added 
to the culture (0 to 1000 nM), we observed a ~5-fold increase in fluorescence (Figure 2.2B), 
compared to a ~100-fold increase in M. smegmatis.(31) Acetamide at these concentrations was 
found to have no effect on final culture absorbance at 600 nm of the empty vector control strain, 
but led to a minor growth reduction in the strain harboring the pAcet construct at higher inducer 
concentrations (Supplementary Figure A.3). This result suggests that acetamide does not directly 
27 
 
affect R. opacus growth, but that the expression of GFP+ and the transcriptional 
regulators/transporter imposes burdens on the cells at higher induction levels. The discrepancy 
between the observed dynamic ranges in R. opacus and M. smegmatis reinforces the need for 
characterization of parts in new hosts.  
 The tetracycline (Tc) inducible pTet promoter is regulated by the tetracycline repressor 
(TetR), which controls the expression of the Tc export protein TetA in E. coli.(32) 
Anhydrotetracycline (aTc) is a derivative of Tc that exhibits reduced antibiotic activities and binds 
to TetR efficiently.(32) Ehrt et al. (2005) and Rock et al. (2017) developed pTet promoters for the 
Actinomycetales M. smegmatis and M. tuberculosis.(33, 34) Both of these promoters were screened 
in R. opacus, but they exhibited non-ideal traits, such as low inducibility and either leakiness or 
over-repression (data not shown). While both Mycobacterium species are members of the 
Actinomycetales order with R. opacus, there are clear differences between the organisms, which 
again reinforces the need to characterize genetic elements within each specific host.  
 To optimize an inducible pTet system for R. opacus, the pTet from Rock et al. (2017) was 
used as a starting point for the creation of a mutagenesis library.(34) Due to a significant growth 
defect and the inability to achieve appreciable induction (~2.5-fold), it was hypothesized that the 
TetR repressor was being too highly expressed. The -10 region of the constitutive TetR promoter 
underwent saturation mutagenesis to reduce transcription. After screening colonies for 
improvements in growth and dynamic range, the best candidate exhibited no growth defect relative 
to the empty vector control and demonstrated a ~67-fold increase in fluorescence when aTc was 
added to the culture (0.05 to 100 ng/mL; Figure 2.2C). The -10 region of the corresponding 
promoter changed from TATAAT to ACCTCT. aTc at these concentrations was found to have no 
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effect on final culture absorbance at 600 nm, suggesting that aTc does not support or inhibit growth 
at these concentrations (|logarithmic regression coefficient| < 0.01; Supplementary Figure A.4). 
 
 
Figure 2.2. Chemically inducible promoters in R. opacus. A) Transfer curve for the arabinose 
inducible pBAD promoter driving EYFP production (~59-fold).(30) B) Transfer curve for the 
acetamide inducible pAcet promoter driving GFP+ production (~5-fold).(31) C) Transfer curve for 
the optimized aTc inducible pTet promoter driving mCherry production (~67-fold).(34) Values 
represent the average of three replicates grown in minimal media A with 1 g/L glucose (pBAD), 
minimal media A with 2 g/L glucose (pAcet), or minimal media B with 2 g/L glucose (pTet), and 
error bars represent one standard deviation. Lines represent the fitted transfer functions (see 
Supplementary Table A.4 for fitted parameters).  
 
2.3.3 Nitrogen metabolite sensor 
 Chemically inducible promoters can precisely tune gene expression, but their use is limited 
in industrial scale fermentations due to prohibitive inducer costs. In contrast, metabolite sensors 
can dynamically regulate gene expression based on concentrations of metabolites. Dynamic 
pathway regulation has previously been demonstrated to improve final product titers, yields, and 
productivity.(25) One of R. opacus’ potential products is triacylglycerol (TAG), a biodiesel 
precursor, and its production is increased when cells are grown in low nitrogen conditions. Lipid 
biosynthesis pathways can also be engineered to synthesize fatty acids of different chain lengths, 
saturation degrees, or chain branching types by introducing heterologous genes.(35) A nitrogen 
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sensor would allow heterologous genes to be expressed only under lipid production conditions, 
thus conserving cellular resources and improving product titers and productivity.  
We tested seven R. opacus promoters with the hope of identifying a nitrogen responsive 
promoter (Supplementary Figure A.5). Although the corresponding seven genes were found to be 
highly transcribed under low nitrogen conditions (from RNA-sequencing),(14) RNA-sequencing 
was not performed under high nitrogen conditions in that study, requiring further tests. To this end, 
the upstream regions of these seven genes were placed in front of GFP+ and screened with either 
0.05 or 2.0 g/L ammonium sulfate (Supplementary Figure A.5). The promoter region of LPD03031 
(pLPD03031), which encodes a putative nitrite extrusion protein, was found to be induced ~18-
fold in fluorescence under low nitrogen stress. To further characterize this promoter, a range of 
initial ammonium sulfate concentrations (0.05 to 0.8 g/L) with 10 g/L glucose were used to 
examine expression over time (Figure 2.3A). The response time of the promoter (time to reach the 
half maximum fluorescence) was linearly correlated (R2 = 0.99; Figure 2.3B) with the initial 
ammonium sulfate concentration. In this way, the nitrogen sensor can be used as a cellular timer 
based on how much nitrogen is initially added to the culture. As the cells consume the available 
nitrogen, the promoter will eventually be induced once nitrogen stress occurs. A saturating amount 
of ammonium sulfate (2.5 g/L) prevented induction within the tested time-frame, demonstrating 
that the promoter is indeed responsive to low nitrogen levels and not to growth phase 
(Supplementary Figure A.6). 
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Figure 2.3. Nitrogen sensor in R. opacus. A) The upstream region of LPD03031 (putative nitrite 
extrusion protein) was cloned in front of GFP+. Cultures were grown with 10 g/L glucose and 
either 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, or 0.8 g/L ammonium sulfate (N). The normalized 
fluorescence (see Methods) was scaled to the maximum value for each respective condition (scale 
0 to 1). Values represent the average of three replicates grown in minimal media B, and error bars 
represent one standard deviation. Continuous lines represent the fitted transfer functions (see 
Supplementary Table A.4 for fitted parameters). B) The response time (time required to reach the 
half-maximal fluorescence; dashed line in 3A) is directly correlated to the initial ammonium 
sulfate concentration (R2 = 0.99; the dotted line represents linear fit).  
 
2.3.4 Aromatic metabolite sensors and insights into aromatic consumption pathways 
 R. opacus is a promising candidate for the valorization of lignocellulose because of its 
ability to consume aromatic monomers. A constituent of lignocellulose is lignin (10-30% by dry 
weight), which when depolymerized produces a large distribution of aromatic compounds.(4, 6) Our 
previous transcriptomic analysis found that genes associated with aromatic transport and 
consumption were upregulated in the presence of phenol when compared to a glucose control.(14) 
To further investigate this upregulation of phenol-related consumption pathways, the upstream 
regions of four of these genes were placed in front of GFP+ (LPD06568 [putative catechol 1,2-
dioxygenase], LPD06575 [putative small subunit of two-component phenol hydroxylase, copy 1], 
LPD06699 [putative shikimate transporter], and LPD06740 [putative small subunit of two 
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component phenol hydroxylase, copy 2]). The fluorescence was measured with the addition of 1 
g/L glucose and either 0, 0.1, 0.3, or 0.75 g/L phenol (Figure 2.4). Fold inductions (0.75 g/L phenol 
vs. 0 g/L phenol) were 80-fold (pLPD06568), 39-fold (pLPD06699), and 247-fold (pLPD06740). 
The fluorescence output of pLPD06575 in the glucose-only condition was “completely off”, 
meaning that it was indistinguishable from the background fluorescence (within one standard 
deviation), and thus a fold change relative to the “off” state could not be calculated.    
 
Figure 2.4. Four phenol sensors characterized using GFP+. The strains were grown with 1 g/L 
glucose and either 0, 0.1, 0.3, or 0.75 g/L phenol. Because increasing concentrations of phenol led 
to lengthening of the cell culture lag phase, early stationary phase fluorescence was measured at 
different time points (see Supplementary Table A.5 and Supplementary Figure A.7). Fold 
inductions (0.75 g/L phenol vs. 0 g/L phenol) were 80-fold (LPD06568), 39-fold (LPD06699), and 
247-fold (LPD06740). The fluorescence value of pLPD06575 at 1 g/L glucose was 
indistinguishable from the background level (*, within one standard deviation) and a fold change 
could not be calculated. Values represent the average of three replicates grown in minimal media 
A, and error bars represent one standard deviation.  
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 The mechanisms of regulation of each of these characterized phenol sensors are not well 
understood. Aromatic metabolic pathways and related genes (Figure 2.5A) in Actinobacteria are 
in general regulated by numerous transcriptional regulators (TRs) that interact directly with the 
aromatic compounds and the DNA.(36, 37) These regulators frequently occur in close genomic 
context to their primary targets (Figure 2.5B). Some of these transcriptional regulators can act as 
activators or repressors, depending on the location of the binding site within the promoter 
region.(36) Additionally, some regulators have been demonstrated to possess multiple substrate 
binding sites and the ability to bind to promoters across various enzymatic pathways to create a 
complex network of interconnected regulation that fosters hierarchical consumption of compounds 
and catabolite repression.(36, 37)  
It was demonstrated in Rhodococcus erythropolis CCM2595 that the promoter of the two-
component phenol hydroxylase operon (pheA2 [small subunit] and pheA1 [large subunit]) is 
activated by the AraC family regulator PheR when it binds to phenol.(37) Both LPD06575 and 
LPD06740 (copy 1 and 2 of putative small subunit of two-component phenol hydroxylases) and 
LPD06574 and LPD06739 (copy 1 and 2 of putative AraC family regulators) show high nucleotide 
and amino acid sequence similarity to pheA2 and pheR, respectively (Figure 2.5B and 
Supplementary Table A.6). The promoters pLPD06575 and pLPD06740 also share high sequence 
conservation with the pheA2 upstream region (Supplementary Table A.6). It was also 
demonstrated that the three gene catABC operon is repressed by the adjacent IcIR family regulator 
CatR in R. erythropolis CCM2595,(37) which all exhibit high nucleotide and amino acid sequence 
similarity to the four gene cluster LPD06566 to LPD06569 (Figure 2.5B and Supplementary Table 
A6). The promoter pLPD06568 also shares high sequence conservation with the catABC operon 
upstream region (Supplementary Table A.6). The regulatory mechanism of LPD06699, encoding 
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a shikimate transporter, is unknown, but an IcIR family regulator (LPD06698) is located adjacent 
to it. 
 We sought to examine how a functionally diverse set of aromatic monomers, typically 
found in depolymerized lignin, would affect each of these promoters (Figure 2.5). Each construct 
was tested in the presence of either of 0.3 g/L phenol (PHE) or an equimolar amount of 
protocatechuic acid (PCA), sodium benzoate (BEN), 4-hydroxybenzoic acid (HBA), vanillic acid 
(VAN), or guaiacol (GUA). All conditions also contained 1 g/L glucose (GLU). Interestingly, the 
tested promoters exhibited differential expression based on the aromatic added, and the response 
generally corresponds to the original annotated gene function. For example, both phenol 
hydroxylase promoters (pLPD06575 and pLPD06740) were substantially induced only in response 
to phenol. Comparatively, the promoter for the shikimate transporter (pLPD06699), which is 
expected to aid in general aromatic transport, was upregulated in the presence of all tested 
compounds. The catechol degradation operon promoter (pLPD06568) was most substantially 
upregulated by compounds known to be metabolized thorough the catechol branch of the β-
ketoadipate pathway (PHE, BEN, and GUA) and minimally affected by compounds (PCA, HBA, 
and VAN) that are degraded via the parallel protocatechuic acid branch.(38-40) This work represents 
the first demonstration of compound-specific, inducible aromatic consumption pathways in R. 
opacus.  
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Figure 2.5. Differential response of native R. opacus promoters to distinct aromatic monomers. 
A) Schematic of lignin model compound conversion to central metabolites via aromatic funneling 
enzymes and the central β-ketoadipate pathway. Arrow colors correspond to those of genes and 
promoters in 5B, and black arrows are for conversion steps whose genes are not shown in 5B. B) 
Native genomic context of aromatic degradation and transporter operons with annotated 
transcriptional regulators (TR). Promoters are represented as small arrows. Genes are represented 
as large arrows and are annotated with LPD gene numbers from the NCBI database (Refseq, 
NZ_CP003949.1). The upstream regions of LPD06568, LPD06575, LPD06699, and LPD06740 
were cloned in front of GFP+. All cultures contained 1 g/L glucose (GLU) in addition to any 
additional aromatic monomers as a carbon source. The fluorescence fold change in the presence 
of 0.3 g/L phenol (PHE) or an equimolar amount of protocatechuic acid (PCA), sodium benzoate 
(BEN), 4-hydroxybenzoic acid (HBA), vanillic acid (VAN), or guaiacol (GUA) was determined 
at early stationary phase (See Supplementary Table A.7 and Supplementary Figure A.7) relative 
to the glucose only condition (GLU). Bar chart colors correspond to functional steps in 5A and 
promoters in 5B. Values represent the average of three replicates grown in minimal media B, and 
error bars represent one standard deviation. 
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2.4 Conclusion 
R. opacus is an ideal candidate for conversion of lignocellulose, particularly lignin, due to 
its natively high tolerance to depolymerization products and ability to consume a broad range of 
functionally diverse aromatic monomers.(11-14) To develop R. opacus as a new chassis for 
lignocellulose conversion, we first expanded the suite of available fluorescence reporters (CFP, 
RFP, mCherry, GFP+, sfGFP, and EYFP). To date, the tool to express genes in R. opacus has been 
limited to constitutive promoters or a thiostrepton inducible promoter.(16, 28) In this work, we 
characterized three chemically inducible promoters (pBAD, pAcet, and pTet) in R. opacus and 
demonstrated expression differences between highly related species, reinforcing the need for re-
characterization of genetic tools. The pTet promoter was engineered to reduce growth defects 
caused by overexpression of the TetR repressor and to maximize dynamic range (2.5-fold to 67-
fold). Additionally, two classes of metabolite sensors were developed. The first is a nitrogen sensor 
that is induced when R. opacus cells undergo nitrogen stress. The second is a set of promoters that 
are induced in the presence of phenol or other aromatic monomers. These aromatic sensors were 
applied to provide insights into native aromatic consumption pathways in R. opacus. The tools 
developed herein set a foundation for more controlled expression of genes for metabolic 
engineering in R. opacus and a step towards enabling this organism to become industrially 
relevant.  
2.5 Methods 
2.5.1 Strains, plasmids and growth conditions 
All plasmids were assembled in E. coli DH10B(41) using either Gibson or Golden Gate 
assembly methods.(42, 43) Kanamycin (20 μg/mL) was added as appropriate. Electrocompetent E. 
coli DH10B and R. opacus cells were transformed as previously described (See Supplementary 
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Materials and Methods A).(41, 44) Plasmid DNA was isolated using Zyppy Plasmid Miniprep Kit 
(Zymo) and PCR products were extracted from electrophoresis gels using Zymoclean Gel DNA 
Recovery Kit (Zymo). The TetR promoter sequence underwent saturation mutagenesis at the -10 
region using degenerate oligonucleotides and blunt end ligation.(45) All genetic part sequences, 
plasmids, and strains are listed in Supplementary Table A.1-3, respectively. Enzymes were 
purchased from New England Biolabs and Thermo Fischer Scientific.  
R. opacus was cultured in one of two defined minimal media, as previously described (see 
Supplementary Materials and Methods A), at 30oC and 250 rpm using 50 mL glass culture tubes.(15) 
Unless noted otherwise, 2 g/L glucose was used as the carbon source and 1 g/L ammonium sulfate 
was used as the nitrogen source. For all cultures, a single colony was transferred from a tryptic soy 
broth (TSB) agar plate into 2.5 mL of minimal media and incubated for ~24 hrs, and then 
subcultured into 10 mL of media to produce a larger quantity of seed culture. For the nitrogen 
sensor, the seed culture was centrifuged at 3000 relative centrifugal force (rcf) and re-suspended 
in nitrogen free media. All inductions and growth experiments were performed in triplicate at the 
10 mL scale, with an initial OD600 of ~0.2. Inducers include arabinose (0.05 to 250 mM), acetamide 
(0.01 to 1000 nM), anhydrotetracycline (aTc; 0.05 to 100 ng/mL), and phenol (0.1, 0.3, and 0.75 
g/L). The nitrogen sensor was induced with filter sterilized (0.22 μM filter) ammonium sulfate 
(0.05 to 0.8 g/L). Fluorescence measurements were performed at ~20 hrs after induction, unless 
noted otherwise. All chemicals were purchased from Sigma-Aldrich. 
2.5.2 Fluorescence measurements 
 Cell fluorescence and absorbance were measured in black 96-well plates (Greiner Bio-One 
flat bottom, chimney well, μclear) using a Tecan Infinite 200 Pro plate reader. The excitation and 
emission wavelengths for fluorescent reporters are listed in Supplementary Table A.8. 
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Fluorescence measurements were normalized using the following equation: 
Fluonorm =
Fluosample
Abs600sample
-
Fluocontrol
Abs600control
, where Fluonorm is the normalized fluorescence, 
Abs600sample is the test strain absorbance at 600 nm, Fluosample is the test strain fluorescence, 
Fluocontrol is the empty vector control strain fluorescence, and Abs600control is the empty vector 
control strain absorbance at 600 nm. For transfer functions, the Hill equation was fitted to the data 
using the Microsoft Excel solver by minimizing the root mean square error (see Supplementary 
Materials and Methods A). 
2.6 Supporting information 
Supplementary Tables A.1-8, Supplementary Figures A.1-8, and Supplementary Materials 
and Methods A can be found in Appendix A. 
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Chapter 3: Construction of genetic logic gates based 
on the T7 RNA polymerase expression system in 
Rhodococcus opacus PD630 
Reprinted with permission from DeLorenzo, D.M. and Moon, T.S. Construction of genetic logic gates 
based on the T7 RNA polymerase expression system in Rhodococcus opacus PD630. ACS Synthetic 
Biology (2019). 8(8), 1921-1930. 
 
 
 The previous chapter detailed the development of a number of tools for tunable gene 
expression in Rhodococcus opacus PD630. The following chapter will discuss the implementation 
of several of these parts, along with newly developed tools for high levels of gene expression (e.g., 
T7 RNAP expression platform, IPTG-inducible pLacRO promoters, selective aromatic sensors), 
into programmable genetic logic gates. Genetic logic allows for more controllable and 
sophisticated genetic constructs that can lead to improvements in cellular functions and enhance 
productivity. I performed all experiments and wrote the manuscript. 
 
3.1 Abstract 
Rhodococcus opacus PD630 (R. opacus) is a non-model, gram-positive bacterium which 
holds promise as a biological catalyst for the conversion of lignocellulosic biomass into value-
added products. In particular, it demonstrates both a high tolerance for and an ability to consume 
inhibitory lignin-derived aromatics, generates large quantities of lipids, exhibits a relatively rapid 
growth rate, and has a growing genetic toolbox for engineering. However, the availability of 
genetic parts for tunable, high-activity gene expression is still limited in R. opacus. Furthermore, 
genetic logic circuits for sophisticated gene regulation have never been demonstrated in 
Rhodococcus spp. To address these shortcomings, two inducible T7 RNA polymerase-based 
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expression systems were implemented for the first time in R. opacus and applied to constructing 
AND and NAND genetic logic gates. Additionally, three IPTG-inducible promoters were created 
by inserting LacI binding sites into newly-characterized constitutive promoters. Furthermore, four 
novel aromatic sensors for 4-hydroxybenzoic acid, vanillic acid, sodium benzoate, and guaiacol 
were developed, expanding the gene expression toolbox. Finally, the T7 RNA polymerase platform 
was combined with a synthetic IPTG-inducible promoter to create an IMPLY logic gate. Overall, 
this work represents the first demonstration of a heterologous RNA polymerase system and 
synthetic genetic logic in R. opacus, enabling complex and tunable gene regulation in this 
promising non-model host for bioproduction. 
3.2 Introduction 
 Living cells naturally use genetic circuits to sense, process, and respond to their 
environment. Bacteria possess thousands of genes, and it would be deleterious if all genes were 
expressed at a constitutive level. In fact, cells implement complex regulatory networks that 
determine when and to what extent each of those genes should be expressed. Initial engineering 
efforts, however, typically begin with high-level, constitutive expression of heterologous genes, 
which can be metabolically taxing to the organism.1 Dynamic pathway regulation, which adds a 
layer of control over gene expression by enabling autonomous feedback in the system, has 
demonstrably improved productivity and cellular fitness.2-4 Furthermore, Boolean logic (e.g., 
AND and NAND) has been implemented in microbial hosts, where the output of a genetic circuit 
is reduced to a binary “true” or “false” based on an array of different inputs, allowing the organism 
to alter gene expression based on a specific set of conditions.5-7 Researchers have also expanded 
these engineered regulatory motifs to construct large synthetic genetic circuits that respond to a 
variety of stimuli and replicate native regulatory networks.8 
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In order to implement these kinds of gene control architecture, genetic parts—particularly 
regulatory elements such as promoters and their cognate transcription factors—must first be 
developed and characterized. Unfortunately, outside of well-studied model organisms (e.g., 
Escherichia coli), genetic toolboxes are often underdeveloped and thus insufficient for 
constructing genetic circuits. Implementing genetic circuits in non-model organisms is further 
complicated by the fact that genetic part performance may differ between organisms and thus 
require additional optimization.9-10 More recently, however, non-model organisms have received 
heightened research attention due to their unusual evolutionary adaptations, diverse metabolic 
pathways, and a variety of novel enzymes and metabolites.11-12 
Rhodococcus opacus PD630 (hereafter R. opacus) is a non-model, gram-positive bacterium 
that holds great promise as a microbial chassis for the conversion of waste lignocellulosic biomass 
into value-added products (e.g., lipids).13-15 Due to its extensive catabolic pathways, notably for 
lignin-derived aromatics, and its tolerance towards inhibitory lignocellulose-derived compounds 
(e.g., furans, phenolics, etc.), R. opacus is ideally suited for the valorization of biomass breakdown 
products.15-19 While its genetic toolbox has steadily grown to comprise an array of parts and 
techniques, including plasmid backbones, selection markers, a methodology for genome 
engineering, CRISPR interference for targeted gene repression, reference genes to quantify gene 
expression, metabolite sensors to detect relevant aromatic feedstocks, and a library of constitutive 
promoters, these parts have yet to be combined into genetic circuits to perform logic.10, 20-21 
Moreover, the ability to highly express and reliably tune gene expression in R. opacus is still 
limited to a handful of promoters.10  
The most readily employed type of promoter for engineering in R. opacus is a constitutive 
promoter, which may reduce productivity due to metabolic burden.20, 22-24 An alternative to this 
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approach is the conversion of a constitutive promoter to an inducible promoter. Native regulatory 
systems can provide inspiration for ways to enact such an alteration. One of the inducible 
promoters, pLac, was derived from the lactose degradation operon in E. coli, which is regulated 
by the LacI repressor.25 In the absence of lactose or a synthetic substitute (e.g., isopropyl β-D-1-
thiogalactopyranoside [IPTG]), LacI binds to a short nucleotide sequence referred to as the lac 
operator site (lacO), preventing RNA polymerase from binding to the promoter.26 When its ligand 
is present, LacI dissociates from the operator, allowing for transcription. Synthetic IPTG-
dependent promoters have previously been constructed for other non-model organisms through the 
insertion of a lacO site into or downstream of a constitutive promoter.27-28 The development of 
tunable promoters is critical for both the optimization of gene expression in R. opacus and the 
construction of genetic logic gates.  
 An additional system that can simultaneously advance both promoter development and 
genetic circuit construction in R. opacus is the T7 RNA polymerase (T7 RNAP) expression 
platform. T7 RNAP was originally isolated from the T7 bacteriophage and was found to recognize 
only its cognate promoter (pT7); furthermore, pT7 is not recognized by native microbial RNA 
polymerases, thus allowing for an orthogonal expression system.29-30 Due to T7 RNAP’s high 
activity, processivity, and selectivity, substantial levels of heterologous gene expression can be 
achieved both in vivo and in vitro compared to traditional expression systems.30-31 The integration 
of an inducible T7 RNAP cassette into the BL21 strain of E. coli [BL21(DE3)] facilitated 
extremely high levels of target protein production (up to 50% of the cellular proteome) and paved 
the way for BL21(DE3) to become a pivotal industrial strain for the production of a range of 
products (e.g., therapeutic proteins).30, 32-33 Furthermore, pT7 can be mutated to change its rate of 
transcription initiation while still retaining specificity to the T7 RNAP, and the T7 RNAP and pT7 
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system can be co-evolved to form novel orthogonal pairs that can drive the expression of multiple 
gene cassettes independently.34-35 Additionally, several forms of genetic logic gates have been 
constructed in E. coli using the T7 RNAP, including AND and IMPLY logic gates.36-37 
The T7 RNAP expression platform has several advantages over a traditional inducible 
promoter (e.g., pBAD, pTet, and pLac) for both the enactment of genetic circuits and the tunable 
expression of genes. Firstly, the reliance on a native RNAP can hinder the implementation of 
predictable, independently-functioning circuits due to multiple factors, including its fluctuating 
total level and the changing demand for endogenous RNAP across the genome.37 Secondly, a 
host’s native RNAP is always expressed at some level, which can lead to leaky basal expression 
from a standard sigma70 promoter.38 In contrast to the native RNAP, the T7 RNAP is typically 
under the control of an inducible promoter, allowing finer tuning over its expression level. This 
system can be further regulated by a secondary mechanism, such as the placement of a lacO site 
downstream of pT7, which can prevent transcription by any basally expressed T7 RNAP.39 
In this work, two different inducible T7 RNAP systems are demonstrated in R. opacus, 
representing the first time that a heterologous RNA polymerase has been implemented for gene 
expression in any Rhodococcus spp. Additionally, these T7 RNAP-based expression platforms 
were used as the basis for AND and NAND genetic logic gates in R. opacus. To further expand 
the number of genetic parts, in particular promoter/regulator pairs that can be used in additional 
genetic circuits, three synthetic IPTG-dependent promoters were developed from newly 
characterized constitutive promoters in R. opacus. These represent the first IPTG-dependent 
promoters demonstrated in Rhodococcus spp. Furthermore, four novel aromatic sensors for 4-
hydroxybenzoic acid, vanillic acid, sodium benzoate, and guaiacol were developed, providing 
potentially useful gene expression systems for future lignin valorization. Finally, the utility of both 
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the T7 RNAP system and one of the new IPTG-dependent promoters was demonstrated by linking 
them together to create an IMPLY genetic circuit. Overall, this work expands the ability to highly 
express heterologous genes in a tunable manner in R. opacus and demonstrates the capacity for 
sophisticated gene regulation in this promising non-model host for bioproduction. 
3.3 Results and discussion 
3.3.1 T7 RNAP expression platform.  
  Similar to the E. coli protein production strain BL21(DE3), the T7 RNAP gene was 
integrated into a previously described R. opacus chromosomal neutral site (ROCI3) under the 
control of an inducible promoter.20 Two different R. opacus strains were created using either a 
previously reported phenol-inducible promoter (pLPD06575; hereafter referred to as pPhenol) or 
an R. opacus-optimized anhydrotetracycline (aTc)-inducible pTet promoter to control T7 RNAP 
expression.10, 20 A hygromycin B antibiotic resistance cassette was co-integrated with the T7 
RNAP expression cassette for selection.20 The consensus T7 promoter (pT7) was placed upstream 
of an enhanced GFP (eGFP) gene on the pAL5000(S) shuttle plasmid.  
 To examine the inducibility of the two integrated T7 RNAP systems, the normalized 
fluorescent output (see Methods for details) was quantified in response to a range of concentrations 
of either phenol or aTc (Figure 3.1). For pPhenol-T7 RNAP, a fold change of 55 was observed in 
the normalized fluorescent output between 0 and 0.5 g/L phenol (Figure 3.1B). For pTet-T7 RNAP, 
a fold change of 5.3 was observed in the normalized fluorescent output between 0 and 1 ng/mL 
aTc (Figure 3.1C). The pPhenol-T7 RNAP strain generated 2.8-fold lower minimum (i.e. tighter 
OFF) and 3.7-fold higher maximum (i.e. higher maximum ON) fluorescent outputs than the pTet-
T7 RNAP strain.  
47 
 
 
Figure 3.1. Inducible T7 RNAP system in R. opacus. A) Schematic of the phenol- or aTc-inducible 
T7 RNA polymerase (T7 RNAP) expression platform. A phenol-inducible promoter (pLPD06575; 
referred to as pPhenol) or an optimized pTet promoter was placed upstream of the T7 RNAP gene 
and integrated into the R. opacus genome at a previously determined neutral site (ROCI3).20 The 
T7 promoter (pT7) was placed upstream of eGFP on the pAL5000(S) plasmid backbone. B) 
Normalized fluorescence of a strain containing pPhenol-T7 RNAP in response to 0, 0.01, 0.025, 
0.05, 0.1, 0.2, 0.3, 0.5, or 0.6 g/L phenol. The increase in fluorescent output from 0 to 0.5 g/L 
phenol was 55-fold. C) Normalized fluorescence of a strain containing pTet-T7 RNAP in response 
to 0, 0.01, 0.025, 0.1, 0.5, 1, 5, or 10 ng/mL aTc. The increase in fluorescent output from 0 to 1 
ng/mL aTc was 5.3-fold. Values are averages of three replicates, and error bars represent one 
standard deviation. The solid black line in each case represents a fitted curve (see Supplementary 
Methods B and Supplementary Table B.4). 
 
3.3.2 AND genetic logic gate 
 The pPhenol- and pTet-T7 RNAP systems were next demonstrated to act as AND logic 
gates. This was accomplished by inserting a lac operator site (lacO) downstream of pT7 and adding 
a constitutive lacI expression cassette to the reporter plasmid. An AND logic gate is a circuit that 
is “true” only when all inputs are present, which helps to reduce leaky output expression as 
multiple conditions must first be met before the circuit turns on. As two inducers (IPTG and either 
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phenol or aTc) are required for complete induction of eGFP (Figure 3.2A), these circuits are 
classified as two-input AND gates (Figure 3.2B).40 Both the pPhenol-T7 RNAP and pTet-T7 RNAP 
systems were highly repressed in response to the uninduced [0 0] input, showing no statistically 
significant difference between their normalized fluorescence and the empty vector control strain’s 
normalized fluorescence (Figures 3.2C and 3.2D). When only one inducer was provided, either 
phenol/aTc [1 0] or IPTG [0 1], some fluorescence was observed; however, it was at least an order 
of magnitude lower than that of the two-input [1 1] condition. The increase in normalized 
fluorescence between either the [1 0] or [0 1] condition and the [1 1] condition for the pPhenol-T7 
RNAP construct was 18- and 27-fold, respectively. The increase in normalized fluorescence 
between either the [1 0] or [0 1] condition and the [1 1] condition for the pTet-T7 RNAP construct 
was 39- and 16-fold, respectively. 
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Figure 3.2. AND logic gate in R. opacus. A) Schematic of the genetic AND gate. B) AND truth 
table. C) Normalized fluorescence of the pPhenol-T7 RNAP circuit in response to different 
combinations of inputs. D) Normalized fluorescence of the pTet-T7 RNAP circuit in response to 
different combinations of inputs. IPTG, phenol, and aTc were provided as appropriate at 
concentrations of 1 mM, 0.5 g/L, and 1 ng/mL, respectively. Due to the [0 0] condition having no 
discernable fluorescence, a fold change between [0 0] and [1 1] cannot be calculated. The increase 
in normalized fluorescence between either the [1 0] or [0 1] conditions and the [1 1] condition for 
the pPhenol-T7 RNAP construct was 18- and 27-fold, respectively. The increase in normalized 
fluorescence between either the [1 0] or [0 1] conditions and the [1 1] condition for the pTet-T7 
RNAP construct was 39- and 16-fold, respectively. Values are averages of three replicates, and 
error bars represent one standard deviation. An asterisk (*) represents that there was no statistical 
difference in normalized fluorescence between the experimental strain and the control strain 
containing an empty control plasmid.  
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3.3.3 NAND genetic logic gate. 
 The pPhenol-T7 RNAP expression system was further applied to build a NAND gate 
(Figure 3.3A), a more complex circuit than the previously demonstrated AND gates. A NAND 
(NOT-AND) logic gate is only “false” when all inputs are present (Figure 3.3B). NAND gates are 
particularly useful as they are functionally complete, meaning that any form of Boolean logic can 
be implemented by layering multiple NAND gates together. A NAND logic gate was constructed 
in the pPhenol-T7 RNAP strain by placing pT7 and a lacO site upstream of tetR and placing the 
TetR-repressible pTet promoter upstream of mCherry on the pAL5000(S) shuttle vector containing 
constitutively expressed lacI. When both phenol and IPTG are provided, the T7 RNAP is 
expressed, the lacO site is not occupied by LacI, and thus TetR is produced, leading to the 
repression of pTet-mCherry. The decrease in normalized fluorescence between the uninduced [0 
0] and the two-input [1 1] conditions was 27-fold (Figure 3.3C). When only one inducer was 
provided, either phenol [1 0] or IPTG [0 1], there was a decrease in the normalized fluorescence 
relative to the [0 0] condition; however, fluorescence was still at least an order of magnitude higher 
than that of the two-input [1 1] condition, with observed decreases of 15- and 20-fold, respectively. 
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Figure 3.3. NAND logic gate in R. opacus. A) Schematic of the genetic NAND gate. B) NAND 
truth table. C) Normalized fluorescence of the NAND genetic circuit in response to different 
combinations of inputs. Phenol and IPTG were provided as appropriate at concentrations of 0.2 
g/L and 1 mM, respectively. aTc was not provided during the main experimental culture (see 
Methods for details). An initial OD600 of 0.1 was used, and cultures were grown in minimal media 
B with 10 g/L glucose as a carbon source. The decrease in normalized fluorescence between 
uninduced [0 0] (the highest ON) and phenol- and IPTG-induced [1 1] (OFF) was 27-fold. The 
decrease in normalized fluorescence between when either phenol [1 0] or IPTG [0 1] was 
individually provided and when both were provided [1 1] was 15- and 20-fold, respectively. The 
response of the NAND logic gate when 0.5 g/L phenol was used is shown in Supplementary Figure 
B.3. Values are averages of three replicates, and error bars represent one standard deviation. 
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3.3.4 Synthetic IPTG inducible promoters. 
 Two-input AND and NAND genetic circuits are just two demonstrations of the many kinds 
of Boolean logic gates that can be constructed in a microbial host. In an extreme example, Nielsen 
et al. constructed numerous multi-tiered genetic circuits consisting of up to ten orthogonal 
regulators to create synthetic signaling networks in E. coli.8 In order to expand the types of genetic 
circuits that can be constructed and to add additional layers of complexity in R. opacus, more 
circuit components (i.e., regulators and promoters) must be developed. To date, two heterologous, 
one-component regulators have been characterized in R. opacus (TetR [repressor] and AraC 
[activator]), in addition to several Rhodococcus regulators that have been identified and 
characterized to varying degrees (e.g., TipA [activator], NlpR [repressor], and NpdR 
[repressor]).10, 41-43  
A common heterologous regulator/promoter system that has not yet been demonstrated in 
Rhodococcus spp. is the IPTG-inducible pLac/LacI system. Constitutive variants of pLac and its 
derivatives (e.g., pTac) have been employed in Rhodococcus spp., but none have been utilized as 
IPTG-dependent promoters.23-24, 44 The previously discussed AND and NAND gates utilize a T7 
promoter that includes a downstream lacO site, as well as a lacI expression cassette. The absence 
or presence of IPTG was sufficient to repress or de-repress, respectively, the expression of the 
fluorescent reporter protein under control of pT7(lacO). The next step was to create novel synthetic 
IPTG-inducible promoters that could be transcribed by the native R. opacus RNAP. To ensure that 
these new promoters would have suitably high levels of gene expression for engineering purposes, 
it was necessary to identify constitutive promoters with strong activity in R. opacus.  
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R. opacus native promoters, as well as highly active promoters from related 
Actinomycetales species, were compared to a baseline promoter (pConstitutive) that was recently 
reported to generate high levels of GFP+ fluorescence in R. opacus (Supplementary Figure B.1).20 
To choose R. opacus native promoters, two criteria were implemented. First, the promoter should 
have high activity based on previously published transcriptomic studies in R. opacus.16-17 Second, 
the promoter should be for ribosomal RNAs (rRNAs) or transfer RNAs (tRNAs). The primary 
reason for the second criterion was that these RNAs, particularly rRNAs, have a substantial 
demand within the cell and are thus transcribed at high levels.45 The secondary reason was that the 
transcription start sites for these promoters are readily identified as the rRNA and tRNA sequences 
are evolutionarily conserved and clearly annotated. The identified endogenous promoters were 
those for rRNA (pRS23365), tryptophan tRNA (pRS28745), threonine tRNA (pRS28770), 
isoleucine tRNA (pRS00085), glutamate tRNA (pRS06620), and serine tRNA (pRS02495). These 
six promoters, in addition to pConstitutive, were placed upstream of RBS-1 and GFP+ 
(Supplementary Figure B.1A). pRS00085 was the only promoter demonstrating a statistically 
higher normalized fluorescence (p < 0.005 based on two-sample t-test) than the normalized 
fluorescence generated by pConstitutive, with an increase of 1.4-fold. 
 Promoters demonstrated to be highly active in other related gram-positive microbes, in 
particular Rhodococcus ruber TH and Corynebacterium glutamicum, were also examined. Three 
strong promoters derived from the R. ruber TH genome (pamiM, pnhM, and pcs) were selected 
and placed upstream of RBS-2 and GFP+ (Supplementary Figure B.1B; Supplementary Table 
B.1).46 Plasmids containing RBS-1 occasionally demonstrated instability in R. opacus, with cells 
exhibiting loss of fluorescence. This led to the use of the slightly weaker RBS-2 (Supplementary 
Figure B.2) as no such instability was observed. The pamiM promoter-containing construct failed 
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to generate any R. opacus transformant. Additionally, two strong synthetic promoters designed for 
C. glutamicum (pCory1 and pCory2), as well as pConstitutive, were placed upstream of RBS-2 
and GFP+ (Supplementary Figure B.1B; Supplementary Table B.1).47 Two promoters 
demonstrated normalized fluorescence that was statistically higher than pConstitutive based on a 
two-sample t-test, namely pnhM (p < 0.0001) and pCory1 (p < 0.005). Of these two, however, 
only pnhM demonstrated a meaningful improvement over pConstitutive, with a 2.4-fold increase 
in normalized fluorescence. To enable the use of the pamiM -10 and -35 sites, which were 
predicted to be strong recruiters of RNA polymerase in R. ruber, these nucleotide sequences were 
placed into a new genetic context. Specifically, by replacing the pcs promoter’s -10 and -35 sites 
with those of the pamiM, a hybrid synthetic promoter was built. The hybrid promoter (referred to 
as pcs/pamiM) had a normalized fluorescence statistically higher than pConstitutive (p < 0.005) 
and also had an 8-fold higher fluorescence level than pcs. 
 Having identified a set of functional constitutive promoters, the next step to creating an 
IPTG-dependent promoter was to insert lacO into the expression cassette of those promoters with 
the strongest expression profiles. To minimize disturbances to surrounding part sequences, the 
initial construct (pLacRO1) utilized an insulated 33-nucleotide (nt) lacO sequence which was 
inserted between pnhM and RBS-2 (Figure 3.4A; Supplementary Table B.1; Supplementary Figure 
B.4A). The normalized fluorescence of pLacRO1, which was measured in response to a range of 
IPTG concentrations, exhibited a 26-fold increase from 0 to 1 mM IPTG. However, the maximum 
normalized fluorescence output of pLacRO1 only reached ~12% of the output of pnhM. To improve 
the maximum output, a minimal 17-nt version of lacO (lacOmin) was overlaid with RBS-2 to create 
pLacRO2 via several nucleotide changes (Supplementary Table B.1; Supplementary Figure B.4B). 
pLacRO2 exhibited a 15-fold increase in normalized fluorescence from 0 to 1 mM IPTG (Figure 
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3.4B). Furthermore, the maximum normalized fluorescence of pLacRO2 was nearly double that of 
pLacRO1, reaching ~21% of the output of pnhM.  
For both pLacRO1 and pLacRO2, the lacO site was placed downstream of the transcription 
start site (TSS), which means that this untranslated region (UTR) is appended to the transcript. In 
some scenarios, such as the expression of small non-coding RNAs (e.g., small guide RNA), a self-
contained IPTG-dependent promoter would be desirable. To enable such leaderless transcription, 
a third IPTG-dependent promoter where lacOmin was placed between the -35 and -10 sites was 
developed. The pcs/pamiM promoter was selected because it has nine identical nucleotides when 
aligned with the 17-nt lacOmin, requiring only 8-nt changes to create pLacRO3 (Supplementary 
Table B.1; Supplementary Figure B.4C). The normalized fluorescence of pLacRO3 was measured 
in response to a range of IPTG concentrations and exhibited a 13-fold increase from 0 to 1 mM 
IPTG (Figure 3.4C). Furthermore, the maximum normalized fluorescence of pLacRO3 reached 
~20% of the maximum output of pcs/pamiM. 
 
Figure 3.4. Synthetic IPTG-inducible promoters in R. opacus. The lac operator (lacO) was inserted 
into different regions of two constitutive promoters (pnhM and pcs/pamiM) to create three IPTG-
inducible promoters. The plots report the normalized fluorescence in response to 0, 0.001, 0.005, 
0.01, 0.05, 0.1, 0.5, 1, and 10 mM IPTG for each respective promoter. A) A 33 nucleotide (nt) 
lacO site was inserted downstream of the pnhM promoter and upstream of RBS-2 and GFP+ to 
create pLacRO1. An increase in normalized fluorescence of 26-fold was observed between 0 and 10 
mM IPTG. B) A minimal 17 nt version of lacO (LacOmin) was overlaid with the RBS-2 
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(downstream of pnhM) to create pLacRO2. An increase in normalized fluorescence of 15-fold was 
observed between 0 and 10 mM IPTG. C) LacOmin was inserted between the -10 and -35 sites of 
the pcs/pamiM hybrid constitutive promoter to create pLacRO3. An increase in normalized 
fluorescence of 13-fold was observed between 0 and 10 mM IPTG. Values are averages of three 
replicates, and error bars represent one standard deviation. The solid black line in each case 
represents a fitted curve (see Supplementary Methods B and Supplementary Table B.4). Promoter 
sequences are provided in Supplementary Table B.1 and Supplementary Figure B.4. 
 
3.3.5 IMPLY genetic logic gate. 
 Combining the T7 RNAP expression system with one of the newly developed IPTG-
dependent promoters allowed for the construction of an IMPLY genetic logic gate (Figure 3.5A). 
An IMPLY gate generates a “false” output only when the [1 0] input is given (Figure 3.5B). An 
IMPLY gate was constructed in the pPhenol-T7 RNAP strain by placing pT7 upstream of lacI and 
placing pLacRO1 upstream of GFP+ (Figure 3.5A). The [1 0] input (phenol only) showed 6-fold, 
10-fold, and 7-fold decreases in normalized fluorescence compared to the [0 0] (no inducer), [0 1] 
(IPTG only), and [1 1] (phenol and IPTG) conditions, respectively (Figure 3.5C). Together with 
the successful construction of AND and NAND gates in R. opacus, this result demonstrates that 
large layered genetic circuits can be built in this non-model organism by assembling engineered 
genetic parts, all of which were encoded in 12 (e.g., IMPLY) or 13 kilobases (e.g., NAND, the 
largest logic gate built so far in any Rhodococcus spp.).  
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Figure 3.5. IMPLY logic gate in R. opacus. A) Schematic of the genetic IMPLY gate. B) IMPLY 
truth table. C) Normalized fluorescence in response to the appropriate combinations of 0.4 g/L 
phenol and 1 mM IPTG. The decrease in normalized fluorescence between the uninduced [0 0] 
(the lowest ON) and phenol-induced [1 0] (OFF) conditions was 6-fold. The normalized 
fluorescent response of this circuit was additionally screened with a range of phenol concentrations 
(Supplementary Figure B.5). Values are averages of three replicates, and error bars represent one 
standard deviation. 
 
3.3.6 Aromatic sensors 
 A phenol responsive sensor was utilized in the previously described experiments to control 
T7 RNAP expression, but lignin breakdown products contain a diversity of aromatic compounds 
and additional orthogonal aromatic sensors may be beneficial for future lignin valorization. Our 
previously published transcriptomic data identified catabolic funneling pathways that were 
selectively upregulated in response to one of four aromatic compounds: 4-hydroxybenzoic acid 
(HBA), vanillic acid (VAN), sodium benzoate (BEN), and guaiacol (GUA).17 The region 
containing the promoter and RBS of each of these identified degradation pathways was placed 
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upstream of GFP+ to develop four novel aromatic sensors, referred to as pLPD06764 (pHBA), 
pLPD00563 (pVAN), pLPD06580 (pBEN), and pLPD06578 (pGUA). The fluorescent output of 
each of these constructs was measured in response to a range of relevant aromatic compound 
concentrations (Figures 3.6A-D). Concentrations were chosen such that they would not cause 
substantial reductions in growth, based on previous toxicity data collected when these compounds 
were used as sole carbon sources, and thus sensor output saturation was not reached for all 
sensors.17 pHBA demonstrated a fold change of 6 in normalized fluorescence from 0 to 1 g/L HBA 
(Figure 3.6A). The fluorescence value of pVAN at 1 g/L glucose was indistinguishable from the 
background level, and a fold change could not be calculated (Figure 3.6B). pBEN demonstrated a 
fold change of 35 in normalized fluorescence from 0 to 5 g/L BEN (Figure 3.6C). pGUA 
demonstrated a fold change of 137 in normalized fluorescence from 0 to 1.5 g/L GUA (Figure 
3.6D). To investigate the selectivity of each of these sensors, each strain was grown on glucose or 
glucose plus protocatechuic acid, phenol, 4-hydroxybenzoic acid, vanillic acid, sodium benzoate, 
or guaiacol (Figures 3.6E-H). Each of these constructs was confirmed to be selectively upregulated 
in the presence of its cognate compound, with different degrees of response to noncognate 
compounds. In addition to the IPTG-inducible promoters developed in this work, these novel 
aromatic sensors expand the gene expression toolbox by providing inducible sensors with different 
output ranges (Figures 3.6A-D and Supplementary Figure B.6). 
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Figure 3.6. Novel aromatic sensors in R. opacus. pLPD06764 (pHBA), pLPD00563 (pVAN), 
pLPD06580 (pBEN), and pLPD06578 (pGUA) were placed upstream of GFP+. A) Normalized 
fluorescence of the strain containing pHBA-GFP+ in response to 0, 0.001, 0.01, 0.025, 0.05, 0.1, 
0.25, 0.5, and 1 g/L 4-hydroxybenzoic acid (HBA). An increase in normalized fluorescence of 6-
fold was observed between 0 and 1 g/L HBA. B) Normalized fluorescence of the strain containing 
pVAN-GFP+ in response to 0, 0.001, 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1, and 1.5 g/L vanillic acid 
(VAN). The fluorescence value of pVAN at 1 g/L glucose was indistinguishable from the 
background level (i.e. within one standard deviation) and a fold change could not be calculated. 
C) Normalized fluorescence of the strain containing pBEN-GFP+ in response to 0, 0.001, 0.01, 
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0.05, 0.1, 0.25, 0.5, 1, 2.5, and 5 g/L sodium benzoate (BEN). An increase in normalized 
fluorescence of 35-fold was observed between 0 and 5 g/L BEN. D) Normalized fluorescence of 
the strain containing pGUA-GFP+ in response to 0, 0.001, 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1, and 
1.5 g/L guaiacol (GUA). An increase in normalized fluorescence of 137-fold was observed from 
0 to 1.5 g/L GUA. The solid black line in each case (A-D) represents a fitted curve (see 
Supplementary Methods B and Supplementary Table B.4). Cultures in A-D were grown in 1 g/L 
glucose. E-H) Selective response of aromatic sensors. The fluorescent response of each construct 
(E: pHBA; F: pVAN; G: pBEN; and H: pGUA) was tested in the presence of 1 g/L glucose (GLU); 
or the combination of 1 g/L GLU and either 0.3 g/L phenol (PHE) or equimolar amount of 
protocatechuic acid (PCA), HBA, VAN, BEN, or GUA. Values are averages of three replicates, 
and error bars represent one standard deviation. An asterisk (*) represents that there was no 
statistical difference in normalized fluorescence between the experimental strain and the control 
strain containing an empty control plasmid. 
 
3.4 Conclusion  
 The availability of well-characterized genetic parts in non-model microbes, such as R. 
opacus, is a common hindrance to the successful engineering of these organisms. In this work, 
multiple genetic logic circuits (AND, NAND, and IMPLY) were constructed in R. opacus using 
newly developed and previously reported parts. To enable predictable and high-activity gene 
transcription, a T7 RNAP-based expression system, under the control of either a phenol- or an 
aTc-inducible promoter, was integrated into the chromosome. This is the first demonstration of 
the T7 RNAP system in Rhodococcus spp. and is an important step toward developing R. opacus 
as a robust industrial strain. Furthermore, the ability to use the T7 RNAP platform for gene 
expression facilitates potential future developments, including the implementation of a high-
throughput, cell-free platform for prototyping pathways prior to their insertion into R. opacus, such 
as that developed for Pseudomonas putida.31, 48-49 Additionally, three synthetic IPTG-dependent 
promoters, including a version capable of leaderless transcription, were developed. These are the 
first IPTG-dependent promoters described in Rhodococcus spp. and present a significant addition 
to the promoter toolbox. Finally, four novel aromatic sensors for 4-hydroxybenzoic acid, vanillic 
acid, sodium benzoate, and guaiacol were developed for use in future genetic circuits and for future 
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lignin valorization. As the number of genetic parts for R. opacus increases, building complex 
genetic circuits in this host becomes easier, enabling sophisticated gene regulation for complicated 
cellular functions required for future applications. 
3.5 Materials and methods 
3.5.1 Strains, plasmids and growth conditions 
All plasmids were assembled in E. coli DH10B using the Gibson assembly method.50 
Kanamycin (20 μg/mL), chloramphenicol (34 μg/mL), or hygromycin B (200 μg/mL) was added 
as appropriate to E. coli cultures. Kanamycin (50 μg/mL), chloramphenicol (15 μg/mL), and/or 
hygromycin B (50 μg/mL) were added as appropriate to R. opacus cultures. Electrocompetent E. 
coli DH10B and R. opacus cells were transformed as previously described.51-52 Plasmid DNA was 
isolated using ZyppyTM Plasmid Miniprep Kit (Zymo), and PCR products were extracted from 
electrophoresis gels using ZymocleanTM Gel DNA Recovery Kit (Zymo). DNA sequencing was 
performed by Genewiz. Chromosomal integrations in R. opacus were performed as previously 
described using a helper plasmid expressing two recombinases to facilitate homologous 
recombination.20 All genetic part sequences, plasmids, and strains used in this study are listed in 
Supplementary Tables B.1, B.2, and B.3, respectively. pTara:500 and pET28:GFP were gifts from 
Prof. Matthew Bennett (Addgene plasmids #60717 and #60733). Enzymes were purchased from 
New England Biolabs. Chemicals were purchased from Sigma-Aldrich. 
R. opacus was cultured in tryptic soy broth (TSB) or minimal media B as previously 
described at 30 oC and 250 rpm using 50 mL glass culture tubes.10, 53 Unless otherwise noted, 
minimal media B was supplemented with 4 g/L glucose as the carbon source and 1 g/L ammonium 
sulfate as the nitrogen source. For all cultures, a single colony was re-streaked from a TSB agar 
plate onto a new TSB agar plate containing appropriate antibiotics and incubated for 48 hours at 
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30 oC. A loopful of cells was used to start a 3 mL seed culture in minimal media B, except for 
strain DMD377 [NAND circuit] which was grown in TSB with 10 ng/mL aTc, and incubated until 
cells reached early stationary phase. Main experimental cultures were performed in triplicate at a 
5 mL scale, with cultures diluted to an initial optical density at 600 nm (OD600) of ~0.2, unless 
otherwise noted. The DMD377 seed culture (NAND circuit) was washed with minimal media prior 
to use in the main experimental culture to remove residual aTc. Inducers (phenol, 
anhydrotetracycline [aTc], isopropyl β-D-1-thiogalactopyranoside [IPTG], protocatechuic acid 
[PCA], 4-hydroxybenzoic acid [HBA], sodium benzoate [BEN], or guaiacol [GUA]) were added 
at the beginning of the main experimental cultures.  
3.5.2 Growth and fluorescence measurements 
The optical density (OD600) of cultures was measured in VWR semi-micro polystyrene 
cuvettes using a Tecan Infinite M200Pro plate reader. Cell fluorescence and absorbance at 600 nm 
were measured at late exponential phase in black-walled 96-well plates (Greiner Bio-One flat 
bottom, chimney well, μclear) using a Tecan Infinite M200Pro plate reader. The excitation and 
emission wavelengths for GFP+, eGFP, and mCherry were 502/536 nm, 490/525 nm, and 570/630 
nm, respectively. Fluorescence measurements were normalized using Equation 1, where Fluonorm 
is the normalized fluorescence, Abs600sample is the test strain absorbance at 600 nm, Fluosample is 
the test strain fluorescence, Fluocontrol is the empty vector control strain fluorescence, and 
Abs600control is the empty vector control strain absorbance at 600 nm.
10 
Eq. 1)                       Fluonorm =
Fluosample
Abs600sample
-
Fluocontrol
Abs600control
 
3.6 Supplementary materials 
 Supplementary Tables B.1-4, Supplementary Figures B.1-6, Supplementary Methods B. 
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Chapter 4: Molecular toolkit for gene expression 
control and genome modification in Rhodococcus 
opacus PD630 
 
Reprinted with permission from DeLorenzo, D.M., Rottinghaus, A.G., Henson, W.R., Moon, T.S. 
Molecular toolkit for gene expression control and genome modification in Rhodococcus opacus 
PD630. ACS Synthetic Biology (2018). 7, 727−738. 
 
The previous two chapters have detailed the development of genetic parts for tunable gene 
expression. More genetic elements, however, are required for heterologous gene expression than 
just promoters. The following chapter will discuss the characterization of tools that facilitate the 
introduction of heterologous DNA into R. opacus, including plasmid backbones, antibiotic 
resistance markers, and neutral integration sites in the genome. Furthermore, a methodology for 
genome recombineering was developed for R. opacus to enable stable gene integrations or gene 
knockouts. Finally, while the preceding chapters have dealt with gene expression, this chapter will 
discuss a newly developed tool for targeted gene repression (CRISPRi). I performed or directed 
all experiments and wrote the manuscript.  
4.1 Abstract 
 Rhodococcus opacus PD630 is a non-model, gram-positive bacterium that possesses 
desirable traits for lignocellulosic biomass conversion. In particular, it has a relatively rapid growth 
rate, exhibits genetic tractability, produces high quantities of lipids, and can tolerate and consume 
toxic, lignin-derived aromatic compounds. Despite these unique, industrially relevant 
characteristics, R. opacus has been underutilized due to a lack of reliable genetic parts and 
engineering tools. In this work, we developed a molecular toolbox for reliable gene expression 
control and genome modification in R. opacus. To facilitate predictable gene expression, a 
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constitutive promoter library spanning ~45-fold in output was constructed. To improve the 
characterization of available plasmids, the copy numbers of four heterologous and nine 
endogenous plasmids were determined using quantitative PCR. The molecular toolbox was further 
expanded by screening a previously unreported antibiotic resistance marker (HygR) and 
constructing a curable plasmid backbone for temporary gene expression (pB264). Furthermore, a 
system for genome modification was devised, and three neutral integration sites were identified 
using a novel combination of transcriptomic data, genomic architecture, and growth rate analysis. 
Finally, the first reported system for targeted, tunable gene repression in Rhodococcus was 
developed by utilizing CRISPR interference (CRISPRi). Overall, this work greatly expands the 
ability to manipulate and engineer R. opacus, making it a viable new chassis for bioproduction 
from renewable feedstocks.  
4.2 Introduction 
 Non-model organisms are gaining traction as new chassis for addressing questions that 
traditional model organisms are not well suited to answer.1, 2 Recent advances in “omics” analysis 
(whole genome sequencing, transcriptomics, etc.) and developments in molecular biology 
techniques have made previously inaccessible organisms with unique properties available to 
investigate and engineer.1, 3 Non-model organisms possess a vast array of novel enzymes, 
adaptation abilities, and metabolic networks that can help address challenges in bioproduction 
from renewable feedstocks.1, 2, 4 A field of study that may benefit from the use of new microbial 
chassis is the bioconversion of lignocellulosic biomass into higher value bioproducts. The 
pretreatment and depolymerization of lignocellulose, particularly lignin, generates an array of 
toxic, aromatic compounds that traditional model organisms are not able to effectively tolerate or 
consume.5-7  
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Rhodococcus opacus PD630 (hereafter R. opacus) is a gram-positive, oleaginous 
Actinobacterium that possesses a native and adaptable tolerance towards biomass breakdown 
products (e.g. furans, organic acids, halogenated compounds, and phenolics), and diverse 
enzymatic pathways for aromatic compound consumption.8-14 Furthermore, R. opacus can dedicate 
a large portion of its cellular resources to lipid production (up to ~78% triacylglycerol [TAG] of 
cell dry weight), has high flux -ketoadipate and Entner Doudoroff pathways, and can consume 
multiple carbon sources simultaneously.10, 15 This unique metabolic topology can be utilized in 
conjunction with catalytic depolymerization of lignocellulose for the production of lipid-based 
fuels and chemicals, or the production of petrochemical replacements (e.g. muconic acid).16-21 
R. opacus has been previously engineered to consume different fractions of biomass (e.g. 
xylose, arabinose, and cellobiose) or to produce simple bio-based products (e.g. TAG and wax 
esters), but the modifications were achieved using borrowed and generally uncharacterized genetic 
parts from related Actinobacteria.22-26 Recent work has sought to develop and characterize a 
number of inducible promoters in R. opacus for static and dynamic control of gene expression, 
including those responsive to aromatics, ammonium, acetamide, anhydrotetracycline (aTc), and 
arabinose.13, 27 A summary of genetic parts available for R. opacus, including plasmid backbones, 
promoters, antibiotic resistance markers, and reporters can be found in Table 4.1.  
To further expand the available genetic toolbox in R. opacus, this work seeks to develop 
and characterize parts and methodologies related to gene expression control and genome 
modification. A constitutive promoter library spanning a ~45-fold range in strength was developed 
to facilitate predicable expression of heterologous genes. As described in Table 4.1, several 
heterologous plasmids are known to be stably maintained in R. opacus, but the number of copies 
maintained per cell was unknown. The numbers of plasmid copies for two common backbones 
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(pNG2 and pAL5000), the newly characterized pB264, and the nine endogenous plasmids 
maintained in R. opacus, were measured using quantitative PCR (qPCR). Two antibiotic resistance 
markers (chloramphenicol and hygromycin B) were either optimized for R. opacus or screened in 
this host to broaden the number of selection markers. To further expand the ability to express 
heterologous genes or to modify the genome, a recombination-based system for genomic 
modification was developed by repurposing two bacteriophage recombinases (Che9c60 and 
Che9c61). By using both a previously published genome assembly and transcriptomic data, in 
addition to experimental measurements, three neutral sites where expression cassettes can be 
integrated without growth defect were identified. Finally, a system for tunable, targeted gene 
repression was developed for the first time in Rhodococcus by utilizing CRISPR interference 
(CRISPRi). Together, these new genetic tools provide the groundwork for the further development 
of R. opacus as an improved chassis for renewable bioproduction. 
Table 4.1. Published genetic elements previously used in R. opacus. Common naming conventions 
of plasmid backbones containing the same or similar origins of replication are given due to various 
nomenclature changes over decades of publication. The two pAL5000 variants (S and L) are 
derived from the same Mycobacterium fortuitum plasmid and are not compatible.85 The ancestrally 
related pNG2 and pGA1 rolling circle origins of replication are derived from cryptic 
Corynebacterium diphtheriae and Corynebacterium glutamicum plasmids, respectively, and share 
~50% replication protein identity.48, 86-88 The pAL5000 and pNG2 origins of replication are 
compatible and maintained concurrently (data not shown).  
Genetic Part Note 
Plasmid 
Backbones 
pXYLA/pNV18 (short variant of pAL5000; S)85, 89-93; pJAM2/pJEM (long 
variant of pAL5000; L)29, 85, 92; pNG2/pAL358/pEP222, 86; pGA125, 29, 87, 94  
Promoters pAcet13 (acetamide-inducible); pTipA95 (thiostrepton-inducible); pLac29 
(constitutive); pTac89 (constitutive); pBAD13 (arabinose-inducible); 
pTet13 (aTc-inducible); a suite of aromatic inducible promoters13 
Selection 
markers  
kanamycin (50 g/mL)64, 96; gentamicin (10 g/mL)22; spectinomycin 
(100 g/mL)22; thiostrepton64; chloramphenicol (34 g/mL)26 
Reporters eGFP97; lacZ97; RFP13; sfGFP13; GFP+13; mCherry13; CFP13; EYFP13 
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4.3 Results and discussion 
4.3.1 Constitutive promoter library 
 Characterized and predictable genetic parts are required when engineering and balancing 
cellular pathways.28 One common component needed for synthetic biology is the promoter, which 
drives gene transcription. Previous work in R. opacus has used borrowed and uncharacterized 
constitutive promoters from related Actinomycetales, such as Mycobacterium spp. and 
Streptomyces spp., or gram-negative bacteria, such as E. coli, for heterologous gene expression.22, 
25, 29 Recently, several inducible promoters (e.g. pBAD, pTet, pAcet, etc.) were characterized in R. 
opacus (Table 4.1), but these require the use of a chemical inducer to modulate gene expression, 
which can be expensive at an industrial scale and lead to heterogeneous expression levels.13, 28 An 
alternative is to have a well characterized and predictable constitutive promoter library that spans 
a range of expression levels. The benefit of a well-defined promoter library was recently 
demonstrated when a metabolic pathway was rapidly optimized by combinatorial assembly of each 
enzyme with a number of constitutive promoters of varying strengths.30  
 To engineer such a library, a strong synthetic promoter from Streptomyces lividans TK24 
(pConstitutive)31 was cloned in front of the gene encoding GFP+ (a modified green fluorescent 
protein with improved folding efficiency and fluorescence yield13, 32, 33), and saturation 
mutagenesis was performed on the -35 and -10 sites, either individually or concurrently. A subset 
of 25 new promoters was selected that spans a fluorescent output range of ~45-fold from the 
weakest to strongest promoter (Figure 4.1). All promoter sequences are listed in Supplementary 
Table B.1. Interestingly, none of the tested promoters exhibited significantly higher fluorescent 
output than the original promoter (pConstitutive). To develop constitutive promoters with very 
high levels of expression in Streptomyces strains, researchers have screened endogenous promoters 
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mined from the genome, or randomized sequences surrounding the -35 and -10 sites to better suit 
the organism’s sigma factor.34-36 Future work in R. opacus could pursue a similar path to develop 
even stronger promoters than those reported here and further expand the ability to reliably express 
heterologous genes or non-coding elements. 
 
Figure 4.1. Constitutive promoter library in R. opacus. The -10 and -35 regions of a strong 
constitutive promoter (Original or pConstitutive) transcribing GFP+ underwent saturation 
mutagenesis to create a library of constitutive promoters (see 4.5 Materials and Methods).31, 32 
Normalized fluorescence (see 4.5 Materials and Methods) spans ~45-fold from the weakest to 
strongest promoter. All promoter sequences are listed in Supplementary Table B.1. Values 
represent the average of three replicates grown in minimal media A, and error bars represent one 
standard deviation. 
 
4.3.2 Heterologous and endogenous plasmid copy numbers 
 The overexpression of genes is typically performed using self-replicating plasmids that can 
be maintained at multiple copies per cell. The number of copies of a plasmid per cell, typically 
measured as copies per chromosome, is determined predominately by the origin of replication.37 
73 
 
In addition to the heterologous origins described in Table 4.1, R. opacus also possesses nine 
endogenous plasmids that range from 37 to 172 kilo base pairs (kbp) in size.38 The role of these 
large plasmids is generally unknown, as 54.5% of all their annotated genes (733) are listed as 
hypothetical proteins (NCBI reference sequence NZ_CP003949.1). However, there are annotated 
pathways for hetero- and polycyclic aromatics (e.g. biphenyl and chlorophenol) in addition to 
many mono- and dioxygenases. Other Rhodococcus spp. host a number of catabolic pathways on 
their plasmids for compounds such as alkanes, aromatics, herbicides, and halogenated 
compounds.39, 40 Interestingly, seven of the native plasmids are linear (endogenous plasmid 3-9).38, 
41 Although plasmids are commonly believed to be exclusively circular, linear plasmids have also 
been observed in related Actinomycetales, including Streptomyces spp. and Mycobacterium spp.39, 
42 The frequent observation of linear plasmids and occurrence of illegitimate recombination in 
Actinobacteria has been hypothesized to be related to a hyper-recombinational gene storage 
strategy.39, 41, 43, 44 In other words, Actinobacteria such as Rhodococcus spp. store a large number 
of catabolic genes for compounds, which they may encounter in their native soil environment, as 
future recombination sources upon adaptation. 
For the purpose of engineering, all plasmids, both heterologous and endogenous, can be 
used for gene overexpression, making it critical to quantify the number of plasmid copies relative 
to the chromosome number. qPCR was used to quantify the absolute number of chromosomal 
DNA and plasmid DNA copies (Figure 4.2).45 R. opacus is believed to have a single copy 
chromosome. The endogenous plasmids had 1 to 2 plasmid copies per chromosome, except 
plasmid 8 which had ~5 copies per chromosome. This observation is consistent with the hypothesis 
that these plasmids are being maintained as gene storage for future recombination with the 
chromosome, as a low copy number would reduce replication costs while increasing genetic 
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potential. The two variants of pAL5000, originally isolated from Mycobacterium sp., had 
significantly different numbers: ~11 and ~3 copies per chromosome for the short (S) and long 
versions (L), respectively.22, 32 This result is generally consistent with the low copy number 
observed in Mycobacterium smegmatus, where pAL5000 variants have ~5 copies per cell.46 pNG2, 
originally isolated from Corynebacterium diphtheriae, demonstrated ~10 copies per chromosome, 
which is consistent with findings of low to medium copy numbers in Corynebacterium 
glutamicum.47, 48 pB264, derived from a plasmid originally isolated from Rhodococcus sp. B264, 
was found to have ~8 copies per chromosome in R. opacus.49 The origin of replication on pB264 
shares homology with the pAL5000 family of origins, although from a divergent evolutionary 
lineage.49 This is the first reported use of a minimal B264 replicon in R. opacus, expanding 
available origins of replication for R. opacus (see the Genome recombineering section for the 
utility of B264). While all the characterized plasmids herein demonstrate low copy numbers in R. 
opacus (1 - 11 copies per cell), a pAL5000 vector demonstrating high copy numbers in 
Mycobacteria (32 - 64 copies per cell) was created using a method that involved enrichment of 
high copy number plasmids by repeated isolation and transformation of mutated plasmids.46 Future 
work in R. opacus could pursue a similar method to obtain higher copy number plasmids. In 
summary, the copy number of 13 uncharacterized plasmids in R. opacus was quantified for 
predictable heterologous gene expression, and a subset of these results may support a hypothesis 
regarding the role of large endogenous plasmids in Rhodococcus spp.  
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Figure 4.2. Copy number ratios of heterologous and endogenous plasmids in R. opacus. The 
numbers of copies of the four heterologous and nine endogenous plasmids relative to the single 
copy chromosome were determined by qPCR as described previously.45 Values represent the 
average of three replicates grown in minimal media A, and error bars represent the propagated 
standard deviation (see B.3 Supplementary Methods). All qPCR primers and PCR amplification 
efficiencies are reported in Supplementary Table B.4.  
 
4.3.3 Antibiotic resistance markers 
Several antibiotic resistance cassettes have been previously described in R. opacus (Table 
4.1). However, it is beneficial to have additional options for selection as the number of plasmid 
backbones and potential genomic integration sites expands. In this work, an optimized 
chloramphenicol resistance cassette was constructed, in addition to characterizing a previously 
unreported hygromycin B resistance marker in R. opacus. The first attempt to characterize 
chloramphenicol resistance in R. opacus failed to bestow antibiotic tolerance. As the marker was 
taken from an E. coli vector, there could have been differences in the gene GC content, codon 
usage, or promoter/RBS activity between the two organisms. To address GC content and codon 
usage variations, the chloramphenicol resistance gene was codon optimized for R. opacus that has 
a high GC content (Integrated DNA Technologies). To improve expression, a strong constitutive 
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promoter (pConstitutive; Figure 4.1) and a synthetic RBS was placed upstream of the optimized 
marker, while a synthetic terminator was placed downstream. The new cassette was placed on 
pNG2 and successfully restored growth (to wild type levels measured without antibiotics) at up to 
30 μg/mL chloramphenicol (Figure 4.3A). In 2017, Lanfranconi and Alvarez reported the use of 
an alternate chloramphenicol resistance marker in R. opacus.26 The second antibiotic marker tested 
in R. opacus was a hygromycin B resistance gene, which had not been previously reported in this 
organism. The hygromycin B resistance cassette on pAL5000 (L) restored growth (to wild type 
levels measured without antibiotics) at up to 100 μg/mL hygromycin B (Figure 4.3B). Part 
sequences are listed in Supplementary Table B.4. 
 
Figure 4.3. Antibiotic resistance cassettes for R. opacus. Dashed line represents the starting optical 
density (OD600, initial = 0.2). A) A chloramphenicol resistance marker (CmR) was codon optimized 
(Integrated DNA Technologies) for R. opacus. A strong promoter from the constitutive promoter 
library and a synthetic RBS was placed upstream, while a synthetic terminator was inserted 
downstream of the gene (see Supplementary Table B.2 for the cassette sequence). The optimized 
CmR cassette was placed on pNG2 and screened with 0 to 300 μg/mL chloramphenicol. The 
tolerance of wild type (WT) is also shown. B) A mycobacterial hygromycin B resistance (HygR) 
cassette on pAL5000 (L) was screened with 0 to 800 μg/mL hygromycin B.32 Values represent the 
average of three replicates grown in minimal media A, and error bars represent one standard 
deviation. 
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4.3.4 Genome recombineering 
Plasmids are not the only option for the expression of heterologous genes. The genome is 
also a candidate for gene integration, having the added benefit of enhanced genetic stability and 
no requirement for long term selection (e.g. addition of antibiotics). Additionally, the ability to 
modify the genome of an organism (e.g. gene deletion or replacement) in a site-specific manner is 
central to gene function analysis and strain engineering. Typically, double homologous 
recombination can be used in conjunction with a selection marker for site directed insertion or 
deletion of DNA (Figure 4.4).50 The DNA to be introduced (referred to as the integration cassette) 
is designed to have flanking DNA homologous to the target site (homologous arm in Figure 
4.4B).44, 51 Many organisms, such as cyanobacteria, can readily facilitate recombination at the 
correct location with both circular and linear integration cassettes when a selection marker is 
utilized.52-54 However, several Actinobacteria, including Mycobacterium tuberculosis and 
Rhodococcus fascians, demonstrate recombination of the integration cassette in the incorrect 
location (illegitimate integration).43, 44 Our initial recombination experiments in R. opacus also 
showed that the cassettes recombined with the genome in the incorrect location (Supplementary 
Figure 4.6). Another method for site-specific recombination demonstrated in E. coli and 
Streptomyces spp. requires the use of a bacteriophage recombinase that recognizes an attB site in 
the genome and an attP site in the exogenous plasmid DNA and facilitates integration into the 
genome.55-57 However, no such system has been demonstrated in Rhodococcus spp., and this 
system does not allow flexibility in the location of DNA integration.  
 To better facilitate recombination at the desired site, several techniques were applied to R. 
opacus for the first time. Previous work in M. tuberculosis found that a linearized integration 
cassette, in which the E. coli origin of replication (used for plasmid assembly) was removed, helped 
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to minimize illegitimate recombination (Supplementary Figure B.2).44 Additionally, a pair of 
bacteriophage (Che9c) recombinases, Che9c60 and Che9c61 (GC rich homologs of RecE and 
RecT), were constitutively expressed to facilitate site specific recombination.44 RecE is an 
exonuclease that produces a single stranded DNA overhang on the integration cassette, while RecT 
is a DNA binding protein that assists in strand invasion of the single stranded integration cassette 
overhang into the targeted DNA.58 The two-gene recombinase operon (Che9c60 and Che9c61) 
was initially acquired on the plasmid pJV53 and was originally expressed using the acetamide 
promoter (pAcet) on an uncharacterized variant of pAL5000.44 While these recombinases 
consistently facilitated site specific recombination, the stably maintained plasmid could not be 
cured post recombination even after the exclusion of selection pressure and multiple rounds of 
serial cultures (data not shown).  
A plasmid that can be selectively cured out after successful recombination is required to 
remove the recombinase-containing plasmid. Previously, a cryptic plasmid from Rhodococcus sp. 
B264 was demonstrated to exhibit temperature sensitivity and could be cured out when the strain 
was grown at or above 37 oC.49 Lessard et al. determined the minimal B264 replicon required for 
stable plasmid replication through a rigorous deletion assay.49 This minimal replicon of 1500 bp 
was synthesized (Integrated DNA Technologies) and assembled with the E. coli origin pBR322 
and a kanamycin resistance marker to create pB264. Interestingly, this plasmid could be cured just 
by removing selection pressure (kanamycin) and performing a round of colony purification; a 37 
oC temperature passage was not required (Supplementary Figure B.4). The Che9c recombinases 
under pAcet were added to this new backbone. However, site specific recombination was no longer 
successful, presumably due to a change in the expression level of Che9c60 and Che9c61. The 
acetamide promoter was replaced with the strong pConstitutive promoter (Supplementary Figure 
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B.3), which restored the ability of the recombinases to facilitate site specific recombination. The 
multiple rounds of optimization required to implement a reliable genome recombineering system 
in R. opacus reiterate the inherent challenges in developing engineering tools for a non-model 
organism.  
 
Figure 4.4. Neutral integration site identification and recombination methodology. A) A schematic 
detailing the criteria developed for identification of candidate neutral integration sites in the 
genome. A previously published R. opacus genome sequence from the NCBI database (Refseq, 
NZ_CP003949.1) was used to identify inward facing genes (sequential 5’ to 3’ and 3’ to 5’) with 
non-critical (hypothetical or putative) gene annotation and an intergenic region greater than 200 
bp.38 The intergenic region between two inward facing genes is anticipated to contain minimal 
regulatory components, besides transcriptional terminator sequences near 3’ end of ORFs, and thus 
minimizes the probability of disturbing critical non-coding regions. Previously published 
transcriptomic data was additionally used to screen the candidate gene pairs and refine the list to 
only include sites with low or zero expression levels.8 B) A schematic demonstrating double 
homologous recombination of a linearized double stranded integration cassette (Intg. Cassette) 
facilitated by the two heterologous recombinases Che9c60 and Che9c61.44 The recombinases were 
constitutively expressed on the curable pB264 backbone, which is lost when antibiotic selection 
pressure is removed (see Supplementary Figure B.4). 
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4.3.5 Neutral integration sites 
With a platform for site specific recombination available, neutral integration sites whose 
disruption does not have a negative impact on the host are necessary if heterologous genes are to 
be inserted into the genome. The definition of a neutral site is variable, but in this work and in 
other reports, it is defined as a site where gene insertion does not cause a reduction in growth rate 
relative to that of the wild type strain.59-61 One approach to neutral site identification is to search 
the genome annotation for redundant, non-essential, or non-functional genes (e.g., 
pseudogenes).59-61 This method may require additional trial and error due to the necessity of certain 
genes not always being clear based solely on the gene annotation. For example, pseudogenes may 
actually play a role as trans-acting antisense RNA and may be important for cellular regulation.62 
An alternative option is to use transcriptomic analysis or RT-qPCR to identify regions or loci of 
minimal transcription, with the assumption that disruption of these non-transcribed regions will 
have a minimal impact.60, 61 This method alone does not consider that non-transcribed DNA may 
still contain critical non-coding elements (e.g. promoters, transcription factor binding sites, etc.) 
whose deletion may lead to unintended consequences.63 
 To maximize the likelihood of identifying neutral sites, a novel and rational set of criteria 
was developed based on the use of transcriptomic data and analysis of genomic architecture. To 
identify genes of negligible expression and importance, and to minimize the disruption of non-
coding elements, we utilized previously published transcriptomic data of R. opacus grown under 
two distinct growth conditions and a complete genome assembly and annotation.8, 38 The following 
list of criteria (Figure 4.4) was developed to identify neutral sites based on this multi-omics data 
such that integrations would not disrupt any open reading frames (ORFs) or regions upstream of 
ORFs, leading to a minimal effect on cell growth. 1) Transcriptomic data must identify two 
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consecutive ORFs with low or zero levels of transcription. 2) The ORFs must have non-essential 
or putative annotations (i.e. hypothetical protein). 3) An intergenic region of at least 200 bp must 
exist between the ORFs to avoid local context effects in case the nearby ORFs do have a function. 
4) The ORFs must be convergent (5’ to 3’ followed by 3’ to 5’). Regulatory regions typically occur 
upstream of an ORF (on the 5’ side), and by selecting a region downstream (3’) of both non-
transcribed ORFs, the likelihood of disrupting potentially important non-coding DNA is reduced.  
Using these criteria, four potential neutral sites were identified in the chromosome and an 
endogenous plasmid (Supplementary Table B.4) and are referred to as R. opacus chromosomal 
integration sites (ROCI-#) and R. opacus endogenous plasmid integration sites (ROP#I-#). 
Endogenous plasmid 8 was chosen for site selection based on our observation that it had the highest 
number of copies per chromosome (~5). A constitutively expressed EYFP gene along with a 
hygromycin B resistance marker was integrated into each of these sites. Site specific integration 
was confirmed using colony PCR (Supplementary Table B.5; Supplementary Figure B.5). R. 
opacus has a much lower transformation efficiency compared to a model organism like E. coli, 
and consequently only 2 to 4 colonies were recovered after electroporation with the linearized 
double stranded integration cassettes.64, 65 However, all colonies tested had the correct PCR bands, 
signifying no false positive for all candidate neutral sites.  
To determine site neutrality, a growth curve of the wild type strain and each recombinant 
strain was generated (Figure 4.5A), and the growth rate was calculated (Supplementary Table B.6). 
Three recombinant strains with integration into ROCI-2, ROCI-3, and ROP8I-1 had statistically 
indistinguishable growth rates compared to wild type (Student’s t-test, p < 0.05), while one strain 
(ROCI-1) had an ~18% decrease in growth rate. All four sites are viable for integration, although 
only ROCI-2, ROCI-3, and ROP8I-1 are confirmed neutral sites. Thus, this targeted rational 
82 
 
approach to identifying neutral integration sites required fewer candidates to successfully 
determine multiple neutral locations than other reports using different screening metrics.59-61 For 
example, among 16 candidate neutral sites in Synechocystis sp. PCC 6803, five integration sites 
were selected for growth tests after an initial assessment (e.g. RT-PCR).61 A statistical analysis of 
the growth data showed that only two sites were neutral in terms of growth. 
The fluorescence from each strain was also measured (Figure 4.5B), demonstrating 
successful gene function after recombination. The normalized fluorescence varied between the 
chromosomal sites, particularly ROCI-3 relative to ROCI-1 and ROCI-4. The location of the 
integration site, particularly in relation to the chromosome’s origin of replication, has recently been 
found to influence gene copy numbers and expression levels in E. coli and Bacillus subtilis.66-68 
The fluorescence of ROP8I-1 was also significantly higher than that of the chromosomal sites, 
which is expected as Plasmid 8 was measured to have ~5 copies per chromosome. However, the 
fluorescence generated by ROP8I-1 is not five-fold higher than that of the chromosomal sites. 
Gene expression levels have been shown to be affected and vary based on genetic context, such as 
surrounding nucleotide sequences.69, 70 Overall, the identification of these three neutral integration 
sites, in addition to the development of recombination plasmids that can be easily modified to 
insert any desired gene, will facilitate the development of R. opacus as a bioproduction strain.  
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Figure 4.5. Neutral site characterization in R. opacus. Four candidate neutral sites were identified 
using the criteria described in Figure 4.4: three in the chromosome (LPD04028/LPD04029, 
LPD04690/LPD04691, and LPD03763/LPD03764) referred to as R. opacus chromosome 
integration sites 1 to 3 (ROCI-1 to ROCI-3); and one in endogenous plasmid 8 
(LPD016184/LPD016185) referred to as R. opacus plasmid eight integration site 1 (ROP8I-1). A 
DNA cassette containing a constitutively expressed EYFP and HygR was integrated into each site. 
A) Growth curves of wild type R. opacus and strains containing integrations. The growth rates of 
ROCI-2, ROCI-3, and ROP8I-1 modified strains were statistically indistinguishable from the wild 
type growth rate (Students t-test, p > 0.05), while one recombinant strain (ROCI-1) had a ~18% 
growth rate reduction (Supplementary Table 6). B) Normalized fluorescence (see 4.5 Materials 
and Methods) produced from each strain. Values represent the average of three replicates grown 
in minimal media B, and error bars represent one standard deviation. Electrophoresis gel images 
confirming correct recombination events are shown in Supplementary Figure B.5. 
 
4.3.6 CRISPRi-mediated gene repression 
 Genome recombineering can be useful for gene function analysis, but it is not an ideal tool 
if the goal is to only decrease gene expression rather than to delete or disrupt the gene. Two primary 
methods exist for prokaryotic gene repression, antisense RNA (asRNA) and CRISPR interference 
(CRISPRi), neither of which has been demonstrated in Rhodococcus spp.71-74 As CRISPRi has 
been demonstrated in other Actinomycetales, it was chosen for our development efforts in R. 
opacus.75-77 CRISPRi utilizes a catalytically dead version of the Cas9 nuclease (dCas9) to interfere 
with gene transcription.78 The most widely used version of dCas9 originates from the AT rich 
Streptococcus pyogenes (dCas9Spy).
72, 78 A previous study concluded that dCas9Spy did not function 
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efficiently in the related Actinomycetales M. tuberculosis, and in fact sensitized the cells to sub-
minimum inhibitory concentrations of proteotoxic compounds.75 After screening 11 Type IIA and 
Type IIC dCas9 homologs, they found that a codon optimized version of dCas9 from Streptococcus 
thermophilus (dCas9Sth1) repressed gene transcription to the highest degree in M. tuberculosis.
75 
The trade-off for dCas9Sth1 is that the required PAM sequence is 7 base pairs compared to the 
dCas9Spy requirement of 3 base pairs, which drastically reduces the number of available target 
sites.75 Notably, the dCas9Sth1 PAM site is much more flexible than the rigid dCas9Spy PAM 
sequence, and Rock et al. demonstrated 19 different PAM sequences with 10-fold repression or 
higher.75  
We placed the codon optimized dCas9Sth1 under the arabinose inducible pBAD promoter 
on pAL5000 (S) and designed three sgRNAs (A, B, and C) based on rules discussed by Rock et 
al.75 The sgRNAs were designed to target either the ribosome binding site (RBS) / 5’ untranslated 
region (sgRNAs B and C) or the coding region (sgRNA A) of the constitutively expressed EYFP 
integrated into ROCI-2 (Supplementary Table B.7). Previous work with dCas9Spy has 
demonstrated that the repression ability is inversely correlated with the distance from the 
transcription start site (TSS).72, 75, 78, 79 However, Rock et al. found that there was no correlation 
between the repression ability and the distance from the TSS when using dCas9Sth1.
75 Originally, 
the sgRNAs were expressed using a pTet promoter optimized for M. tuberculosis, but after strains 
failed to demonstrate repression, the pTet promoter was replaced with the strong pConstitutive 
promoter. Eight concentrations of arabinose were used to demonstrate tunable repression of EYFP 
fluorescence (Figure 4.6), with percent repression ranges of 27-58%, 4-42% and 28-53% for 
sgRNAs A-C, respectively. The increased expression of dCas9Sth1 did not lead to any growth 
defects between induction concentrations (Supplementary Figure B.7). This is the first reported 
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demonstration of a CRISPRi-based system for targeted and tunable gene repression in 
Rhodococcus spp. Our observations are also consistent with Rock et al.’s finding of the sgRNA 
binding position having no correlation with the repression ability, as sgRNA A targeted a site over 
200 bp into the coding region, compared to sgRNAs B and C which both started binding within 
15 bp of the TSS.75 Future work would be a systematic investigation into the effect of diverse 
parameters (e.g. PAM sequences, target locations/strands, and sgRNA lengths/levels) on 
repression efficiency to increase the predictability of this gene repression tool in R. opacus.  
 
Figure 4.6. Tunable repression with CRISPRi in R. opacus. A codon optimized version of dCas9 
from Streptococcus thermophilus (dCas9Sth1) was placed under the control of the arabinose 
inducible pBAD promoter. The strong pConstitutive promoter drives sgRNA transcription. Three 
sgRNAs (A, B, and C) were designed to target a constitutively expressed EYFP gene integrated 
into ROCI-4. A) Normalized fluorescence (see 4.5 Materials and Methods) at early stationary 
phase in the presence of 0, 0.1. 0.25, 1, 5, 10, 25, and 100 mM arabinose. The red dashed line 
represents the positive control (EYFP only) value. B) The percent repression of each sgRNA (see 
4.5 Materials and Methods). The solid black line in each case represents a fitted curve (see B.3 
Supplementary Methods). Values represent the average of three replicates grown in minimal media 
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B with 4 g/L glucose, and error bars represent one standard deviation (A) or the propagated 
standard deviation (B; see B.3 Supplementary Methods). 
 
4.4 Conclusion 
 R. opacus is a gram-positive Actinobacterium that has demonstrated promise as an 
industrially relevant strain for lignocellulosic biomass conversion due to its high aromatic 
tolerance and substantial number of catabolic genes for a broad range of feedstocks.8, 11, 12, 39 
Previously, this non-model strain had relatively few well-characterized genetic parts and tools 
available for engineering compared to even other Actinomycetales (e.g. Mycobacterium spp., 
Streptomyces spp., and Corynebacterium spp.), let alone model organisms like E. coli and S. 
cerevisiae (Table 4.1).31, 47, 56, 75 This work has substantially expanded the molecular toolbox for 
gene expression by characterizing a constitutive promoter library, two antibiotic resistance 
markers, and the copy number of heterologous and endogenous plasmids. Furthermore, a curable 
plasmid backbone (pB264) was developed for temporary heterologous gene expression (e.g. 
recombinase expression). While engineering in R. opacus has been accomplished in the past, the 
actual expression level of heterologous enzymes has been unclear due to the use of uncharacterized 
parts.22, 24-26 The characterization of promoters and plasmid vectors reported here, along with our 
recent work regarding chemical and metabolite sensors, provides a foundation for future metabolic 
engineering in R. opacus.13 Furthermore, our characterization of the nine cryptic plasmids and 
observation of illegitimate integration events in R. opacus may support an interesting hypothesis 
regarding the role of large linear plasmids as hyper-recombinational gene storage devices in 
Rhodococcus and other Actinomycetales.39  
Expanding beyond the development and characterization of fundamental genetic parts for 
heterologous gene expression, we also report methods for genome modification and gene 
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repression. For genome editing, we describe the development of a recombinase-based technique 
for site-specific genomic modification, in addition to a novel methodology for identification of 
neutral integration sites for stable heterologous gene expression. While site-specific recombinase-
based techniques have been reported in other Actinomycetales, to our knowledge, this is the first 
use in Rhodococcus. Furthermore, our novel set of criteria for neutral site identification is 
applicable to other prokaryotes and will facilitate the rapid identification of non-deleterious 
candidate integration sites. Additionally, a CRISPRi platform was developed and demonstrated 
for tunable and targeted gene repression for the first time in Rhodococcus. CRISPRi has proved 
useful as a method for quickly and efficiently remodeling native metabolic pathways in 
prokaryotes.77, 80 When combined with our tools for heterologous gene expression, CRISPRi will 
allow the lignocellulose consumption abilities of R. opacus to be paired with its extensive 
metabolic pathways for the production of valuable bioproducts.8, 15, 26, 39 Notably, even though both 
of these systems were originally developed for the closely related M. tuberculosis, they still 
required significant optimization, reinforcing the challenges in engineering a non-model 
organism.44, 75 The results of this, and other recent work, have contributed significantly towards 
making R. opacus a relevant strain for future industrial applications. 
4.5 Materials and methods 
4.5.1 Strains, plasmids and growth conditions 
All plasmids were assembled in E. coli DH10B using either Gibson or Golden Gate 
assembly methods.81-83 Kanamycin (20 μg/mL), gentamicin (10 μg/mL), chloramphenicol (34 
μg/mL), or hygromycin B (200 μg/mL) was added as appropriate to E. coli cultures. 
Electrocompetent E. coli DH10B and R. opacus cells were transformed as previously described.64, 
83 Plasmid DNA was isolated using Zyppy Plasmid Miniprep Kit (Zymo), and PCR products were 
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extracted from electrophoresis gels using Zymoclean Gel DNA Recovery Kit (Zymo). All genetic 
part sequences, plasmids, and strains are listed in Supplementary Tables B.2, B.8, and B.9, 
respectively. Enzymes were purchased from New England Biolabs and Thermo Fischer Scientific.  
The pConstitutive promoter sequence driving GFP+ underwent saturation mutagenesis at 
the -10 and -35 regions, either individually or concurrently, using degenerate oligonucleotides for 
PCR, followed by blunt end ligation to circularize the DNA.84 Approximately 100 R. opacus 
colonies were screened in triplicate for fluorescence output. 25 promoters spanning ~45-fold 
difference in fluorescence output were selected (Figure 4.1), and the promoter sequences are 
shown in Supplementary Table B.1.  
R. opacus was cultured in one of two defined minimal media (A or B; medium composition 
as previously described by DeLorenzo et al.)13, 15 at 30 oC and 250 rpm using 50 mL glass culture 
tubes. Unless otherwise noted, 2 g/L glucose was used as the carbon source, and 1 g/L ammonium 
sulfate was used as the nitrogen source. For all cultures, a single colony was transferred from a 
tryptic soy broth (TSB) agar plate into 4.5 mL of minimal media and incubated for ~18 to 24 hrs, 
and then subcultured in 10 mL of media to create a larger volume of seed culture. Growth 
experiments were performed in triplicate at the 10 mL scale, with an initial optical density at 600 
nm (OD600) of ~0.2, unless otherwise noted. Kanamycin (50 μg/mL), gentamicin (10 μg/mL), 
chloramphenicol (15 μg/mL), and hygromycin B (50 μg/mL) were added as appropriate to R. 
opacus cultures. All chemicals were purchased from Sigma-Aldrich unless otherwise noted. 
4.5.2 Growth and fluorescence measurements 
The optical density (OD600) was measured in VWR semi-micro polystyrene cuvettes at 600 
nm using a Tecan Infinite 200 Pro plate reader. Cell fluorescence and absorbance at 600 nm 
(Abs600) were measured in black 96-well plates (Greiner Bio-One flat bottom, chimney well, 
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clear) using a Tecan Infinite 200 Pro plate reader. An absorbance value at 600 nm can be 
converted into an optical density value (for R. opacus cultures) by using the experimentally 
determined relationship (OD600 = 1.975 × Abs600). The excitation and emission wavelengths for 
GFP+ were 488 and 530 nm, respectively.13 The excitation and emission wavelengths for EYFP 
were 485 and 528 nm, respectively.13 Fluorescence measurements were normalized using Equation 
1, where Fluonorm is the normalized fluorescence, Abs600sample is the test strain absorbance at 600 
nm, Fluosample is the test strain fluorescence, Fluocontrol is the empty vector control strain 
fluorescence, and Abs600control is the empty vector control strain absorbance at 600 nm.
13 
Eq. 1)                       Fluonorm =
Fluosample
Abs600sample
-
Fluocontrol
Abs600control
 
4.5.3 Total DNA extraction and quantitative PCR 
 Total DNA (genomic DNA [gDNA] and plasmids) was extracted from 30 mL biological 
triplicates of R. opacus at an OD600 of ~1.0. Cultures were centrifuged at 3500 rcf and re-suspended 
in 1 mL of sterile deionized water. Cells were then frozen at -80 oC for one hour and then lysed at 
100 oC for thirty minutes. The Zymo Quick-DNA Fungal/Bacterial Midiprep Kit was used for total 
DNA isolation. Final DNA concentrations were measured using a Nanodrop 2000 UV-Vis 
Spectrophotometer. All samples were diluted to 1 ng DNA/μL for further use. 
 qPCR was used to determine the absolute copy number ratio of the heterologous and 
endogenous plasmids relative to the chromosome, as previously described.45 Primers were 
designed to amplify 140-224 base pairs of DNA from each target and are listed in Supplementary 
Table B.4. To determine the copy number ratio, an external standard dilution curve of cycle 
threshold (CT) versus log copy number is required for each amplicon (Supplementary Figure B.1). 
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Amplified PCR product was used as an external standard and serially diluted from 109 to 105 copies 
of amplicon/μL. Equation 2 was used to initially dilute PCR product to 109 copies/μL. 
Eq. 2)   𝐴𝑚𝑝𝑙𝑖𝑐𝑜𝑛 𝐶𝑜𝑝𝑦 𝑁𝑢𝑚𝑏𝑒𝑟 =
6.02∗1023 (
𝑐𝑜𝑝𝑦
𝑚𝑜𝑙
)∗𝐷𝑁𝐴 𝑎𝑚𝑜𝑢𝑛𝑡 (𝑔)
𝐴𝑚𝑝𝑙𝑖𝑐𝑜𝑛 𝑙𝑒𝑛𝑔𝑡ℎ (𝑏𝑝)∗660 (
𝑔
𝑚𝑜𝑙∗𝑏𝑝
)
 
 qPCR was first performed in duplicate on the serially diluted PCR product using a Bio-
Rad CFX96 real time thermocycler and SYBR Select Master Mix for CFX. 1 μL of mixed 5 mM 
primers and 1 μL of DNA were used for each reaction. Cycling conditions were 95 °C for 10 min, 
followed by 40 cycles of 95 °C for 15 s, 60 °C for 1 min, and fluorescence measurement. A 
threshold value of 3650 was set for all reactions. To confirm that no off-target amplification had 
occurred, a melting curve analysis was performed at the end of each PCR program and a single 
melting peak was verified for each amplicon. The efficiency of the PCR reaction was calculated 
using Equation 3 and a linear regression was performed to confirm linearity (Supplementary Table 
B.3).  
   Eq. 3)                𝑃𝐶𝑅 𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = 100 ∗ (10
  
−1
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑐𝑢𝑟𝑣𝑒 𝑠𝑙𝑜𝑝𝑒 − 1) 
 qPCR, as described above, was then performed on the extracted, biological triplicate DNA 
samples. 1 μL of mixed 5 mM primers and 1 μL of 1 ng DNA/μL were used for each reaction. The 
standard curves were used to determine the number of copies of each plasmid in the sample based 
on the measured sample CT values. The copy number ratio was then determined by dividing the 
number of copies of each plasmid by the number of copies of the chromosome.  
4.5.4 Identification of neutral sites 
 The criteria for identifying candidate neutral sites are displayed in Figure 4.4. The first step 
involved using previously collected transcriptomic data to find two sequential genes with zero or 
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very low levels of transcription.8 The genetic architecture of the identified low expression gene 
pairs was analyzed using a previously published R. opacus genome (NCBI database Refseq, 
NZ_CP003949.1; referred to as LPD genome).38 The desired orientation was for the two ORFs to 
be facing each other (sequential 5’ to 3’ and 3’ to 5’). Furthermore, a gap of at least 200 bp between 
the respective stop codons was required. The LPD genome annotation of each gene was examined 
to avoid genes of critical function. All genes were further analyzed using NCBI blastn to confirm 
non-critical gene function (Supplementary Table B.4).  
4.5.5 Gene integration 
 PCR was used to amplify a ~500 bp region up- and downstream of the selected integration 
site in the genome. These two pieces were assembled into a plasmid containing an E. coli origin 
of replication (p15a), a constitutively expressed EYFP, and a hygromycin B selection cassette 
(Supplementary Figure B.2A). This plasmid was then linearized by a PCR reaction such that the 
p15a origin was removed (Supplementary Figure B.2B). Approximately 1 μg of linearized DNA 
was transformed via electroporation, as previously described, into R. opacus competent cells 
harboring the constitutively expressed recombinases Che9c60 and Che9c61 (Supplementary 
Figure B.3).13, 44 The electroporated cells were allowed to recover in TSB at 30 oC for 6 hours, 
compared to the 3 hours normally allowed for transformations. Cells were then plated on a TSB 
agar plate containing hygromycin B. The vector containing the recombinase genes was cured after 
removal of selection pressure and a round of colony purification (Supplementary Figure B.4). 
Successful recombination at each integration site was confirmed by colony PCR (Supplementary 
Figure B.5).  
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4.5.6 CRISPRi 
 The codon optimized dCas9 from S. thermophilus (dCas9Sth1) was placed under the control 
of the pBAD promoter. sgRNAs were designed based on rules described by Rock et al.75 The 
tested sgRNAs were driven by the original strong constitutive promoter (pConstitutive). Both the 
pBAD-Cas9Sth and pConstitutive-sgRNA cassettes were placed onto pAL5000 (S). The three 
CRISPRi constructs (sgRNAs A, B, and C) were transformed into the strain containing 
BbaJ23104-EYFP integrated into ROCI-4. To increase the number of cell doublings, the culture 
media were modified to contain 4 g/L glucose and the initial inoculum density was reduced to an 
OD600 of 0.1. CRISPRi strains were induced with 0-100 mM arabinose. Fluorescence was 
measured at early stationary phase. Percent repression was calculated using Equation 4, where 𝜇𝐼 
is the normalized fluorescence measured from the induced culture and 𝜇𝑈 is the normalized 
fluorescence measured from the positive control (EYFP only) culture.  
Eq. 4)   𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑅𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 = 100 ∗ (1 −
𝜇𝐼
𝜇𝑈
) 
4.6 Supporting information 
Supplementary Tables B.1-10, Supplementary Figures B.1-7, and Supplementary Methods can be 
found in Appendix B. 
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Chapter 5: Selection of stable reference genes for RT-
qPCR in Rhodococcus opacus PD630 
 
Reprinted with permission from DeLorenzo, D.M. and Moon, T.S. Selection of stable reference 
genes for RT-qPCR in Rhodococcus opacus PD630. Scientific Reports (2018). 8, 6019. 
 
The genetic parts developed as part of this dissertation enable the ability to controllably 
express or repress either heterologous or endogenous genes in R. opacus. The expression level of 
most genes, however, can be difficult to estimate if there is no easily quantifiable metric (e.g., 
fluorescence from a reporter protein). In this chapter, a methodology for directly quantifying the 
mRNA concentration of any gene—reverse transcription quantitative polymerase chain reaction 
(RT-qPCR)—will be established in R. opacus through the identification of stable reference genes 
for data normalization. I performed all experiments and wrote the manuscript. 
5.1 Abstract  
Rhodococcus opacus PD630 is a gram-positive bacterium with promising attributes for the 
conversion of lignin into valuable fuels and chemicals. To develop an organism as a cellular 
factory, it is necessary to have a deep understanding of its metabolism and any heterologous 
pathways being expressed. For the purpose of quantifying gene transcription, reverse transcription 
quantitative PCR (RT-qPCR) is the gold standard due to its sensitivity and reproducibility. 
However, RT-qPCR requires the use of reference genes whose expression is stable across distinct 
growth or treatment conditions to normalize the results. Unfortunately, no in-depth analysis of 
stable reference genes has been conducted in Rhodococcus, inhibiting the utilization of RT-qPCR 
in R. opacus. In this work, ten candidate reference genes, chosen based on previously collected 
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RNA sequencing data or literature, were examined under four distinct growth conditions using 
three mathematical programs (BestKeeper, Normfinder, and geNorm). Based on this analysis, the 
minimum number of reference genes required was found to be two, and two separate pairs of 
references genes were identified as optimal normalization factors for when ribosomal RNA is 
either present or depleted. This work represents the first validation of reference genes for 
Rhodococcus, providing a valuable starting point for future research. 
5.2 Introduction 
Rhodococcus opacus PD630 (hereafter R. opacus) is a gram-positive, oleaginous bacterium 
that possesses beneficial traits for the conversion of lignin into valuable fuels and chemicals1-4. 
Some of these features include a number of catabolic pathways for lignin-derived aromatic 
compound consumption and a high native tolerance towards these and other inhibitory 
lignocellulosic biomass breakdown products2-5. Furthermore, R. opacus can consume multiple 
types of carbon sources simultaneously6, thereby facilitating higher rates of feedstock conversion. 
Additionally, this organism can direct a large fraction of its cellular resources to the production of 
biofuel precursors (up to ~78% triacylglycerol [TAG] of cell dry weight)1. R. opacus has been 
previously engineered to facilitate lignocellulose conversion3,4,7,8 and a substantial genetic toolbox 
has recently been developed9,10. However, a deep understanding of this organism’s metabolism 
and any heterologous pathways being expressed is required to maximize its potential.  
A number of technologies exist for examining an organism’s gene expression (i.e. the 
transcriptome), which is the first step to a systems level understanding. One such technology is the 
microarray, which allows for gene expression profiling11. RNA sequencing (RNA-Seq) is a newer 
technology that has become the default method for examining the entire transcriptome of an 
organism12. However, it can add additional costs if only several genes are of interest, is limited 
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when mRNA concentrations are low (although this is changing with the advent of single cell 
sequencing13), and generally still requires corroboration via additional quantitative methods12. One 
such complimentary method is reverse transcription quantitative PCR (RT-qPCR), which is 
considered the gold standard of mRNA quantification due to its high sensitivity, reproducibility, 
speed, ability to examine numerous samples simultaneously, and large dynamic range14,15.  Both 
microarrays and RT-qPCR require the use of an internal standard, optimally a gene that is stably 
expressed across the tested growth or treatment conditions, to normalize expression data between 
samples and conditions16.  
 Unfortunately, no in-depth analysis of stable reference genes (RGs) has been performed in 
Rhodococcus, limiting the ability to quantitatively analyze gene expression. One qPCR study in 
Rhodococcus equi even stated that no reference gene was included in their experiment and that 
such an inclusion could have improved their work17. We could find only two examples of reference 
genes previously reported in Rhodococcus. The first reference gene was a gene encoding sigma 
factor A (sigA) in Rhodococcus sp. RHA118, although no justification for this choice was provided. 
The second reference gene was a gene encoding DNA Polymerase IV, which was used in 
Rhodococcus sp. RHA1, Rhodococcus jostii, and Rhodococcus erythropolis, and this choice was 
justified based on a microarray experiment performed in Rhodococcus sp. RHA119,20. Both of these 
reference genes were used in isolation and their characterization was incomplete, which fails to 
satisfy the current minimum information guidelines for publication of quantitative PCR 
experiments (i.e. MIQE guidelines stating that the minimum number of reference genes needs to 
be quantitatively determined and that one gene is not generally sufficient for normalization)21,22.  
In this work, we identified ten candidate reference genes (RGs) and examined the stability 
of their expression in R. opacus across four distinct growth conditions using three mathematical 
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models (BestKeeper23, NormFinder24, and geNorm16,25). Additionally, the minimum number of 
required reference genes was identified. Two different sets of genes were identified as optimal 
normalization factors (NFs) depending on whether ribosomal RNA (rRNA) is either present or 
depleted. This work facilitates the utilization of RT-qPCR in R. opacus, in addition to providing a 
valuable preliminary set of reference genes for further future validation in other Rhodococcus spp. 
5.3 Results and discussion 
5.3.1 Choice of candidate reference genes 
Two methods were utilized for the selection of candidate reference genes (RGs). The 
primary approach used our previously published transcriptomic data collected from R. opacus 
grown in a minimal salts medium with either glucose or phenol to identify stably expressed genes3. 
We selected nine genes as candidates (RG1 to RG9; Table 5.1) whose DeSeq2 normalized 
transcript level did not vary significantly between the two growth conditions, whose DeSeq2 
expression value was greater than 750, and whose coding region is at least 350 bp in length3,26. 
The secondary approach utilized a literature review which found that sigA had been previously 
used as a RG in Rhodococcus sp. RHA118 and that a DNA Polymerase IV gene has been previously 
used in Rhodococcus jostii, Rhodococcus erythropolis, and Rhodococcus sp. RHA1 as a RG19,20. 
sigA was ruled out due to no justification for its selection as a RG being provided18. As 
PD630_RS27310 is annotated as a DNA Polymerase IV gene in R. opacus, it was selected as the 
tenth candidate RG (RG10; Table 5.1).  
Table 5.1. List of candidate reference genes (RG). The amplicon size, PCR efficiency percentage, 
minimum and maximum threshold cycle (CT) values observed across all tested growth conditions, 
the standard deviation of CT values across all tested growth conditions (determined by 
BestKeeper), and the CT value of the no template control (NTC) are listed for each RG. See 
Supplementary Figure D.1 for standard curves used to calculate PCR efficiency. See 
Supplementary Figure D.2 for melting curve analysis. See Supplementary Table D.1 for 
oligonucleotide sequences and melting and annealing temperatures.  
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N.d. = no amplification detected 
Reference 
gene (RG) 
Gene 
number 
Gene  
annotation 
Amplicon 
size (bp) 
PCR 
efficiency 
Min  
CT 
Max  
CT 
CT Std 
Dev 
NTC
CT 
RG1 
PD630_ 
RS22865 
Pup-protein ligase 157 94% 23.44 25.23 0.40 N.d. 
RG2 
PD630_ 
RS20570 
Hypothetical protein 87 94% 25.86 28.20 0.67 N.d. 
RG3 
PD630_ 
RS03840 
23S rRNA 87 95% 8.74 10.16 0.33 N.d. 
RG4 
PD630_ 
RS15810 
Polyribonucleotide 
nucleotidyltransferase 
115 101% 22.93 27.41 1.37 N.d. 
RG5 
PD630_ 
RS25785 
L,D-transpeptidase 
Mb0493 
90 101% 24.56 25.96 0.37 N.d. 
RG6 
PD630_ 
RS13910 
NAD(P)H 
dehydrogenase  
82 100% 25.47 29.01 1.13 N.d. 
RG7 
PD630_ 
RS25530 
ATP-dependent Clp 
protease ATP-binding 
subunit ClpX 
94 92% 24.93 25.77 0.21 N.d. 
RG8 
PD630_ 
RS01395 
16S rRNA 101 92% 10.48 11.74 0.29 N.d. 
RG9 
PD630_ 
RS37755 
rRNA small subunit 
methyltransferase G 
102 92% 28.32 30.33 0.46 N.d. 
RG10 
PD630_ 
RS27310 
DNA polymerase IV  71 94% 28.34 30.61 0.61 N.d. 
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5.3.2 RT-qPCR primer characterization and data collection 
 RT-qPCR primers were designed based on previously published suggestions22, in addition 
to the specific criteria discussed in the Supplementary Materials. The size and specificity of each 
amplicon was confirmed using agarose gel electrophoresis and melting curve analysis (Figure 5.1 
and Supplementary Figure D.2), and the no template controls (NTCs) demonstrated non-detectable 
levels of amplification (Table 5.1 and Supplementary Figure D.2). To calculate the PCR 
amplification efficiency, a ten-fold serial dilution of template DNA (PCR amplified product) was 
performed and followed by qPCR (Supplementary Figure D.1). A linear regression analysis was 
performed on the resultant CT values to confirm the linearity of each serial dilution and to calculate 
the PCR amplification efficiency (Table 5.1 and Supplementary Figure D.1). As all serial dilutions 
had an acceptable R2 of at least 0.97 and PCR efficiencies ranged from 92 to 101%, all primer sets 
were deemed suitable for qPCR (Table 5.1 and Supplementary Figure D.2).   
 
Figure 5.1. Confirmation of specificity of primers used in RT-qPCR analysis. A) Contrast 
enhanced image of electrophoresis gel confirming amplicon size and primer specificity using RT-
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qPCR amplification product. The sizes for nucleotide ladder are indicated to left of bands (50 to 
200 bp). The size of each amplicon is denoted in Table 5.1. The original non-enhanced gel image, 
in addition to the corresponding gel image of no template controls (NTCs), can be found in 
Supplementary Figure D.5. B) Representative melt curves post RT-qPCR for RG1 and RG2 as 
well as the corresponding NTCs (see Supplementary Figure D.2 for all melt curves).  
 
R. opacus was cultured in four distinct growth conditions, and RNA was extracted from 
biological triplicate cultures for candidate RG expression stability analysis. The growth conditions 
are described in full in the Materials and Methods, but in summary they consist of a minimal salts 
medium with glucose and either high nitrogen (HN) or low nitrogen (LN), a rich tryptic soy broth 
medium (TSB), or a minimal salts medium with phenol and high nitrogen (PHE). Each medium 
was selected based on growth conditions that R. opacus is likely to experience during general 
research endeavors and based on the diverse predicted changes in metabolic topology required for 
catabolism of each respective feedstock. Glucose was chosen as a representative sugar feedstock 
as it is frequently provided in R. opacus cell cultures3,9,27. High and low nitrogen concentrations 
were examined because R. opacus undergoes a metabolic flux shift to produce large quantities of 
industrially relevant lipids during nitrogen deprivation1,28,29. TSB was selected as it contains an 
array of amino acids, which are utilized by a diverse set of metabolic pathways30. Phenol was 
selected as a representative aromatic compound that may be found in depolymerized lignin3,4 and 
because it requires a different subset of metabolic pathways than glucose and amino acids6. 
RT-qPCR was then performed on the cDNA generated from the triplicate RNA samples 
collected from the HN, LN, TSB, and PHE growth conditions (Figure 5.2). The raw CT values 
ranged from 9.2 to 30.2 for RG1 through RG10 across all growth conditions. The minimum and 
maximum CT values, in addition to the standard deviation, observed for each candidate RG across 
all growth conditions are listed in Table 5.1. A visual appraisal of Figure 5.2 can provide initial 
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insight into candidate RG expression stability, as some RGs demonstrated a tight clustering of CT 
values (e.g. RG1, RG3, RG5, RG7, RG8, and RG9) while others demonstrated a spread in CT 
values (e.g. RG2, RG4, RG6, and RG10) across growth conditions. 
 
Figure 5.2. CT values for ten candidate reference genes in R. opacus. RNA was extracted from 
biological triplicates of R. opacus grown in four distinct growth conditions (HN [circle], LN 
[triangle], TSB [diamond], and PHE [square]; see 5.5 Materials and Methods for full description). 
RT-qPCR was performed in technical triplicate on each biological replicate. Each point represents 
the average threshold cycle (CT) value of all replicates for the listed gene and growth condition. 
Error bars represent one standard deviation.  
 
5.3.3 Expression stability of candidate reference genes across distinct growth 
conditions 
 Candidate RG expression stability was quantitatively examined using three different 
statistical programs: BestKeeper23, NormFinder24, and geNorm16,25. Each of these programs 
generates a gene expression stability coefficient (r-value for BestKeeper, stability value for 
Normfinder, and M value for geNorm) and rank order for the candidate RGs (see 5.5 Materials 
and Methods for full description; Figure 5.3). Additionally, candidate RGs were ranked based on 
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their CT standard deviation calculated by BestKeeper (Supplementary Table D.2). A CT standard 
deviation greater than 1 is considered unstable23.  
 All analyses identified the same three candidate RGs, albeit in different rank orders, as 
being the most stably expressed across all four growth conditions. According to BestKeeper, the 
top three most stable RGs from 1st to 3rd, based on the smallest standard deviation of CT values, 
were RG7, RG8, and RG3 (Supplementary Table D.2). The top three RGs with the lowest 
BestKeeper r-value from 1st to 3rd were RG3, RG7, and RG8 (Figure 5.3A1). Normfinder 
determined that the top three most stable RGs from 1st to 3rd, based on its stability value calculation, 
were RG7, RG3, and RG8 (Figure 5.3B1). Finally, geNorm determined that the top three most 
stable RGs from 1st to 3rd, based on its M value, were RG7, RG8, and RG3 (Figure 5.3C1).  
 Two of the top three most stable candidate RGs encode rRNAs (RG3 and RG8), which is 
consistent with previous works in other organisms that identified an rRNA gene as a stable RG31,32. 
However, rRNA is often depleted from mRNA samples being prepared for RNA-Seq33. If RT-
qPCR is to be used to corroborate RNA-Seq results, other non-rRNA RGs need to be identified. 
All analyses were repeated on the non-rRNA candidate RGs, and two genes (RG7 and RG9) 
appeared in the top 3 rankings of three analyses, while another (RG5) appeared in the top 3 
rankings of two analyses (Figure 5.3). The BestKeeper r-value identified the top three non-rRNA 
RGs from 1st to 3rd as RG6, RG7, and RG9 (Figure 5.3A2). As RG6 had a CT standard deviation 
greater than 1 (Supplementary Table D.2), it was ruled out as a candidate. Normfinder identified 
the top three non-rRNA RGs from 1st to 3rd as RG7, RG5, and RG9 (Figure 5.3B2). geNorm 
identified the top three non-rRNA RGs from 1st to 3rd as RG9, RG5, and RG7 (Figure 5.3C2).   
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Figure 5.3. Rankings of candidate reference genes. Genes were ranked from the least stable (on 
the left) to the most stable (on the right). Analysis was performed after pooling CT data across all 
four growth conditions. The designation of 1 means that the analyses were performed on all ten 
candidate RGs. The designation of 2 means that the analyses were performed on the eight non-
rRNA candidate RGs. A) Genes were ranked according to their BestKeeper r-value. BestKeeper 
r-value significance can be found in Supplementary Tables D.3 and D.4. B) Genes were ranked 
according to their Normfinder stability value. C) Genes were ranked according to their geNorm M 
value.  
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5.3.4 Minimum required number of reference genes 
Analyses of candidate RG expression stability identified several consistently transcribed 
genes across the four distinct growth conditions, but it was still unknown how many RGs were 
required for optimal normalization of expression data. The geNorm software is also capable of 
producing a V value (see Materials and Methods), which produces a quantitative suggestion for 
the ideal number of required RGs. By calculating the pairwise variation of Vn/Vn+1 (V value), 
where n is the number of RGs, the benefit of using n versus n+1 RGs for normalization can be 
quantified. A V value below 0.15 signifies that there is no additional benefit from adding another 
RG to the normalization factor (NF)16,25. A V value was calculated for all ten candidate RGs and 
the non-rRNA RG subset, and both had a V2/V3 value below 0.15 (0.087 and 0.145, respectively), 
meaning that there is no benefit of using three RGs over two RGs in the NF (Figure 5.4 and 
Supplementary Figure D.3). 
 
Figure 5.4. Minimum number of reference genes. The pair-wise variation Vn/Vn+1, where n 
represents the number of RGs used in the normalization factor (NF), was calculated by geNorm to 
determine the minimum number of RGs required for normalization. A geNorm V value below 0.15 
signifies that no additional benefit is gained from increasing the number of reference genes from 
n to n+1. The dashed line represents a V value of 0.15.  
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5.3.5 Validation of the selected reference genes 
 To examine the effect of utilizing different combinations of RGs in the NF, a normalized 
expression analysis was performed using expression data from PD630_RS15810 (RG4) grown 
under the four distinct growth conditions (Figure 5.5). A box plot visualizing the non-normalized 
expression data for PD630_RS15810 was generated to show the general trends in expression level 
changes across the four growth conditions (Figure 5.5A). The normalized relative fold changes in 
expression going from the HN condition to either the LN, TSB, or PHE condition were calculated 
using REST 2009 with one of six NFs, including RG6, RG10, RG3/RG7, RG3/RG8, RG7/RG8, 
and RG3/RG7/RG8 (Figure 5.5). Confidence intervals of 95% were calculated by REST 2009 and 
used for comparison between different NFs. RG6 was chosen as an example of a poor RG 
candidate, while RG10 was chosen as DNA Polymerase IV had been used as a RG in other 
Rhodococcus spp.19,20. All two-component combinations (NF2) of RG3, RG7, and RG8 were 
examined as it was unclear whether there were differences between them, in addition to a NF 
comprising all three to confirm that there was no significant difference between a NF2 and a NF3.  
 The results of the normalized expression analysis revealed that there was no significant 
difference in the normalized relative fold change ratio going from the HN condition to either the 
LN, TSB, or PHE condition when using a NF2 comprising any two selections of RG3, RG7, and 
RG8 or a NF3 comprising all three genes. As the NF2 comprising RG7 and RG8 (RG7/RG8) had 
the smallest 95% confidence interval, it was chosen as the optimal pair of RGs for future use in R. 
opacus under the tested growth conditions. RG7/RG8 normalization revealed that 
PD630_RS15810 expression with 95% confidence was downregulated between 0.054 to 0.088-
fold when going from HN to LN, 0.355 to 0.575-fold when going from HN to TSB, and 0.494 to 
0.916-fold when going from HN to PHE (Figure 5.5).  
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Figure 5.5. Effect of reference gene choice on RT-qPCR normalization. A) Box plots of averaged 
PD630_RS15810 expression data (CT) for all four growth conditions (HN, LN, TSB, and PHE). 
Each gray box represents the first through third quartiles, the solid black line represents the median, 
and the whiskers represent the minimum and maximum values. B-D) The normalized relative 
expression ratio of PD630_LPD05540 going from HN to either LN (B), TSB (C), or PHE (D). The 
expression data was normalized with a NF, including RG6, RG10, RG3/RG7, RG3/RG8, 
RG7/RG8, and RG3/RG7/RG8 using REST 2009. Error bars represent the 95% confidence 
interval (CI) as calculated by REST 2009. Stars indicate that a 95% CI range falls outside of the 
95% CI range of the RG3/RG7/RG8 (and RG7/RG8) normalized ratio.  
 
The effect of non-optimal RGs was also examined in comparison to the NF3 comprising 
RG3, RG7 and RG8. When PD630_RS15810 expression was normalized with RG6, there was a 
significantly different 95% confidence range (p < 0.05) of 0.120 to 0.240-fold downregulation 
when going from HN to LN, a comparable 0.430 to 0.824-fold downregulation going from HN to 
TSB, and a significantly different (p < 0.05) 4.009 to 7.703-fold upregulation when going from 
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HN to PHE (Figure 5.5). When PD630_RS15810 expression was normalized with the literature-
based selection RG10, there was a significantly different 95% confidence range (p < 0.05) of 0.013 
to 0.032-fold downregulation when going from HN to LN, a comparable 0.294 to 0.490-fold 
downregulation going from HN to TSB, and a comparable 0.480 to 0.971-fold downregulation 
when going from HN to PHE. These results demonstrate that a poorly selected RG can 
substantially alter the observed change in gene expression (e.g. RG6), and that RGs should be 
examined in all relevant growth conditions prior to use as they may be stable in some instances 
but not in others (e.g. RG10).  
To determine an optimal NF for a scenario where rRNA has been depleted, a normalized 
expression analysis was performed again on PD630_RS15810 using the top three non-rRNA 
candidate RGs (RG5, RG7, and RG9). The normalized expression ratio of all NF2 combinations 
of these three genes, in addition the NF3 comprising all of them, was examined in comparison to 
the best NF2 comprising RG7 and RG8 (Supplementary Figure D.4). The NFs including RG5/ 
RG7, RG5/RG9, and RG5/RG7/RG9 all produced 95% confidence normalized expression fold 
change ranges that were significantly different (p < 0.05), compared to the expression fold change 
range produced by RG7/RG8 when going from HN to TSB (Supplementary Figure D.4C). The NF 
comprising RG7 and RG9 was comparable to RG7/RG8 in all scenarios, with 95% confidence 
normalized expression ranges of PD630_RS15810 similarly changing 0.072 to 0.127-fold when 
going from HN to LN, 0.534 to 0.909-fold when going from HN to TSB, and 0.550 to 1.096-fold 
when going from HN to PHE.  
5.4 Conclusion 
This study represents the first in-depth analysis of stable reference genes in Rhodococcus 
and identified two comparable normalization factors in R. opacus for samples with or without 
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rRNA. The expression of ten candidate reference genes was examined across four distinct growth 
conditions (HN, LN, TSB, and PHE) using three mathematical models (BestKeeper, Normfinder, 
and geNorm) to identify and rank gene expression stability. Based on the geNorm V value and 
corroboration via a normalized gene expression analysis using REST 2009, only two reference 
genes are required for an optimal normalization factor in R. opacus. For samples containing rRNA, 
the two best reference genes were RG7 (PD630_RS25530; ATP-dependent Clp protease ATP-
binding subunit ClpX) and RG8 (PD630_RS01395; 16S rRNA). For samples depleted in rRNA, 
the best two reference genes were RG7 and RG9 (PD630_RS37755; rRNA small subunit 
methyltransferase G). The diversity of growth conditions tested in this work bestows confidence 
in our selections of reference genes for R. opacus, in addition to providing a valuable starting point 
in the choice of reference genes when studying other Rhodococcus spp. 
5.5 Materials and methods 
5.5.1 Strain and culture conditions 
Rhodococcus opacus PD630 (DSMZ 44193) was grown in either a minimal salts medium 
as previously described (minimal media recipe B)9, with one of three distinct combinations of 
carbon and nitrogen sources (discussed in detail in the Gene expression studies section), or a rich 
tryptic soy broth (TSB) medium. Cultures were incubated at 30 oC and 250 rotations per minute 
(rpm). For the growth experiment, all cultures were grown in triplicate 10 mL cultures with an 
initial optical density at 600 nm (OD600) of 0.2. Chemicals were purchased from Sigma-Aldrich 
(St. Louis, MO) unless otherwise noted. MIQE guidelines were applied as appropriate to the design 
and execution of experiments21,22. 
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5.5.2 Candidate reference gene selection and primer design 
The selection of candidate reference genes was based on either previously published 
transcriptomic data for R. opacus3 or literature for other Rhodococcus spp.19,20. RG1 through RG9 
were selected as potentially stable genes based on analysis of RNA-Seq data performed on R. 
opacus grown in a minimal salts medium with either glucose or phenol3. RG10 was chosen based 
on its gene annotation as DNA Polymerase IV, as other Rhodococcus spp. studies have used a 
DNA Polymerase IV gene as a reference gene19,20. RT-qPCR primers (Integrated DNA 
Technologies) were designed based on literature suggestions21,22 and guidelines discussed in the 
Supplementary Materials.  
5.5.3 Primer amplification efficiency and specificity 
To calculate primer amplification efficiency, a serial dilution of template DNA and a linear 
regression analysis of the resultant qPCR results were required. PCR product was obtained by 
using 0.5 μL of GoTaq G2 polymerase (Promega), 10 μL of GoTaq buffer, 1.5 μL of a mixture 
containing the forward and reverse primers (5 μM each), 0.5 μL of genomic DNA (gDNA), 1 μL 
of 10 mM dNTPs (GBiosciences), and 36.5 μL of H2O; and thermocycler conditions of 95 °C for 
2 min, followed by 35 cycles of 95 °C for 15 s, 62 °C for 30 s, and 72 oC for 30 s. PCR products 
were gel extracted using the Zymoclean DNA Gel Recovery kit (Zymo Research) and prepared 
for qPCR using the DNA Clean and Concentrator kit (Zymo Research). Five rounds of a 10-fold 
serial dilution were performed on the purified PCR product. qPCR was performed in duplicate on 
the serially diluted PCR product using a Bio-Rad CFX96 real time thermocycler, TempPlate 96-
well semi-skirt 0.1 mL PCR plates (USA Scientific), and Power SYBR Green PCR Master Mix 
(Applied Biosystems). 10 μL of Power SYBR Green PCR Master Mix, 0.5 μL of a mixture 
containing the forward and reverse primers (5 μM each), 1 μL of PCR product, and 8.5 μL of H2O 
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were used for each reaction. Cycling conditions were 95 °C for 10 min, followed by 40 cycles of 
95 °C for 15 s, 62 °C for 20 s, 72 oC for 20 s, and a fluorescence measurement. A fluorescence 
threshold value of 750 was set for all reactions. To confirm that no off-target amplification had 
occurred, a melting curve analysis was performed at the end of each qPCR program and a single 
melting peak was verified for each amplicon. A linear regression was performed on the threshold 
cycle (CT) values observed from each serial dilution to confirm linearity (R
2) and to calculate the 
equation of the line, which was used to estimate the efficiency of the PCR (Equation 1; 
Supplementary Figure D.1). 
 Eq. 1)       𝑷𝑪𝑹 𝑬𝒇𝒇𝒊𝒄𝒊𝒆𝒏𝒄𝒚 𝑷𝒆𝒓𝒄𝒆𝒏𝒕𝒂𝒈𝒆 = 𝟏𝟎𝟎 ∗ ([𝟏𝟎
  
−𝟏
𝒔𝒕𝒂𝒏𝒅𝒂𝒓𝒅 𝒄𝒖𝒓𝒗𝒆 𝒔𝒍𝒐𝒑𝒆] − 𝟏) 
5.5.4 Gene expression studies 
To examine gene expression stability, R. opacus was grown in four distinct growth 
conditions. The first condition was a rich TSB medium. The other three conditions were minimal 
salts media with carbon and nitrogen sources as follows: glucose with high nitrogen (HN; 2 g/L 
glucose and 1 g/L ammonium sulfate), glucose with low nitrogen (LN; 2 g/L glucose and 0.05 g/L 
ammonium sulfate), and phenol with high nitrogen (PHE; 0.75 g/L phenol + 1 g/L ammonium 
sulfate). A 5 mL seed culture in a 50 mL glass tube containing the minimal salts medium with 2 
g/L glucose and 1 g/L ammonium sulfate was used for the HN, LN, and TSB growth conditions, 
while the PHE seed culture also had 0.3 g/L phenol added to acclimate the cells to the inhibitory 
aromatic. To remove remaining glucose and ammonium sulfate from the seed cultures, samples 
were centrifuged at 3500 relative centrifugal force (rcf), washed with minimal media containing 
no carbon or nitrogen sources, centrifuged again at 3500 rcf, and re-suspended in their final growth 
condition media. When the cultures reached mid-exponential phase, the cells were centrifuged at 
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3500 rcf and re-suspended in DNA/RNA Shield (Zymo Research), per the instructions. Samples 
were stored at -80 oC until needed for further use. 
5.5.5 RNA extraction and cDNA synthesis 
 RNA was extracted from the triplicate biological samples stored at -80 oC in the DNA/RNA 
Shield using the Quick-RNA MiniPrep Plus kit (Zymo Research), per the instructions. The 
optional ZR BashingBead Lysis Tubes (0.1 and 0.5 mm beads; Zymo Research) were used to lyse 
the cells. All samples were treated with the TURBO DNA-free kit (Ambion) to remove any gDNA 
present in the samples and then purified using the RNA Clean and Concentrator kit (Zymo 
Research). To confirm that all gDNA was depleted, PCR was performed by using the previously 
described GoTaq protocol with primers targeting the genome. Gel electrophoresis was performed 
to confirm that no PCR amplification bands existed. Any samples with persisting gDNA were re-
treated with the TURBO DNA-free kit, purified again, and examined via PCR and gel 
electrophoresis. RNA concentration and purity were quantified using a NanoDrop 2000c (all 
samples had a 260 nm/280 nm absorbance ratio of 2 to 2.1). 1 ug of RNA per sample was converted 
to cDNA using the AffinityScript QPCR cDNA synthesis kit (Agilent Technologies).  
5.5.6 RT-qPCR 
RT-qPCR was performed in technical triplicate on the biological triplicate RNA extracts 
using a Bio-Rad CFX96 and Power SYBR Green PCR Master Mix (Applied Biosystems). 10 μL 
of Power SYBR Green PCR Master Mix, 0.5 μL of a mixture containing the forward and reverse 
primers (5 μM each), 1 μL of cDNA, and 8.5 μL of H2O were used for each reaction. Cycling 
conditions were 95 °C for 10 min, followed by 35 cycles of 95 °C for 15 s, 62 °C for 20 s, 72 oC 
for 20 s, and a fluorescence measurement. A threshold value of 750 was set for all reactions. To 
confirm that no off-target amplification had occurred, a melting curve analysis was performed at 
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the end of each qPCR program and a single melting peak was verified for each amplicon 
(Supplementary Figure D.2). Additionally, a negative control (no template control; NTC) was 
included for each primer pair (Table 5.1 and Supplementary Figure D.2). Gel electrophoresis was 
also performed post RT-qPCR to confirm the existence of a single amplicon (Figure 5.1A and 
Supplementary Figure D.5). Gel images were captured using a DigiDoc-It imaging system and its 
accompanying Doc-ItLS software. The original Figure 5.1A gel image was cropped, and contrast 
and exposure settings for the whole image were modified using Adobe Lightroom to improve 
image interpretation. The original image can be found as Supplementary Figure D.5. 
5.5.7 Reference gene expression stability analysis 
The expression level stability of the ten candidate RGs across the four distinct growth 
conditions was assessed and ranked using three commonly used software tools: BestKeeper23, 
NormFinder version 0.95324, and geNorm (built into qBase+ [Biogazelle])16,25 (Figures 5.3 and 
5.4; Supplementary Tables D.2 and D.3). Additionally, all analyses were performed again using 
just candidate RGs 1, 2, 4-7, 9, and 10 to accommodate a situation where rRNA (RG3 and 8) has 
been depleted from the sample (Figure 5.3, Supplementary Figures D.3 and D.4, and 
Supplementary Table D.4). 
 BestKeeper is a Microsoft Excel based tool that calculates the standard deviation and 
coefficient of variance of the CT value for each candidate RG, and creates an index based on the 
geometric mean of the CT values, which it uses to facilitate pair-wise comparisons against and 
between RGs. A Pearson correlation coefficient (r-value) is calculated for each RG, with higher r-
values representing greater stability (max value of 1)23. The technical triplicate CT values for each 
biological replicate were averaged prior to entry into BestKeeper and all four growth conditions 
were pooled and analyzed together. Candidate RGs were ranked on both their CT value standard 
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deviation (values > 1.0 deemed unstable23; Supplementary Table D.2) and their r-value (Figures 
5.3A1 and 5.3A2, and Supplementary Tables D.3 and D.4).  
Normfinder is also a Microsoft Excel based tool that utilizes a model-based approach to 
compare intra- and inter-group variation between candidate RGs and then generates a stability 
value and ranking for each candidate gene24. The lower the stability value, the more stable the 
gene’s expression. The technical triplicate CT values for each biological replicate were averaged 
and samples from all four growth conditions were pooled. Values were then converted to a log-
scale per Equation 2, where E is the amplicon specific PCR efficiency, prior to entry into 
Normfinder24. Candidate RGs were ranked on their stability value (Figures 5.3B1 and 5.3B2). 
Eq. 2)            𝑳𝒐𝒈 𝒕𝒓𝒂𝒏𝒔𝒇𝒐𝒓𝒎𝒆𝒅 𝒗𝒂𝒍𝒖𝒆 = 𝑬 −𝑪𝑻 𝒂𝒗𝒈  
geNorm, formerly a Microsoft Excel based tool that has been incorporated into the qBase+ 
software package (Biogazelle), examines the pairwise variation between RGs and creates a 
stability M value, where lower values represent more stably expressed genes16,25. The program 
iterates its calculations wherein it eliminates the gene with the highest M value and then 
recalculates the stability of the remaining genes. Thus, geNorm creates a ranking of RG stability 
(Figures 5.3C1 and 5.3C2). A geNorm M value lower than 1 is generally considered stable for 
heterogeneous growth conditions22. geNorm can also determine the minimum number of RGs 
required for optimal RT-qPCR normalization. Various normalization factors (NF) are calculated 
by first taking the geometric mean of the two most stable RGs’ CT values and then generating 
additional factors by adding the next best RG until all RGs are used. A pairwise variation (Vn/Vn+1) 
V value is then calculated by comparing the benefit of going from NFn to NFn+1, where n is a 
number of RGs (Figure 5.4 and Supplementary Figure D.3). Once the V value is less than 0.15, 
there is no additional benefit of going from n to n+116,25. 
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5.5.8 Validation of reference gene selection 
The effect of different combinations of the top candidate RGs was examined by creating 
multiple different NFs and normalizing the same set of expression data using REST 2009 (Qiagen).  
The relative expression ratio data of PD630_RS15810 going from the HN condition to either the 
LN, TSB, or PHE condition was normalized by a NF2 comprising any two of the top three RGs 
identified across all analyses (RG3, RG7, and RG8), in addition to a NF3 comprising all three. 
Additionally, RG6 was used as an example of an unsuitable RG, while RG10 was used based on 
literature references for other Rhodococcus spp19,20. 95% confidence intervals were generated by 
REST 2009. If 95% confidence intervals failed to overlap, they were labelled as significantly 
different (p < 0.05). As two of the top three RGs identified encode rRNAs (RG3 and RG8), which 
are frequently depleted when performing RNA-Seq, additional NFs comprising non-rRNA RGs 
(RG5, RG7, and RG9) were examined in comparison to the overall top NF combination (RG7 and 
RG8; Supplementary Figure D.4).   
5.6 Supplementary materials 
The Supplementary Materials can be found in Appendix D and consist of Supplementary 
Table D.1 through D.4, Supplementary Figure D.1 through D.5, and RT-qPCR primer design 
criteria. 
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Chapter 6: Elucidation of the role of the β-ketoadipate 
pathway and transporter genes in aromatic catabolism 
in Rhodococcus opacus PD630. 
 
This work is a modified subset reprinted with permission from Henson, W.R.*, Campbell, T.*, 
DeLorenzo, D.M.*, Gao, Y., Berla, B., Kim, S.J., Foston, M., Moon, T.S., Dantas, G. Multi-omic 
elucidation of aromatic catabolism in adaptively evolved Rhodococcus opacus. Metabolic 
Engineering (2018). 49, 69-83. * = co-first authorship 
 
The development of a genetic toolbox for an organism is just the first of many steps towards 
successfully engineering it. In this chapter, a handful of genetic parts and methodologies described 
in previous chapters will be applied towards elucidating the role of two aromatic degradation 
routes and several transporters identified in R. opacus. Understanding how this organism 
catabolizes lignin-derived aromatic compounds is critical for its application of upgrading biomass 
into value-added products. I engineered the five knockout strains used in this study, performed 
growth assays related to β-ketoadipate pathway knockout strains, and wrote the related sections of 
the manuscript.  
6.1 Abstract 
Lignin utilization has been identified as a key factor in biorefinery profitability. However, 
lignin depolymerization generates heterogeneous aromatic mixtures that inhibit microbial growth 
and conversion of lignocellulose to biochemicals. Rhodococcus opacus is a promising aromatic-
catabolizing, oleaginous bacterium, but mechanisms for its aromatic tolerance and utilization 
remain under-characterized. To better understand aromatic catabolism, gene knockout 
experiments were performed to confirm the primary degradation routes of five aromatic 
compounds. Additionally, the specificity of three transporters that were upregulated based on 
125 
 
transcriptomic analysis were examined through gene knockouts. These results provide an 
improved understanding of aromatic bioconversion and facilitate development of R. opacus as a 
biorefinery host. 
6.2 Introduction 
Lignocellulosic biomass is a potential source of renewable bio-based fuels and chemicals. 
A large fraction of lignocellulose (~70-85%) is cellulose and hemicellulose, which can be 
depolymerized into monomeric sugars, such as glucose and xylose 1-2. The remaining 15-30% of 
lignocellulose is lignin, a highly cross-linked, heterogeneous, and recalcitrant aromatic polymer 3. 
Microbial conversion of lignocellulose holds promise as a new way to produce a variety of novel 
products and petrochemical replacements (e.g., drop-in fuels) 4-13. Current biomass pretreatment 
approaches, which aim to increase sugar extractability from lignocellulose, also release aromatics 
from lignin that negatively affect microbial product titers, yields, and productivities 14-15. Current 
processes separate the carbohydrate fraction from the lignin fraction, and the separated lignin is 
either discarded or burned for process heat or on-site electricity generation 16. However, removal 
of lignin-derived inhibitors from sugar streams is still challenging and costly, and techno-economic 
analyses have identified the co-utilization of lignin as an important factor in biorefinery 
profitability 17-18. Therefore, efforts are underway to develop microbial strains that can tolerate and 
convert inhibitory, lignin-derived compounds into value-added products 19-28.  
Rhodococcus opacus PD630 (hereafter R. opacus) is a promising bacterial strain for 
producing valuable products from lignocellulose. R. opacus is a gram-positive soil bacterium that 
has been shown to have an inherently high tolerance to aromatic compounds 29-30. Additionally, it 
accumulates high levels (up to ~78% as cell dry weight) of the biofuel precursor triacylglycerol 
(TAG) and demonstrates a moderately high growth rate 30-31. R. opacus can natively consume, or 
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has been engineered to consume, hexose and pentose sugars present in lignocellulosic feedstocks 
31-32. R. opacus can also consume aromatic compounds found in depolymerized lignin, such as 
phenol, 4-hydroxybenzoate, and vanillate 33-35, making it uniquely qualified to utilize all three 
primary depolymerized components of lignocellulose.  
The inherent heterogeneity of lignin is a major barrier to lignin valorization, and 
economical strategies require rapid conversion of complex aromatic mixtures to products 36-39. 
Microbial degradation of diverse aromatic compounds is typically accomplished by biological 
funnelling, where compounds are converted into common metabolites (e.g., catechol and 
protocatechuate), prior to their catabolism via a central aromatic degradation pathway, such as the 
β-ketoadipate pathway 39-40. In this work, gene knockout experiments in R. opacus confirmed the 
degradation route of five aromatic compounds through the β-ketoadipate pathway and the 
importance of upregulated transporters for growth on aromatic compounds.  
6.3 Results and discussion 
6.3.1 Examining the degradation routes of five aromatic compounds in R. opacus 
The funnelling pathways convert aromatic compounds into two intermediates, CAT or 
PCA, for degradation by the β-ketoadipate pathway (Figure 6.1). Previous analyses of 
Rhodococcus strains suggest that VAN and HBA are converted to PCA, while GUA, BEN, and 
PHE are converted to CAT 41. To confirm whether the five tested aromatic compounds (PHE, 
GUA, HBA, VAN, and BEN) were catabolized via the CAT or PCA branch of the β-ketoadipate 
pathway, critical genes from both branches were knocked out, and growth assays were performed. 
β-ketoadipate gene cluster #3, which contains the CAT degradation pathway, was knocked out by 
a disruption of RS30730 (cis,cis-muconate cycloisomerase; ΔCAT), while β-ketoadipate gene 
cluster #1, which contains the PCA degradation pathway, was knocked out by a disruption of 
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RS25360 (3-carboxy-cis,cis-muconate cycloisomerase; ΔPCA). The knockout of the PCA 
degradation pathway was complicated by the fact that other central β-ketoadipate pathway genes 
required for CAT degradation are located further downstream in β-ketoadipate gene cluster #1 
(Figure 6.1A). To ensure transcription of those downstream genes, a constitutive promoter was 
integrated into the genome. The ΔCAT strain was unable to grow using PHE, GUA, and BEN as 
sole carbon sources, while the ΔPCA strain was unable to grow using HBA and VAN as sole 
carbon sources (Figure 6.1B, 6.1C). Together, these results confirm that PHE, GUA, and BEN are 
funnelled through the CAT branch, and HBA and VAN are funnelled through the PCA branch of 
the β-ketoadipate pathway in R. opacus. 
 
Figure 6.1. Identification of β-ketoadipate degradation branch degradation routes for five aromatic 
compounds in R. opacus PD630. A) Pathway map showing genes involved in β-ketoadipate 
pathway gene clusters in R. opacus. Gene codes are from the NCBI reference sequence 
NZ_CP003949.1. Red crosses represent gene knockouts performed. B) Difference between initial 
OD600 and final OD600 after 24 hours of growth for the RS30730 knockout (ΔCAT) strain and the 
WT strain using different sole carbon sources. C) Difference between initial OD600 and final OD600 
after 24 hours of growth for the RS25360 knockout (ΔPCA) strain and the WT strain using 
different sole carbon sources. Asterisk (*) indicates that the difference between initial and final 
OD600 values is less than one standard deviation. Bars represent the average of three biological 
replicates and error bars represent one standard deviation. 
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6.3.2 Transporters for lignin model compounds.  
Transporter expression control may be related to aromatic tolerance mechanisms. The 
putative shikimate transporter (RS31355), which was significantly upregulated in other phenol-
adapted R. opacus strains 34, was also upregulated in PHE (281 to 299-fold) and the mixture (87 
to 295-fold) for both WT and PVHG6 relative to the glucose condition at both time points. An 
MFS transporter (RS33590) was moderately upregulated in response to PCA precursors VAN (137 
to 193-fold) and HBA (10 to 15-fold), and the mixture (45 to 115-fold), but was minimally 
upregulated by CAT precursors PHE, GUA, and BEN (1.0 to 3.7-fold) in WT and PVHG6 at both 
time points (Table S11). Another MFS transporter (RS30810) located adjacent to the BEN 
degradation cluster was upregulated in BEN (1330 to 1720-fold) and the mixture (958 to 2620-
fold) for both WT and PVHG6 at the first time point. The MFS transporter RS30810 was also 
moderately upregulated by CAT precursor GUA (57 to 62-fold), but only minimally upregulated 
by PCA precursors VAN (1.6 to 7.5-fold) and HBA (1.1 to 8.7-fold) in both strains compared to 
the glucose condition. The branch-dependent upregulation of MFS transporters RS33590 and 
RS30810 is similar to what was observed for the β-ketoadipate pathway. Overall, we observed 
multiple transporters whose expression was responsive to lignin model compounds. 
To explore the role of transporters in aromatic tolerance and utilization, we compared the 
growth of three putative transporter knockout mutants (RS31355, RS33590, and RS30810) to that 
of the WT strain using different carbon sources (Figure 6.2). The growth of these knockout mutants 
and the WT strain were compared using 0.75 g/L PHE, 1.25 g/L GUA, 1.75 g/L VAN, 2 g/L HBA, 
5 g/L BEN, and the combined mixture (2.5 g/L total aromatics) as sole carbon sources. The 
putative shikimate transporter (RS31355) knockout mutant had lower cell densities (OD600) after 
48 hours than the WT strain using PHE and the mixture as sole carbon sources, which matches 
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previous reports of RS31355 having a role in PHE transport (Yoneda et al., 2016). The putative 
vanillate transporter (RS33590) knockout mutant had lower OD600 values than the WT strain using 
VAN, PHE, and the mixture as sole carbon sources. The putative benzoate transporter (RS30810) 
knockout mutant had lower OD600 values than the WT strain using BEN, VAN, GUA, PHE, and 
the mixture as sole carbon sources (Figure 6.2). None of the transporter knockout mutants 
exhibited growth impairments on HBA (Figure 6.2). The impaired growth of the putative aromatic 
transporter knockout mutants on some compounds suggests transporter specificity and that the 
influx or efflux of aromatic compounds plays an important role in aromatic tolerance and 
utilization (Figure 6.2). 
 
Figure 6.2. Growth of transporter knockout mutants compared to that of the WT strain using 
aromatic carbon sources. Bars represent the average of three biological replicates and error bars 
represent one standard deviation. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, 
GUA = guaiacol, BEN = sodium benzoate, and Mix = 0.5 g/L of PHE, VAN, HBA, GUA and 
BEN (2.5 g/L total aromatics). ΔShikiT = RS31355 knockout mutant, ΔBenT = RS30810 knockout 
mutant, and ΔVanT = RS33590 knockout mutant.  
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6.4 Materials and methods 
6.4.1 Chemicals and strains 
Chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise 
indicated, and Rhodococcus opacus PD630 (DSMZ 44193) was used as the ancestral strain (WT) 
for comparison to all mutated strains. For all growth experiments (unless otherwise indicated), 
cells were grown at 30 °C and 250 rpm in one of two defined minimal salts media (A or B; medium 
composition as previously described 41). Culture media were filter-sterilized using a 0.22 µm filter, 
and pH was adjusted to 7.0 using 6M HCl or 2M NaOH.  Carbon and nitrogen sources were added 
as sterile-filtered stock solutions. R. opacus strains were maintained on tryptic soy broth (TSB) 
plates supplemented with 1.5% agar. 
6.4.2 Generation of R. opacus knockout mutants 
Knockout mutants were generated via homologous recombination in the wild type R. 
opacus strain as described previously 42. Briefly, a helper plasmid expressing a pair of 
recombinases (pDD120) was introduced via electroporation into WT R. opacus. Electrocompetent 
cells were made from this strain as previously described 41. An integration vector containing an 
antibiotic resistance marker and DNA regions homologous to each target gene (~500 bp per 
homologous arm) was then introduced into the strain harboring the recombinase helper plasmid 
by electroporation 42. Successful recombination was confirmed by colony PCR. See Table S16 for 
plasmids utilized for knockouts and Table S17 for all strains generated. Plasmid DNA was isolated 
from Escherichia coli DH10B for electroporation into R. opacus using the Zyppy Plasmid 
Miniprep Kit (Zymo). 
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6.4.3 Growth of R. opacus knockout mutants 
For the β-ketoadipate pathway knockout experiment, the WT, ΔCAT, and ΔPCA strains 
were initially cultured in 2 mL of minimal medium B containing 1 g/L ammonium sulfate, 4 g/L 
glucose, and either no aromatic compound, 0.2 g/L PHE, 0.25 g/L GUA, 0.5 g/L HBA, 0.25 g/L 
VAN, or 0.5 g/L BEN. Cells were then centrifuged, washed with minimal medium B containing 
no carbon source, and re-suspended to an initial OD600 of 0.2 in 10 mL of minimal medium B 
containing 1 g/L ammonium sulfate and either 1 g/L glucose, 0.4 g/L PHE, 0.5 g/L GUA, 1.0 g/L 
HBA, 0.5 g/L VAN, or 1 g/L BEN as sole carbon sources. For the transporter knockout experiment, 
all strains were initially cultured in 2 mL of minimal medium A supplemented with 0.2 g/L of 
sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 
1 g/L ammonium sulfate for 24 hours, and then subcultured into 10 mL of the same media for 24 
hours to an OD600 of ~0.5. Cells were then diluted to an OD600 of 0.05 in 10 mL of minimal media 
A supplemented with 1 g/L ammonium sulfate and either 0.75 g/L PHE, 1.75 g/L VAN, 2 g/L 
HBA, 1.25 g/L GUA, 5 g/L BEN or a mixture of 0.5 g/L of each compound (2.5 g/L total 
aromatics). The optical density at 600 nm was measured for all cultures after 48 hours of growth.  
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Chapter 7: Conclusion and future directions 
 
7.1 Conclusion 
 The discovery of fossil fuels and their by-products has allowed humanity to rapidly 
industrialize and achieve many notable accomplishments over the past two and a half centuries. 
As the human population increases, however, fossil fuel consumption continues to increase while 
reserves diminish. Furthermore,  research has definitively linked greenhouse gas emissions from 
the burning of fossil fuels with detrimental changes in atmospheric composition. As we improve 
our understanding of these changes, society must face the harmful environmental side-effects of 
large-scale carbon burning. Alternative sources of fuel and petroleum-derived products are 
required to help displace those currently produced from hydrocarbon deposits. One such 
alternative is renewable plant biomass, which, when depolymerized, forms easily fermentable 
sugars along with aromatic compounds similar to those found in petroleum. Biomass breakdown 
products—particularly those derived from the lignin fraction—exhibit a large diversity of 
monomers and oligomers that make chemical separations difficult.  
 A biological catalyst can be employed to funnel a variety of different biomass breakdown 
products into single value-added products using their vast catabolic pathways and central 
metabolism. Rhodococcus opacus PD630 was chosen as a suitable biological catalyst due to its 
ability to consume an array of compounds found in depolymerized biomass, such as aromatics 
derived from lignin and hexose and pentose sugars derived from the cellulose and hemicellulose 
fractions, respectively. Lignocellulose-derived feedstocks can readily be funneled into the central 
metabolite acetyl CoA and then into lipid metabolism, wherein R. opacus generates high levels of 
triacylglycerides (TAGs). TAGs are readily converted into biodiesel via a simple 
136 
 
transesterification reaction. Furthermore, R. opacus has a high native tolerance to aromatic 
compounds, which are generally toxic and inhibitory to most microbes, allowing higher substrate 
loads and greater product titers.  
The work described in this dissertation promotes the use of R. opacus as a microbial chassis 
for the conversion of biomass-derived products into biofuels, or other value-added products, and 
provides insight into its aromatic catabolism in a number of ways. These advances include: 1) the 
development of strong constitutive promoters for the overexpression of heterologous genes, 2) the 
development of chemical and metabolite sensors for inducible and dynamic gene expression, 3) 
the characterization of native and endogenous plasmid backbones and resistance markers, 4) a 
heterologous T7 RNA polymerase platform for high levels of gene transcription, 5) the 
demonstration of genetic logic circuits for programmable gene expression, 6) a recombinase-based 
platform for gene knockouts and insertions, 7) a CRISPR interference (CRISPRi) platform for 
targeted gene repression, 8) the identification of stable reference genes for RT-qPCR applications, 
9) insight into aromatic degradation through the β-ketoadipate pathway, and 10) insight into the 
role of aromatic transporters. Taken together, this work greatly advances the ability to engineer R. 
opacus for any desired application, in addition to providing understanding into its catabolism of 
aromatic compounds.  
7.2 Future directions 
7.2.1 Investigating aromatic-related degradation pathways, gene regulation, and 
tolerance mechanisms in R. opacus 
 The utilization of a biological catalyst to “funnel” a mixture of biomass breakdown 
products through an organism’s metabolism into a single, high-value product is one approach to 
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upgrading a low-value, heterogeneous feedstock.1 R. opacus is one of several prokaryotic and 
eukaryotic organisms (e.g., Pseudomonas putida2, Escherichia coli3, Trichosporon cutaneum4) 
that could be used as a biological funnel. One of the primary requirements for this function is that 
the organism be able to import and consume the majority of the lignin breakdown products in the 
mixture. The mechanisms that facilitate these processes in R. opacus are understudied, as only 
three transporters—those described in Chapter 6—and a handful of aromatic degradation pathways 
have been characterized.5-10 Thus far, R. opacus has been demonstrated to consume the lignin 
model compounds 4-hydroxybenzoate5, benzoate5, phenol5, vanillate5, guaiacol5, catechol5, 
protocatechuate5, ferulic acid11, and trans-p-coumaric acid12, in addition to several types of actual 
lignin breakdown products, such as switchgrass pyrolysis oil13, alkali-treated corn stover and 
poplar wood 14-16, and depolymerized kraft lignin17. Very recently, an engineered strain of R. 
opacus that secretes a heterologous laccase was demonstrated to grow on insoluble kraft lignin.18 
Further research into the types of aromatics that R. opacus can consume and the mechanisms that 
allow it to do so (i.e., compound import, funneling pathways, redox shifts) should be conducted.  
 Knowing that R. opacus is capable of consuming aromatics derived from lignin is just the 
first step in utilizing this host as a biological catalyst. While transcriptomic and proteomic data has 
been analyzed to identify gene candidates for many aromatic funneling pathways, gene knockouts 
still need to be performed to confirm these degradation routes, such as was done in Chapter 6 with 
the catechol and protocatechuate branches of the β-ketoadipate pathway.5, 18 Furthermore, as the 
current reference genomes available for R. opacus have been discovered to contain many 
inaccuracies in gene annotation, a more comprehensive bioinformatic analysis based on protein 
homology should be performed, as has been done in Pseudomonas putida. These pathways can 
then also be confirmed in R. opacus through gene knockouts.19 To fill in researchers knowledge 
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of other critical pathways and funneling enzymes in R. opacus,  additional transcriptomic and 
proteomic data should be collected on a much wider variety of lignin model compounds, in 
addition to various forms of depolymerized lignin. To maximize the potential of this host, a 
comprehensive knowledge of all its transporters, catabolic, and other aromatic-related genes 
should be investigated.  
 If considering a cost-effective and efficient industrial process, R. opacus must not only be 
able to consume lignin-derived feedstocks but also perform this function at a high rate. On a single 
lignin model compound (phenol), R. opacus has demonstrated record level microbial degradation 
rates at the highest reported concentrations for a free cell.20 A mixture of lignin model compounds 
proved more problematic though, as R. opacus has been observed to consume aromatics in a 
preferential order, rather than simultaneously.5 The source of this consumption hierarchy could 
arise through either enzyme kinetics (i.e., varying transport and degradation rates for each 
compound) or via transcriptional, post-transcriptional, translational, or post-translational 
regulation. In P. putida, another viable biological catalyst for lignin valorization, a single catabolite 
repression control (Crc) protein was found to inhibit the consumption of 4-hydroxybenzoate and 
vanillate when either glucose or acetate were present.21 When this gene was deleted, higher rates 
of conversion of these compounds was measured. Knockout studies of regulators identified in R. 
opacus to be upregulated in previous transcriptomic studies conducted on mixtures of lignin model 
compounds could lead to similar discoveries. Furthermore, small RNA and proteomic studies 
conducted when R. opacus is grown on single aromatic compounds and mixtures of compounds 
could provide insight into post-transcriptional, translational and post-translational regulation 
mechanisms, which to date has not been studied in R. opacus. 
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Regarding post-transcriptional regulation, recent work has revealed that in the related 
organism Mycobacteria tuberculosis, small regulatory RNA (sRNA) act in a functionally distinct 
manner than in model organisms, such as E. coli, to modulate translational rates.22 Rather than 
depending on a protein to assist in sRNA:mRNA binding, as occurs with the Hfq protein in E. coli, 
these mycobacterial sRNA are protein independent and use looping structures to facilitate gene 
repression. Small RNA have been previously detected in R. opacus, but no research has been 
performed to further investigate the mechanism or function of these non-coding RNAs.20 
Additional studies into native sRNA could provide both insight into an entire level of regulatory 
mechanisms previously ignored in R. opacus and also enable the development of synthetic RNA 
regulators for tunable gene repression. 
The final topic related to lignin conversion that should be investigated once catabolic 
pathways and their regulation are better understood is the tolerance mechanisms that R. opacus 
employs in the presence of toxic lignin-derived compounds. Recent work has found that wild type 
R. opacus modulates its lipidome in the presence of phenol, including changes such as fewer 
double bonds in multiple lipid species and increased levels of phosphatidylinositols.23 Another 
study found that R. opacus mutants adapted on mixtures of aromatics were able to generate higher 
levels of triacylglycerol than the wild type strain.5, 20 These lipid changes are hypothesized to alter 
the ability of phenolics to cross the cellular membrane, although it is unclear if the changes are 
inhibiting or promoting transfer. It is also not known which genes in particular are responsible for 
the observed changes in the lipidome. Past studies have identified lists of possible gene targets, 
whether they be genes that were up- or downregulated in the presence of aromatics or genes that 
were mutated during adaptive evolution on aromatics, but no follow-up work has yet been 
performed to narrow down these lists to the  key genes.  
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Another suspected aromatic tolerance mechanism in R. opacus is its catabolic capabilities. 
As R. opacus consumes inhibitory aromatics inside or nearby the cell, the effective concentration 
of those compounds is lowered. The more efficiently this process occurs, the higher the observed 
tolerance. This is supported by the fact that different lineages of R. opacus mutants adapted on 
mixtures of aromatics had recurrent mutations in genes related to the reduction-oxidation (redox) 
state within the cell. In particular, genes for superoxide dismutase and cytochrome ubiquinol 
oxidase were frequently mutated, with protein models predicting reduced activity.5 The activity of 
superoxide dismutase was tested between one adapted strain (PVHG6) and wild type R. opacus, 
and the mutated version was found to have substantially lower activity. The role of superoxide 
dismutase is to remove superoxide radicals from the cell. Superoxide radicals, however, are 
required as part of the aromatic ring cleaving step. Thus, an increase in the prevalence of 
superoxide radicals could lead to improvements in aromatic consumption, facilitating increases in 
tolerance. Further research via gene knockouts and knockdowns, gene overexpressions, and the 
re-creation of single nucleotide polymorphisms (SNPs) observed in adapted strains should be 
performed for gene targets identified in both the lipidome and redox state tolerance mechanisms 
to better understand the sources of tolerance in R. opacus.  
7.2.2 Engineering branched-chain fatty acid production in R. opacus 
The engineering of lipid metabolism in common lab microbes, such as E. coli and 
Saccharomyces cerevisiae, has primarily focused on altering metabolic pathways to lead to the 
overproduction of straight chain fatty acids.24-27 R. opacus is well-known for being an oleaginous 
organism innately capable of high levels of TAG accumulation (up to 76% cell dry weight when 
grown on gluconate).28 TAGs are comprised of three fatty acid esters attached to a glycerol and 
are a valuable product due to the ease in which they can be converted into biodiesel via a simple 
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transesterification reaction that generates straight chain free fatty acids.29 However, fatty acids that 
contain branching have a number of improved properties relevant to biofuel—valuable military-
grade jet fuel, in particular—including a lower freezing point and better cold-flow.27, 30-31 
Furthermore, these properties can be tuned by altering the number and location of the branch 
points.31 Other valuable applications of branched-chain fatty acids include petroleum replacements 
for use as plasticizers, surfactants, and flavorings.32  
Branched-chain fatty acid synthesis has been engineered in several model organisms, such 
as E. coli and S. cerevisiae, using glucose as a feedstock.27, 32 The benefit of using R. opacus for 
branched-chain fatty acid production is that low-grade lignin can be used as a feedstock instead of 
the more valuable glucose. In addition, previous lipid analysis of R. opacus strains have found 
varying levels of native branched-chain fatty acids, up to 34% when grown on aromatics.28, 33-34 
This innate ability to produce branched-chain fatty acids, in addition to being an oleaginous 
organism, could result in a reduction in engineering efforts to generate high product titers 
compared to other potential aromatic consuming microbes. Furthermore, as branched-chain fatty 
acids can lead to more valuable products that traditional biofuels, an industrial process utilizing 
this strain would more easily achieve a positive economic return.  
7.2.3 Domestication of R. opacus 
 Microbial cell culture in a laboratory or industrial setting significantly contrasts with what 
an organism is exposed to in its native habitat. For instance, R. opacus is natively a soil bacterium, 
but it is cultured in liquid media. Additionally, native cellular mechanisms that are beneficial in 
the wild, such as the ability to recombine DNA, is a nuisance when an engineered DNA construct 
is inadvertently disrupted. Microbial strains have been previously domesticated to a lab setting 
similar to how higher-order organisms, such as dogs, have been domesticated for human-
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associated life.35 Domestication to improve cell growth can be achieved simply by serially 
culturing the microbe in the desired media over many generations. For instance, R. opacus strains 
passaged on a mixture of aromatic compounds were found to have lost up to two of the nine 
endogenous plasmids that the wild type harbors.5 This loss of two large plasmids (172 kilo base 
pairs [kbps] and 97 kbps) could improve R. opacus growth by reducing the metabolic cost of DNA 
repair and replication. These plasmids are thought to harbor genes that are non-essential for cell 
growth but could be beneficial to the cell under extreme conditions.36 In a controlled setting, these 
genes are likely unnecessary and the removal of all nine endogenous plasmids could lead to an 
improvement in the growth rate of R. opacus. Furthermore, origins of replication and maintenance 
systems (i.e., toxin-antitoxin systems) could be isolated from these removed endogenous plasmids 
to create a suite of synthetic plasmid backbones.  
Passive domestication of a microbe is not the only option, as rational engineering can be 
applied to make a better performing lab strain. For instance, the common E. coli DH10B cloning 
strain was modified from its ancestor E. coli K-12 MG1655 in several ways to improve plasmid 
assembly and stability. To reduce recombination events that disrupt plasmid DNA, the recA 
recombinase gene was deleted from the genome. To avoid possible issues with plasmid 
propagation, native restriction/modification systems that could digest introduced plasmid DNA 
were also knocked out.37 To further reduce metabolic burden, unnecessary genes, such as 
redundant gene duplications that add genetic bloat to the genome, could be removed from the R. 
opacus genome. In a K-12 strain of E. coli, 15% of the genome was deleted leading to 
improvements in growth and allowing for simplified engineering efforts.38 Any efforts to 
domesticate R. opacus into a more stable host would be beneficial if the strain is to be used in an 
industrial setting in the future. 
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7.2.4 Improving R. opacus consumption on actual lignin breakdown products  
 The eventual goal for R. opacus is to use this host as a biological catalyst to convert low-
value lignin breakdown products into higher value compounds, such as lipids. Thus far, it has been 
shown that R. opacus is capable of growth on a variety of aromatic compounds, in addition to 
several forms of real-world lignin.5, 15, 20, 39-40 The adaptive capacity of R. opacus has also been 
demonstrated, as the growth and consumption of different inhibitory compounds found in 
depolymerized lignocellulose (e.g., furans, hydroxymethylfurfural, phenolics, organic acids) has 
been improved through evolutionary selection.5, 20, 41 However, no adaption of R. opacus on real-
world lignin has been performed. Performing directed evolution using real lignin as a feedstock, 
which contains a greater diversity of compounds than previously published carbon sources, would 
be the most beneficial step to improving R. opacus as a chassis for lignin valorization. Performing 
a multi-omics analysis on these adapted strains could provide a wealth of insight into the catabolic 
and tolerance mechanisms that R. opacus possesses and provide even more gene targets that can 
be investigated using the tools developed in this dissertation.  
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Appendix A: Supplementary information for 
development of chemical and metabolite sensors for 
Rhodococcus opacus PD630 
 
A.1 Supplementary data tables 
Supplementary Table A.1. List of genetic elements. 
      
Part Nucleotide Sequence 
Kanamycin 
Resistance Gene 
Cassette1 
tcagaagaactcgtcaagaaggcgatagaaggcgatgcgctgcgaatcgggag
cggcgataccgtaaagcacgaggaagcggtcagcccattcgccgccaagctct
tcagcaatatcacgggtagccaacgctatgtcctgatagcggtccgccacacc
cagccggccacagtcgatgaatccagaaaagcggccattttccaccatgatat
tcggcaagcaggcatcgccatgggtcacgacgagatcctcgccgtcgggcatc
cgcgccttgagcctggcgaacagttcggctggcgcgagcccctgatgctcttc
gtccagatcatcctgatcgacaagaccggcttccatccgagtacgtgctcgct
cgatgcgatgtttcgcttggtggtcgaatgggcaggtagccggatcaagcgta
tgcagccgccgcattgcatcagccatgatggatactttctcggcaggagcaag
gtgagatgacaggagatcctgccccggcacttcgcccaatagcagccagtccc
ttcccgcttcagtgacaacgtcgagcacagctgcgcaaggaacgcccgtcgtg
gccagccacgatagccgcgctgcctcgtcttggagttcattcagggcaccgga
caggtcggtcttgacaaaaagaaccgggcgcccctgcgctgacagccggaaca
cggcggcatcagagcagccgattgtctgttgtgcccagtcatagccgaatagc
ctctccacccaagcggccggagaacctgcgtgcaatccatcttgttcaatcat
gcgaaacgatcctcatcctgtctcttgatcagatcttgatcccctgcgccatc
agatccttggcggcaagaaagccatccagtttactttgcagggcttcccaacc
ttaccagagggcgccccagctggcaattccggttcgcttgctgtccataaaac
cgcccagtctagctatcgccatgtaagcccactgcaagctacctg 
pAL5000 – Origin 
of Replication1 
ttagaacagcggtggattgtcggcttcgttgtgggccttttgagccgcttcct
gttctgccgcacgctctttcctcgcccgatagccgagtcgcttaacggtgtcc
agatgcagcccgaaatgtttggccgtttgcggccaagagtggccctcgtcgtc
gtgataggcgcggatgcgttcgcggcgtgcagcctgctcggcgagccactcgc
tgcgttcctgcgccacgagccggacgacgtggcgttcggatagtccggtgatt
cgagcgccttcggcggcggtcacgcgccgctttttgcggacagtcggctgccg
gttgtagccgtcgctgtagccgtcgctcatagcaatgcctccatggctgacgc
ggactttgcgcgccgcgcaactgtgctcgccgccgtgcgcgctgctgcgccct
tccgcgagatggccgactggcgcgcactgagtgtggcctcgtagaccacgatc
ccgtccgcccaaatgcgcgacttggttgtgatccaacgccaaatgctgttggc
gatggcgcggacctcgctgtccggtagcggtccgggacacacgtcgttgcacg
ggaactcggcgtttcgcgcgtggcactcggcatagatcgcgcggccgagtccg
tccacgttccgggtcggcaggtagatccgcatgagggcgggacgataggccca
caacctgacggaatcgaacagtgcgcaattccgccctagcggcgtcggagccg
ctttgtacgtggtctgctgacgccagcgcggcggtggcatgttcgcgccgagc
tcggcctcgatgtggctgagtgtgtagagatctgagtggagccattccgtttc
ccaggcgatgtggccggggtttttggtcatgaggcctgagtaactgcggtcgc
cgtccacggcgcgccgaaggccttcggcgcacgccgccatgtatgcgagcggc
148 
 
ttacgccgcgcgtattcggtgcgtggaacaggggcgttgagtgcccacactgc
gtgtgcgtggccgttggcgcgattgcccacgatcgcgttgggcagcggatggg
acccccgggcgctgagcgctcggagcgctgcgtctggatggtctacgtccacg
accagcaggtttgccagcgctgttgggttcgcctcgatgtaccggcggcctag
ggccgacgcgcggctttggcggtagatcccctcgagcagatcgtcgcttgcca
gcggccagtacggcagccagagctgctcaaattcgtcggcgacgtggctca 
pMB1 – Origin of 
Replication1 
cgcgttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaa
atcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccag
gcgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccgct
taccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcaat
gctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggc
tgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaacta
tcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagcca
ctggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttcttg
aagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgc
tctgctgaagccagttaccttcggaaaaagagttggtagctcttgatccggca
aacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacg
cgcagaaaaaaaggatctcaagaagatcctttgatct 
Strong Constitutive 
Promoter + UTR 
(for Figure 1.1)2 
tgtgcgggctctaacacgtcctagtatggtaggatgagcaacatttcgacgcc
gagagattcgccgcccgaaatgagcacgatccgcatgcttaattaagaaggag
atatacat 
araC Cassette + 
pBAD Promoter + 
UTR3 
ttatgacaacttgacggctacatcattcactttttcttcacaaccggcacgga
actcgctcgggctggccccggtgcattttttaaatacccgcgagaaatagagt
tgatcgtcaaaaccaacattgcgaccgacggtggcgataggcatccgggtggt
gctcaaaagcagcttcgcctggctgatacgttggtcctcgcgccagcttaaga
cgctaatccctaactgctggcggaaaagatgtgacagacgcgacggcgacaag
caaacatgctgtgcgacgctggcgatatcaaaattgctgtctgccaggtgatc
gctgatgtactgacaagcctcgcgtacccgattatccatcggtggatggagcg
actcgttaatcgcttccatgcgccgcagtaacaattgctcaagcagatttatc
gccagcagctccgaatagcgcccttccccttgcccggcgttaatgatttgccc
aaacaggtcgctgaaatgcggctggtgcgcttcatccgggcgaaagaaccccg
tattggcaaatattgacggccagttaagccattcatgccagtaggcgcgcgga
cgaaagtaaacccactggtgataccattcgcgagcctccggatgacgaccgta
gtgatgaatctctcctggcgggaacagcaaaatatcacccggtcggcaaacaa
attctcgtccctgatttttcaccaccccctgaccgcgaatggtgagattgaga
atataacctttcattcccagcggtcggtcgataaaaaaatcgagataaccgtt
ggcctcaatcggcgttaaacccgccaccagatgggcattaaacgagtatcccg
gcagcaggggatcattttgcgcttcagccatacttttcatactcccgccattc
agagaagaaaccaattgtccatattgcatcagacattgccgtcactgcgtctt
ttactggctcttctcgctaaccaaaccggtaaccccgcttattaaaagcattc
tgtaacaaagcgggaccaaagccatgacaaaaacgcgtaacaaaagtgtctat
aatcacggcagaaaagtccacattgattatttgcacggcgtcacactttgcta
tgccatagcatttttatccataagattagcggatcctacctgacgctttttat
cgcaactctctactgtttctccatacagcggataaagtagcaaagagaaggag
gttagga 
LPD06575 
Upstream Region4 
cgcaaagcggatcacctccgcgctcagcggatcgacgcgccgttcccacggtc
gtactttcgtccgtacctcatcagcgccccggacaggaagggaggctccgacc 
LPD06568 
Upstream Region4 
ccaccagcgattcgtgtacgtattcggactcggggttgacatttcaatgtgac
tgcgcgcacagtagtggtgtacgcacagcgtgatggtagtacgcagagcgtac
agaatgcaagaccctcggcgcgtgaacacccaccgcgtcgcccaaaactcgat
atcagcccattccgctccctcccagcccaaggagaaacag 
149 
 
LPD06699 
Upstream Region4 
agaaatcccttcggcgctactccgggtgtgatgtgcgtcgctgattcggaaaa
gtgtgtacgagtcgtgggggctccggaaccgccgattcggtgaaattcgcgcg
gtcgagatagacgaaacggcagtaccacgcatctgcgccttcttgacaacgcg
gaaacgctatggctaccgtcacattattcaaccagcggacatgcgttcggtat
gcgaacaggatctgtccggtaccaacctagacgggacatcgga 
LPD06740 
Upstream Region4 
aactcccgaccttagcatcgcctgtgactcacgtcactgcaagtgccggcgac
ccccgtccggcgaacccgtttcgcgttccggatcgcgccttcgcaatgcggat
cgacggactgtgatgcccgtcatacgttgtgctggtccccattcgcgggggtt
accgcacgaatcgtgcagaaaggcggtcaggagaa 
LPD03031 
Upstream Region4  
cggacgctcttcgacacgcctaggaaacatgcaggaaacctcacatcggcccg
gctgaaaagtgaggatcagttgacgttgcggtcaccgaccgcagcaccgccgc
aacaccggttttctacctttgggtctcccacacaacgaggaggcccggg 
pTet promoter 
(optimized for 
Mycobacterium 
sp.)5 
tctgaccagggaaaatagccctctgacctggggatttgacttccctatcagtg
atagagataatctgggagtccctatcagtgatagagaAGGCGGtatcgat 
R. opacus 
optimized 
pConstitutive + 
UTR + tetR 
(derived from Rock 
et al., 2017)5 
gtgatagattgcgatgcgtgtgctcggttgaacctctctgtcagatcaggagg
acttcgcatgtcgcggttggataagtccaaggtcatcaactcggcgctggagc
tgctgaacgaggtcggtatcgagggactgaccacgcgcaagttggcccaaaag
ctcggcgtggaacaaccgaccctctactggcacgtgaagaacaagcgcgcgct
gctggatgcgttggccatcgagatgctggatcgccatcacacgcacttttgcc
ccctggagggcgagagctggcaggattttctgcggaacaacgcgaagtcgttc
cggtgcgccctcctgagccatcgggatggcgccaaagtccacttgggcacccg
cccgaccgagaagcaatacgagaccctggagaaccagctggccttcctctgtc
aacagggtttttcgttggagaacgccctgtatgccctgtccgccgtgggacac
ttcaccttgggctgcgtgttggaggatcaggaacatcaggtggcgaaagagga
acgggagacccccacgacggattcgatgcccccgttgttgcgccaggcgatcg
aactgtttgaccaccagggcgccgaacccgcctttttgttcgggctggagctg
atcatctgcgggctggaaaagcaactgaagtgcgaaagcggttcgtga 
amiA, amiC, amiD, 
and amiS + 
pAcet Promoter + 
UTR6 
gaactccgttgtagtgcttgtggtggcatccgtggcgcggccgcggtaccaga
tctttaaatctagataaagaagtgacgcggtctcaagcgtcgagcgtcgtcag
cgtgtcgaggatgtcgaagtcgtagccgtcggcgctggcgatgtagacctgct
ggtcgaattgactgtcgcgcatacacatcgggccccggggcccgtcgaacccg
acatcgtgcgcggatgccatcaggtccggtatctcgggggagtgggcccgctg
gaagatggcctcgagcgcaacgagaccctcgtaacaggattcggccatcgcgt
tgagcggtggcgcgtcggcgccgtagcgggcgacgtagctgcccatcaggtcc
atggcacccgcggtggccagtgaactgaagtacgccgcggcgacatagaggtt
ttcggtggagccggcgccgctggccagcagcatgttctcctccatcagcgggc
tgaaccgcgccatgcggtcgtgcccgccggcgcgcgcgaactcgcggttgaac
aacacggcgtcctggccgacgagcagcatcaacacggcctgcgcccccgacgc
gatggccttgcggaccggtgcgcggaaatcgtcggtgccgtacgggacgtaga
tctcccgtctgagctcgaggtccagatctcggcagtacgcgcgggcggccgcg
gcggaacggcgcggccagatgtagtcatcgccgaccaggcaccaggaccggat
gccgaagtggtcgcgcagccaggcgagcgcgggcgcgatctggatctgcggtg
tctcgcctgtgcagaacacgcccggtgtgcgttcaccgccctcgtacaacgag
gtgtagacgtacgggatgcggtcgcggaccaccggggagatgcggttgcgcac
ggccgagatgtgccagccggtcacggcgtcgagaccgtgacctcgcaaccggt
cggcgacggtccgggcgacgtcgtcgccgggccgtccgccgtcgagcacctcg
atggtgaccttgcggccctgcaggccgcctcggtcgttgacctccttggccgc
gagctcggccacggcctcgcacgaaggcgcgaagattcccgctggcccttgaa
gcggaatcaccagcccgacgcggaactcaacctcgccgtcctgcactccagat
150 
 
caccgtcgatcccgtgtagtctgcgcttcaaagctttctagcagaaataattc
attctgaacagaccccgccgtcgacacgaggagacacccaccatggccgccgg
acagcagcgccgccccaacctcctgctgccgttggtgcgtctgacccacctcg
cggagtcggcgatcgaacgcgtgctcgcggactcgtcgctcaagatcgaggac
tggcgcgtgctcgacgagttggccggacggcgcaccgtgcccatgagcgatct
cgcgcaggccacgctgatcacgggtccgactctcaccagaaccgtcgatcgcc
ttgtgtcgcaagggatcatctaccggactgccgatctgcatgaccgccggcgg
gtgctcgtggcgttgaccccgcgggggcggacgctgcgcaaccgcctggtgga
cgcggtagccgaggccgagtgtgcggcttttgaatcgtgcgggctggacgtcg
accagttgcgcgaactcgtcgacaccacctcgaatttgacttcgtaaccaccc
gcgcccggccggcgttcacccttgacttttattttcatctggatatatttcgg
gtgaatggaaaggggtgaccatgccgacctacacattccgttgttcccactgc
ggtcccttcgatctcacctgcgcgatctccgagcgcgatgcggcggcgacctg
tccggagtgccggacgccggcgcgccgggtcttcggttcggtagggctgacga
cattcaccgcgggacatcaccgcgcattcgacgcggcgtccgcgagcgccgaa
agtcccacggtggtgaagtcgattcccgcaggcgcggaccgcccgcgggcccc
gcgccgcaatcccggtctaccgagtctgccgaggtactagcgacatgggtggc
gtcgggctcttctacgtgggtgcggtgctcatcatcgacgggctgatgctgct
gggccgcatcagcccacgaggcgcaacaccgctgaacttcttcgtcggcggac
tgcaggtggtgacgcctacggtgctgatcctgcagtccggcggagacgcggcc
gtgatcttcgcggcctccgggctctacctgttcggcttcacctacctgtgggt
ggccatcaacaacgtgaccgactgggacggagaaggtctcggatggttctcgc
tgttcgtcgcgatcgccgcactcggctactcgtggcacgcgttcaccgccgag
gccgacccggcgttcggggtgatctggctgctgtgggcagtgctgtggttcat
gctgttcctgctgctcggcctggggcacgacgcactggggcccgccgtcgggt
tcgtcgcggtggccgaaggcgtgatcaccgccgccgtgccggccttcctgatc
gtgtcgggcaactgggaaaccggcccgctccccgccgcggtcatcgccgtgat
cggttttgccgcagttgttctcgcataccccatcgggcgccgtctcgcagcgc
cgtcagtcaccaaccctccaccggccgcgctcgcggccaccacccgataagag
aaagggagtccacatatgtaacggatccagctgcagaattcgaagcttatcga
tgtcgacgtagttacgagatcggcggccgcat 
CFP7 atgactagcaaaagaagcaaaggtgaagaactgttcactggtgttgttccaat
tctggttgaactggatggtgatgttaatggtcacaaattttctgtctctggtg
agggtgaaggtgatgcaacctacggtaaactgaccctgaaatttatttgcact
actggtaaactgcctgttccgtggccaaccctggtcactactctgacttgggg
tgttcaatgctttgctcgttacccagatcacatgaaacagcatgactttttca
agtctgccatgccggaaggttatgttcaggaacgtactatctttttcaaagat
gacggtaactacaagacccgtgctgaagtcaagtttgaaggtgataccctggt
taatcgtatcgagctgaaaggtattgattttaaagaagatggtaacattctgg
gtcacaaactggaatacaacgctatttctgataatgtatacatcactgctgac
aaacaaaagaatggtatcaaagctaatttcaaaattcgtcacaacattgaaga
tggtagcgttcaactggcagaccattatcaacaaaatactccaattggcgatg
gccctgtcctgctgccagacaaccattacctgtccacccaatctcgtctgtct
aaagatccgaacgaaaagcgcgatcacatggtcctgctggagtttgtaaccgc
tgctggtattaccctgggcatggatgaactgtataaataatag  
RFP7 atggcgagtagcgaagacgttatcaaagagttcatgcgtttcaaagttcgtat
ggaaggttccgttaacggtcacgagttcgaaatcgaaggtgaaggtgaaggtc
gtccgtacgaaggtacccagaccgctaaactgaaagttaccaaaggtggtccg
ctgccgttcgcttgggacatcctgtccccgcagttccagtacggttccaaagc
ttacgttaaacacccggctgacatcccggactacctgaaactgtccttcccgg
aaggtttcaaatgggaacgtgttatgaacttcgaagacggtggtgttgttacc
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gttacccaggactcctccctgcaagacggtgagttcatctacaaagttaaact
gcgtggtaccaacttcccgtccgacggtccggttatgcagaaaaaaaccatgg
gttgggaagcttccaccgaacgtatgtacccggaagacggtgctctgaaaggt
gaaatcaaaatgcgtctgaaactgaaagacggtggtcactacgacgctgaagt
taaaaccacctacatggctaaaaaaccggttcagctgccgggtgcttacaaaa
ccgacatcaaactggacatcacctcccacaacgaagactacaccatcgttgaa
cagtacgaacgtgctgaaggtcgtcactccaccggtgcttaa 
mCherry8 atggtgagcaagggcgaggaggataacatggccatcatcaaggagttcatgcg
cttcaaggtgcacatggagggctccgtgaacggccacgagttcgagatcgagg
gcgagggcgagggccgcccctacgagggcacccagaccgccaagctgaaggtg
accaagggtggccccctgcccttcgcctgggacatcctgtcccctcagttcat
gtacggctccaaggcctacgtgaagcaccccgccgacatccccgactacttga
agctgtccttccccgagggcttcaagtgggagcgcgtgatgaacttcgaggac
ggcggcgtggtgaccgtgacccaggactcctccctgcaggacggcgagttcat
ctacaaggtgaagctgcgcggcaccaacttcccctccgacggccccgtaatgc
agaagaagaccatgggctgggaggcctcctccgagcggatgtaccccgaggac
ggcgccctgaagggcgagatcaagcagaggctgaagctgaaggacggcggcca
ctacgacgctgaggtcaagaccacctacaaggccaagaagcccgtgcagctgc
ccggcgcctacaacgtcaacatcaagttggacatcacctcccacaacgaggac
tacaccatcgtggaacagtacgaacgcgccgagggccgccactccaccggcgg
catggacgagctgtacaagtaa 
GFP+9 atggctagcaaaggagaagaacttttcactggagttgtcccaattcttgttga
attagatggtgatgttaatgggcacaaattttctgtcagtggagagggtgaag
gtgatgctacatacggaaagcttacccttaaatttatttgcactactggaaaa
ctacctgttccatggccaacacttgtcactactttgacctatggtgttcaatg
cttttcccgttatccggatcatatgaaacggcatgactttttcaagagtgcca
tgcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggaac
tacaagacgcgtgctgaagtcaagtttgaaggtgatacccttgttaatcgtat
cgagttaaaaggtattgattttaaagaagatggaaacattctcggacacaaac
tcgagtacaactataactcacacaatgtatacatcacggcagacaaacaaaag
aatggaatcaaagctaacttcaaaattcgccacaacattgaagatggctccgt
tcaactagcagaccattatcaacaaaatactccaattggcgatggccctgtcc
ttttaccagacaaccattacctgtcgacacaatctgccctttcgaaagatccc
aacgaaaagcgtgaccacatggtccttcttgagtttgtaactgctgctgggat
tacacatggcatggatgagctctacaaataa 
sfGFP10 atgcgtaaaggcgaagagctgttcactggtgtcgtccctattctggtggaact
ggatggtgatgtcaacggtcataagttttccgtgcgtggcgagggtgaaggtg
acgcaactaatggtaaactgacgctgaagttcatctgtactactggtaaactg
ccggtaccttggccgactctggtaacgacgctgacttatggtgttcagtgctt
tgctcgttatccggaccatatgaagcagcatgacttcttcaagtccgccatgc
cggaaggctatgtgcaggaacgcacgatttcctttaaggatgacggcacgtac
aaaacgcgtgcggaagtgaaatttgaaggcgataccctggtaaaccgcattga
gctgaaaggcattgactttaaagaagacggcaatatcctgggccataagctgg
aatacaattttaacagccacaatgtttacatcaccgccgataaacaaaaaaat
ggcattaaagcgaattttaaaattcgccacaacgtggaggatggcagcgtgca
gctggctgatcactaccagcaaaacactccaatcggtgatggtcctgttctgc
tgccagacaatcactatctgagcacgcaaagcgttctgtctaaagatccgaac
gagaaacgcgatcatatggttctgctggagttcgtaaccgcagcgggcatcac
gcatggtatggatgaactgtacaaatga 
EYFP3 atggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcga
gctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagg
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gcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggcaag
ctgcccgtgccctggcccaccctcgtgaccaccttcggctacggcctgcaatg
cttcgcccgctaccccgaccacatgaagctgcacgacttcttcaagtccgcca
tgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaac
tacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcat
cgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagc
tggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaag
aacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgt
gcagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgc
tgctgcccgacaaccactacctgagctaccagtccgccctgagcaaagacccc
aacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggat
cactctcggcatggacgagctgtacaaggctgcgaattga  
 
 
Supplementary Table A.2. Summary of plasmids.   
 
Plasmid Name Functional Insert Origin of 
Replication 
Antibiotic 
Resistance 
Length 
(bp) 
pDD56 pBAD.EYFP  pAL5000/pMB1 Kanamycin 6013 
pDD57 pConstitutive.GFP+ pAL5000/pMB1 Kanamycin 4776 
pDD65 Empty Vector pAL5000/pMB1 Kanamycin 3659 
pDD86 pAcet.GFP+ pAL5000/pMB1 Kanamycin 7451 
pDD87 pLPD03031.GFP+ pAL5000/pMB1 Kanamycin 4818 
pDD89 pLPD02697.GFP+ pAL5000/pMB1 Kanamycin 5026 
pDD90 pLPD06364.GFP+ pAL5000/pMB1 Kanamycin 4904 
pDD91 pLPD06132.GFP+ pAL5000/pMB1 Kanamycin 5009 
pDD93 pLPD06131.GFP+ pAL5000/pMB1 Kanamycin 4780 
pDD94 pLPD02061.GFP+ pAL5000/pMB1 Kanamycin 5020 
pDD95 pLPD03169.GFP pAL5000/pMB1 Kanamycin 4821 
pDD101 pConstitutive.EYFP pAL5000/pMB1 Kanamycin 4782 
pDD102 pConstitutive.RFP pAL5000/pMB1 Kanamycin 4736 
pDD103 pConstitutive.mCherry pAL5000/pMB1 Kanamycin 4769 
pDD104 pConstitutive.CFP pAL5000/pMB1 Kanamycin 4790 
pDD105 pConstitutive.sfGFP pAL5000/pMB1 Kanamycin 4775 
pDD122 pTet.mCherry + pConstitutive.TetR pAL5000/pMB1 Kanamycin 6225 
pDD131 pTet.mCherry + pConstitutive 
(optimized).TetR 
pAL5000/pMB1 Kanamycin 6225 
pRH033 pLPD06740.GFP+ pAL5000/pMB1 Kanamycin 4857 
pRH035 pLPD06568.GFP+ pAL5000/pMB1 Kanamycin 4861 
pRH036 pLPD06575.GFP+ pAL5000/pMB1 Kanamycin 4768 
pRH037 pLPD06699.GFP+ pAL5000/pMB1 Kanamycin 4917 
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Supplementary Table A.3. Summary of strains.   
 
Strain Name 
 
Genus Species Strain Plasmid Contained 
DMD056 Escherichia coli DH10B Empty Vector pAL5000.pMB1.Kanamycin  
DMD057 Escherichia coli DH10B pBAD.EYFP.pAL5000.pMB1.Kanamycin 
DMD066 Rhodococcus opacus PD630 pBAD.EYFP.pAL5000.pMB1.Kanamycin 
DMD081 Rhodococcus opacus PD630 Empty Vector pAL5000.pMB1.Kanamycin  
DMD082 Rhodococcus opacus PD630 pLPD06575.GFP+.pAL5000.pMB1.Kanamycin  
DMD083 Rhodococcus opacus PD630 pLPD06568.GFP+.pAL5000.pMB1.Kanamycin  
DMD084 Rhodococcus opacus PD630 pLPD06740.GFP+.pAL5000.pMB1.Kanamycin  
DMD086 Rhodococcus opacus PD630 pLPD06699.GFP+.pAL5000.pMB1.Kanamycin  
DMD097 Escherichia coli DH10B Max.Const.GFP+.pAL5000 
DMD099 Escherichia coli DH10B pAcet.GFP+.pAL5000.pMB1.Kanamycin  
DMD100 Rhodococcus opacus PD630 pAcet.GFP+.pAL5000.pMB1.Kanamycin  
DMD105 Escherichia coli DH10B pLPD03031.GFP+.pAL5000.pMB1.Kanamycin 
DMD107 Escherichia coli DH10B pLPD02697.GFP+.pAL5000.pMB1.Kanamycin 
DMD108 Escherichia coli DH10B pLPD06364.GFP+.pAL5000.pMB1.Kanamycin 
DMD109 Escherichia coli DH10B pLPD06132.GFP+.pAL5000.pMB1.Kanamycin 
DMD111 Escherichia coli DH10B pLPD06131.GFP+.pAL5000.pMB1.Kanamycin 
DMD112 Escherichia coli DH10B pLPD02061.GFP+.pAL5000.pMB1.Kanamycin 
DMD113 Escherichia coli DH10B pLPD03169.GFP.pAL5000.pMB1.Kanamycin 
DMD116 Rhodococcus opacus PD630 pLPD03031.GFP+.pAL5000.pMB1.Kanamycin 
DMD118 Rhodococcus opacus PD630 pLPD02697.GFP+.pAL5000.pMB1.Kanamycin 
DMD119 Rhodococcus opacus PD630 pLPD06364.GFP+.pAL5000.pMB1.Kanamycin 
DMD120 Rhodococcus opacus PD630 pLPD06132.GFP+.pAL5000.pMB1.Kanamycin 
DMD122 Rhodococcus opacus PD630 pLPD06131.GFP+.pAL5000.pMB1.Kanamycin 
DMD123 Rhodococcus opacus PD630 pLPD02061.GFP+.pAL5000.pMB1.Kanamycin 
DMD124 Rhodococcus opacus PD630 pLPD03169.GFP.pAL5000.pMB1.Kanamycin 
DMD135 Escherichia coli DH10B Max.Const.EYFP.pAL5000 
DMD136 Escherichia coli DH10B Max.Const.RFP.pAL5000 
DMD137 Escherichia coli DH10B Max.Const.mCherry.pAL5000 
DMD138 Escherichia coli DH10B Max.Const.CFP.pAL5000 
DMD139 Escherichia coli DH10B Max.Const.sfGFP.pAL5000 
DMD146 Rhodococcus opacus PD630 Max.Const.GFP+.pAL5000 
DMD147 Rhodococcus opacus PD630 Max.Const.EYFP.pAL5000 
DMD148 Rhodococcus opacus PD630 Max.Const.RFP.pAL5000 
DMD149 Rhodococcus opacus PD630 Max.Const.mCherry.pAL5000 
DMD150 Rhodococcus opacus PD630 Max.Const.CFP.pAL5000 
DMD151 Rhodococcus opacus PD630 Max.Const.sfGFP.pAL5000 
DMD163 Escherichia coli DH10B pTet.mCherry + pConstitutive.TetR.pAL5000 
DMD170 Rhodococcus opacus PD630 pTet.mCherry + pConstitutive.TetR.pAL5000 
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DMD174 Rhodococcus opacus PD630 pTet.mCherry + pConstitutive 
(optimized).TetR.pAL5000 
WRH079 Escherichia coli DH10B pLPD06740.GFP+.pAL5000.pMB1.Kanamycin  
WRH081 Escherichia coli DH10B pLPD06568.GFP+.pAL5000.pMB1.Kanamycin  
WRH082 Escherichia coli DH10B pLPD06575.GFP+.pAL5000.pMB1.Kanamycin 
WRH083 Escherichia coli DH10B pLPD06699.GFP+.pAL5000.pMB1.Kanamycin  
 
 
Supplementary Table A.4. Fitted Hill equation parameters. The modified Hill equation, described 
below in Supplementary Methods, was fit to each promoter data set by minimizing the root mean 
square error (RMSE). Fmax and Fmin represent the maximum and minimum fluorescence, 
respectively. The Hill coefficient (n), half-maximal constant (K), and RMSE are also reported. 
 
Figure Strain Fmax Fmin n K RMSE 
1.2A pBAD-EYFP-pAL5000 22222 au 279 au 0.869 4.387 mM 986.298 
1.2B pAcet-GFP+-pAL5000 821 au 162 au 0.772 0.249 nM 39.364 
1.2C pTet-mCherry-pAL5000 608 au 0 au 1.126 0.175 ng/mL 2.055 
1.3 pLPD03031-GFP+-pAL5000; 0.05 g/L N 0.916 0 11.162 7.134 hr 0.081 
1.3 pLPD03031-GFP+-pAL5000; 0.1 g/L N 0.942 0 11.022 9.118 hr 0.043 
1.3 pLPD03031-GFP+-pAL5000; 0.2 g/L N 0.963 0 17.653 11.309 hr 0.039 
1.3 pLPD03031-GFP+-pAL5000; 0.3 g/L N 0.950 0 20.963 12.845 hr 0.028 
1.3 pLPD03031-GFP+-pAL5000; 0.4 g/L N 0.965 0 23.140 14.551 hr 0.019 
1.3 pLPD03031-GFP+-pAL5000; 0.5 g/L N 0.980 0 24.414 16.549 hr 0.023 
1.3 pLPD03031-GFP+-pAL5000; 0.6 g/L N 0.936 0 21.849 19.765 hr 0.032 
1.3 pLPD03031-GFP+-pAL5000; 0.7 g/L N 0.938 0 25.948 21.312 hr 0.036 
1.3 pLPD03031-GFP+-pAL5000; 0.8 g/L N 0.987 0 17.003 23.867 hr 0.0315 
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Supplementary Table A.5. Phenol sensor time points (hr) for Figure 1.4. Based on growth curves 
(see Supplementary Figure A.7), the time point closest to early stationary phase was identified for 
each growth condition such that fluorescent values could be compared on an equal growth basis. 
The time points (hr) identified for each strain and growth condition are reported below. Cultures 
were grown in minimal media A. 
 
Construct 1 g/L 
Glucose 
1 g/L Glucose + 0.1 
g/L Phenol 
1 g/L Glucose + 0.3 
g/L Phenol 
1 g/L Glucose + 0.75 
g/L Phenol 
Empty Vector 18 20 31.5 43 
pLPD06568 16 18 23 40 
pLPD06575 18 20 31.5 43 
pLPD06699 14 14 20 34 
pLPD06740 23 31.5 34 61 
 
 
Supplementary Table A.6. Phenol and catechol degradation operon homology. R. opacus PD630 
genes were compared to the R. erythropolis CCM2505 genome and proteome using NCBI blastn 
and blastx (https://blast.ncbi.nlm.nih.gov/Blast.cgi). The nucleotide percent identity based on local 
alignment (blastn) is reported as the number of identical base pairs, in addition to the expect (E) 
value. The E value represents the number of expected hits when searching a database (the smaller 
value, the more significant match). Local alignment scores for the promoter sequences are not 
reported because the nucleotide sequences are too short. Once the R. erythropolis CCM2505 
homologs were identified, a global alignment between each pair of gene or promoter sequences 
was performed using NCBI global alignment (Needleman-Wunsch). The nucleotide percent 
identity based on global alignment is reported as the number of identical basepairs. The amino acid 
positive percent identity between each protein pair is reported as the number of identical or 
physically similar amino acids, in addition to the E value.  
 
R. opacus 
PD630 Gene 
or Promoter 
R. erythropolis 
CCM2505 Gene 
or Promoter 
Nucleotide Local 
Alignment 
Percent Identity 
Nucleotide 
Local 
Alignment 
E value 
Nucleotide 
Global 
Alignment 
Percent 
Identity 
Amino 
Acid 
Positive 
Percent 
Identity 
Amino 
Acid E 
value 
LPD06566 catC 224/284 (79%) 2e-62 224/284 
(79%) 
83/93 
(89%) 
2e-55 
LPD06567 catB 892/1121 (80%) 0.0 892/1122 
(80%) 
350/373 
(93%) 
0.0 
LPD06568 catA 638/844 (76%) 5e-165 640/943 
(68%) 
222/263 
(84%) 
2e-141 
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pLPD06568 catA promoter N/A N/A 130/220 
(59%) 
N/A N/A 
LPD06569 catR 513/674 (76%) 1e-135 567/774 
(73%) 
209/254 
(82%) 
6e-136 
LPD06574 pheR 544/786 (69%) 3e-80 648/1008 
(64%) 
227/302 
(75%) 
1e-139 
LPD06575 pheA2 412/530 (78%) 2e-118 432/570 
(76%) 
163/184 
(88%) 
5e-113 
pLPD06575 pheA2 promoter N/A N/A 61/112 
(54%) 
N/A N/A 
LPD06576 pheA1 1316/1559 (84%) 0.0 1359/1632 
(83%) 
517/543 
(95%) 
0.0 
LPD06739 pheR 486/742 (65%) 2e-43 608/957 
(64%) 
224/311 
(72%) 
9e-120 
LPD06740 pheA2 422/540 (78%) 6e-90 434/578 
(75%) 
157/186 
(84%) 
3e-107 
pLPD06740 pheA2 promoter N/A N/A 107/214 
(50%) 
N/A N/A 
LPD06741 pheA1 1308/1564 (84%) 0.0 1340/1632 
(82%) 
508/540 
(94%) 
0.0 
 
 
Supplementary Table A.7. Aromatic sensor time points (hr) for Figure 1.5. Based on growth 
curves (see Supplementary Figure A.7), the time point closest to early stationary phase was 
identified for each growth condition such that fluorescent values could be compared on an equal 
growth basis. The time points (hr) identified for each strain and growth condition are reported 
below. Cultures were induced with 0.3 g/L phenol (PHE) or an equimolar amount of 
protocatechuic acid (PCA), sodium benzoate (BEN), 4-hydroxybenzoic acid (HBA), vanillic acid 
(VAN), or guaiacol (GUA) in minimal media B, in addition to 1 g/L glucose (GLU). 
 
Strain GLU PHE PCA BEN HBA VAN GUA 
Empty Vector 7.5 11.5 7.5 8.5 8.5 10.5 10.5 
pLPD06568 7.5 10.5 7.5 8.5 8.5 10.5 9.5 
pLPD06575 7.5 11.5 7.5 8.5 8.5 10.5 9.5 
pLPD06699 7.5 11.5 7.5 8.5 8.5 10.5 10.5 
pLPD06740 7.5 29 8.5 8.5 8.5 10.5 10.5 
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Supplementary Table A.8. Fluorescent reporter excitation and emission wavelengths. 
 
Reporter Excitation (nm) Emission (nm) 
CFP 435 483 
EYFP 485 528 
GFP+ 488 530 
sfGFP 488 530 
RFP 535 620 
mCherry 535 620 
 
 
A.2 Supplementary figures 
 
 
Supplementary Figure A.1. Expression of mCherry in R. opacus. Cells constitutively expressing 
mCherry (DMD149) are shown under white ambient light.  
 
Supplementary Figure A.2. Effect of arabinose on R. opacus growth. The absorbance at 600 nm 
was plotted versus the arabinose inducer concentration (0 to 250 mM). Values represent the 
average of three replicates, and error bars represent one standard deviation. The dashed line 
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represents a logarithmic regression, with the equation of the line reported. The addition of 
arabinose had no significant effect (|logarithmic coefficient| < 0.01) on R. opacus growth (strain 
containing pBAD-EYFP-pAL5000; DMD066). Cells were grown in minimal media A with 1 g/L 
glucose. 
 
 
Supplementary Figure A.3. Effect of acetamide on R. opacus growth. The absorbance at 600 nm 
was plotted versus the acetamide inducer concentration (0 to 1000 nM). Values represent the 
average of three replicates, and error bars represent one standard deviation. The dashed lines 
represent logarithmic regressions, with the equations of the line reported. The addition of 
acetamide demonstrated no significant effect (|logarithmic coefficient | < 0.01) on the empty vector 
strain’s (DMD081) growth but led to a reduction in the pAcet-GFP+-pAL5000 strain’s (DMD100) 
growth. The pAcet promoter requires the heterologous expression of four proteins, which in 
addition to GFP+ adds burdens to the cell. Cells were grown in minimal media A with 2 g/L 
glucose. 
 
 
Supplementary Figure A.4. Effect of aTc on R. opacus growth. The absorbance at 600 nm was 
plotted versus the aTc inducer concentration (0 to 100 ng/mL). Values represent the average of 
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three replicates, and error bars represent one standard deviation. The dashed line represents a 
logarithmic regression, with the equation of the line reported. The addition of aTc had no 
significant effect (|logarithmic coefficient| < 0.01) on R. opacus growth (strain containing pTet-
mCherry-pAL5000; DMD174). Cells were grown in minimal media B with 2 g/L glucose. 
 
 
 
Supplementary Figure A.5. Nitrogen sensor candidate promoters. The promoters of seven genes 
(LPD02061, LPD02697, LPD03031, LPD03169, LPD06131, LPD06132, and LPD06364) that 
were found to be highly transcribed under low nitrogen conditions (using previously published 
RNA-Seq data) were placed in front of GFP+.4 Cultures were grown in minimal media A with 2 
g/L glucose and either 0.05 g/L (low nitrogen) or 1.0 g/L (high nitrogen) ammonium sulfate. 
Fluorescence was measured after 48 hrs. pLPD03031 was found to be induced ~18-fold in 
fluorescence between low and high nitrogen conditions. Values represent the average of three 
replicates, and error bars represent one standard deviation. 
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Supplementary Figure A.6. Activation of the nitrogen sensor is not dependent on growth phase. 
The nitrogen sensor strain (containing pLPD3031) was grown in minimal media B with 10 g/L 
glucose and either 0.6 g/L or 1.5 g/L ammonium sulfate. The absorbance at 600 nm (proxy for 
growth) was plotted on the primary y-axis (left). The normalized fluorescence was plotted on the 
secondary y-axis (right). Values represent the average of three replicates, and error bars represent 
one standard deviation. Lines are drawn to aid eyes and linearly connect data points. 
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Supplementary Figure A.7. Growth curves of cells expressing GFP+ under the control of 
pLPD06575. An example of how time points were chosen to compare fluorescence values between 
different phenol concentrations. R. opacus was grown in minimal media A with 1 g/L glucose and 
either 0, 0.1, 0.3, or 0.75 g/L phenol for Figure 1.4. Increasing concentrations of phenol led to 
longer lag phases, preventing fluorescent values from being compared on an equal growth basis at 
a single time point. Fluorescent values were compared at early stationary phase (i.e., when the 
absorbance at 600 nm, a proxy for cell density, first reaches a plateau). The vertical lines, color 
coded to match data sets, designate which time point was chosen. This process was performed for 
each phenol inducible promoters; additional plots are not shown, but time points are reported in 
Supplementary Table 5. Additionally, this process was applied to Figure 1.5 (cells grown in 
minimal media B), as each aromatic compound tested (PHE, PCA, BEN, HBA, VAN, and GUA) 
produced a lag phase of different length (time points listed in Supplementary Table 7). Values 
represent the average of three replicates, and error bars represent one standard deviation. Lines are 
drawn to aid eyes and linearly connect data points. 
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Supplementary Figure A.8. Normalized phenol promoter fluorescence. The upstream regions of 
LPD06575, LPD06568, LPD06740, and LPD06699 were cloned in front of GFP+. The strains 
were grown with 1 g/L glucose and either 0, 0.1, 0.3, or 0.75 g/L phenol. This figure represents 
the fluorescence data shown in Figure 1.4 prior to normalization by the maximum fluorescence 
value produced by each promoter. Values represent the average of three replicates grown in 
minimal media A, and error bars represent one standard deviation. 
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A.3 Supplementary materials and methods 
A.3.1 Minimal media recipe A - Used for the fluorescent reporter, pBAD, pAcet, and 
phenol induction experiments.   
Recipe adapted from Schlegel et al., 1961.11  
Recipe for 1 L of media: Media were filter-sterilized (0.22 M filter) after all components were 
mixed and pH was adjusted to 7.0 using 6M HCl.  
Chemical/Component Amount per 1 L of media 
10x salt solution 100 mL 
Hoagland salt solution 1 mL 
CaCl2 1 mL of 20 mg/mL stock 
(NH4)5[Fe(C6H4O7)2] 1 mL of 1.2 mg/mL stock 
NaHCO3 0.5 g 
 
10x salt solution: 
Chemical Amount per 1 L 
Na2HPO4 35.7 g 
KH2PO4 15 g 
MgSO4*7H2O 2 g 
 
Hoagland salt solution: 
 
Chemical mg/L 
(NH4)3PO4 115.03 
H3BO3 2.86 
Ca(NO3)2 656.4 
CuSO4*5H2O 0.08 
Na2EDTA*2H2O 33.534 
FeSO4*7H2O 25.02 
MgSO4 240.76 
MnCl2*4H2O 1.81 
MoO3 0.016 
KNO3 606.6 
ZnSO4*7H2O 0.22 
 
• Carbon and nitrogen sources were added as filter-sterilized solution. 
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A.3.2 Minimal media recipe B - Used for the pTet, nitrogen sensor, and aromatic sensor 
induction experiments. 
 
Recipe adapted from: Chartrain et al., 199812. 
 
Recipe for 1 L of media: Media were filter-sterilized (0.22 M filter) after all components were 
mixed and pH was adjusted to 7.0 using 6M HCl.  
Chemical/Component Amount per 1 L of media 
MgSO4*7H2O 1.0 g 
CaCl2*2H2O 0.015 g (1 mL of 15 g/L stock) 
Sodium bicarbonate 0.5 g 
Trace Element Solution 1 mL of stock 
Stock Solution A 1 mL of stock 
Phosphate Buffer (1M) 20 mL of stock  
 
Trace element stock solution: 
Chemical g/L 
FeSO4*7H2O 0.5 
ZnSO4*7H2O 0.4 
MnSO4*H2O 0.02 
H3BO3 0.015 
NiCl2*6H2O 0.01 
EDTA 0.25 
CoCl2*6H2O 0.05 
CuCl2*2H2O 0.005  
 
Stock A solution: 
Chemical g/L 
NaMoO4 2.0 
FeNa*EDTA 5.0 
 
Phosphate buffer stock (1 M):  
Chemical g/L 
K2HPO4 113.0 
KH2PO4 47.0 
 
• Carbon and nitrogen sources were added as filter-sterilized solution. 
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A.3.3 Electrocompetent cell preparation and transformation protocol for R. opacus 
PD63013 
2 mL of tryptic soy broth (TSB) in a 50 mL glass tube was inoculated with R. opacus 
PD630 and incubated overnight at 30oC and 250 rpm. Overnight cultures were diluted to an OD600 
of 0.05 in 100 mL of TSB media, supplemented with 8.5 g/L glycine and 10 g/L sucrose, in a 250 
mL baffled shake flask and incubated at 30oC and 250 rpm for ~16 hrs (until OD600 reaches ~0.5). 
Cells were centrifuged in 50 mL conicals (Falcon) at 3500 relative centrifugal force (rcf) and 
washed twice with sterile deionized water. Cells were re-suspended in 10% glycerol at an OD600 
of ~10-15. Aliquots of 200 L were frozen at -80oC. Electrocompetent cells were incubated at 
45oC for 5 min, electroporated at 2500 mV with ~500 ng plasmid DNA (Bulldog Bio 2 mm cuvette; 
time constant 5-6 ms), diluted with 600 L TSB media, and incubated again at 45oC for 5 min. 
Transformed cells were then transferred to a 50 mL glass tube and incubated at 30oC and 250 rpm 
for 3 hrs. Cells were plated on TSB agar plates with kanamycin (50 g/mL). Colonies appeared 
after 2-3 days.  
 
A.3.4 Hill equation fitting 
The Hill equation was modified, as described in Immethun et al. (2017), to model the promoter 
transfer function.3 The model was fit to the experimentally determined fluorescence data such that 
the RMSE was minimized (Microsoft Excel Solver GRG Nonlinear). Fitted values are listed in 
Supplementary Table 4.  
 
For pBAD, pAcet, and pTet: 
𝐹 =  
(𝐹𝑚𝑎𝑥 − 𝐹𝑚𝑖𝑛) ∗ 𝐼𝑛𝑑𝑢𝑐𝑒𝑟
𝑛
𝐼𝑛𝑑𝑢𝑐𝑒𝑟𝑛 + 𝐾𝑛
+  𝐹𝑚𝑖𝑛 
 
𝐹 = 𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐹𝑚𝑎𝑥 = 𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐹𝑚𝑖𝑛 = 𝑀𝑖𝑛𝑖𝑚𝑢𝑚 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐾 = 𝐻𝑎𝑙𝑓 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 
𝑛 = 𝐻𝑖𝑙𝑙 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
𝐼𝑛𝑑𝑢𝑐𝑒𝑟 = 𝑟𝑒𝑠𝑝𝑒𝑐𝑡𝑖𝑣𝑒 𝑝𝑟𝑜𝑚𝑜𝑡𝑒𝑟 𝑖𝑛𝑑𝑢𝑐𝑒𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 
 
 
For the nitrogen sensor: 
𝐹 =
(𝐹𝑚𝑎𝑥 − 𝐹𝑚𝑖𝑛) ∗ 𝑡
𝑛
𝑡𝑛 + 𝐾𝑛
+ 𝐹𝑚𝑖𝑛 
𝑡 = 𝑇𝑖𝑚𝑒 (ℎ𝑟) 
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Root mean square error (RMSE): 
√
∑ (𝐹 − 𝐹𝑜𝑏𝑠)2
𝑛
𝑖=1
𝑛 − 2
  
𝐹𝑜𝑏𝑠 = 𝑂𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
n = Number of data points 
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Appendix B: Construction of genetic logic gates based 
on the T7 RNA polymerase expression system in 
Rhodococcus opacus PD630 
 
B.1 Supplementary tables 
Supplementary Table B.1. List of genetic parts. 
Part Nucleotide Sequence 
kanR1 atgattgaacaagatggattgcacgcaggttctccggccgcttgggtggagaggctattcggct
atgactgggcacaacagacaatcggctgctctgatgccgccgtgttccggctgtcagcgcaggg
gcgcccggttctttttgtcaagaccgacctgtccggtgccctgaatgaactccaagacgaggca
gcgcggctatcgtggctggccacgacgggcgttccttgcgcagctgtgctcgacgttgtcactg
aagcgggaagggactggctgctattgggcgaagtgccggggcaggatctcctgtcatctcacct
tgctcctgccgagaaagtatccatcatggctgatgcaatgcggcggctgcatacgcttgatccg
gctacctgcccattcgaccaccaagcgaaacatcgcatcgagcgagcacgtactcggatggaag
ccggtcttgtcgatcaggatgatctggacgaagagcatcaggggctcgcgccagccgaactgtt
cgccaggctcaaggcgcggatgcccgacggcgaggatctcgtcgtgacccatggcgatgcctgc
ttgccgaatatcatggtggaaaatggccgcttttctggattcatcgactgtggccggctgggtg
tggcggaccgctatcaggacatagcgttggctacccgtgatattgctgaagagcttggcggcga
atgggctgaccgcttcctcgtgctttacggtatcgccgctcccgattcgcagcgcatcgccttc
tatcgccttcttgacgagttcttctga 
hygR2 atgagccggatgaccggcaccacctggcggtccgcgatggacggcacgaccgaccggaacgcgc
tgctcgccctggcccgcgaactcggccgggtgctcggccggctgcacagggtgccgctgaccgg
gaacaccgtgctcaccccccattccgaggtcttcccggaactgctgcgggaacgccgcgcggcg
accgtcgaggaccaccgcgggtggggctacctctcgccccggctgctggaccgcctggaggact
ggctgccggacgtggacacgctgctggccggccgcgaaccccggttcgtccacggcgacctgca
cgggaccaacatcttcgtggacctggccgcgaccgaggtcaccgggatcgtcgacttcaccgac
gtctatgcgggagactcccgctacagcctggtgcaactgcatctcaacgccttccggggcgacc
gcgagatcctggccgcgctgctcgacggggcgcagtggaagcggaccgaggacttcgcccgcga
actgctcgccttcaccttcctgcacgacttcgaggtgttcgaggagaccccgctggatctctcc
ggcttcaccgatccggaggaactggcgcagttcctctgggggccgccggacaccgcccccggcg
cctga 
R. opacus origin of 
replication on pAL5000 
(short variant;  S)1  
ttagaacagcggtggattgtcggcttcgttgtgggccttttgagccgcttcctgttctgccgca
cgctctttcctcgcccgatagccgagtcgcttaacggtgtccagatgcagcccgaaatgtttgg
ccgtttgcggccaagagtggccctcgtcgtcgtgataggcgcggatgcgttcgcggcgtgcagc
ctgctcggcgagccactcgctgcgttcctgcgccacgagccggacgacgtggcgttcggatagt
ccggtgattcgagcgccttcggcggcggtcacgcgccgctttttgcggacagtcggctgccggt
tgtagccgtcgctgtagccgtcgctcatagcaatgcctccatggctgacgcggactttgcgcgc
cgcgcaactgtgctcgccgccgtgcgcgctgctgcgcccttccgcgagatggccgactggcgcg
cactgagtgtggcctcgtagaccacgatcccgtccgcccaaatgcgcgacttggttgtgatcca
acgccaaatgctgttggcgatggcgcggacctcgctgtccggtagcggtccgggacacacgtcg
ttgcacgggaactcggcgtttcgcgcgtggcactcggcatagatcgcgcggccgagtccgtcca
cgttccgggtcggcaggtagatccgcatgagggcgggacgataggcccacaacctgacggaatc
gaacagtgcgcaattccgccctagcggcgtcggagccgctttgtacgtggtctgctgacgccag
cgcggcggtggcatgttcgcgccgagctcggcctcgatgtggctgagtgtgtagagatctgagt
ggagccattccgtttcccaggcgatgtggccggggtttttggtcatgaggcctgagtaactgcg
gtcgccgtccacggcgcgccgaaggccttcggcgcacgccgccatgtatgcgagcggcttacgc
cgcgcgtattcggtgcgtggaacaggggcgttgagtgcccacactgcgtgtgcgtggccgttgg
cgcgattgcccacgatcgcgttgggcagcggatgggacccccgggcgctgagcgctcggagcgc
tgcgtctggatggtctacgtccacgaccagcaggtttgccagcgctgttgggttcgcctcgatg
taccggcggcctagggccgacgcgcggctttggcggtagatcccctcgagcagatcgtcgcttg
ccagcggccagtacggcagccagagctgctcaaattcgtcggcgacgtggctca 
E. coli origin of 
replication pMB13 
cgcgttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctca
agtcagaggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaagctccc
tcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcggg
aagcgtggcgctttctcaatgctcacgctgtaggtatctcagttcggtgtaggtcgttcgctcc
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aagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatc
gtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggat
tagcagagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctac
actagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttg
gtagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagca
gattacgcgcagaaaaaaaggatctcaagaagatcctttgatct 
pConstitutive from 
Streptomyces lividans 
TK24 + RBS4  
tgtgcgggctctaacacgtcctagtatggtaggatgagcaacatttcgacgccgagagattcgc
cgcccgaaatgagcacgatccgcatgcttaattaagaaggagatatacat 
GFP+2, 5 atggctagcaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtg
atgttaatgggcacaaattttctgtcagtggagagggtgaaggtgatgctacatacggaaagct
tacccttaaatttatttgcactactggaaaactacctgttccatggccaacacttgtcactact
ttgacctatggtgttcaatgcttttcccgttatccggatcatatgaaacggcatgactttttca
agagtgccatgcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggaacta
caagacgcgtgctgaagtcaagtttgaaggtgatacccttgttaatcgtatcgagttaaaaggt
attgattttaaagaagatggaaacattctcggacacaaactcgagtacaactataactcacaca
atgtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgccacaa
cattgaagatggctccgttcaactagcagaccattatcaacaaaatactccaattggcgatggc
cctgtccttttaccagacaaccattacctgtcgacacaatctgccctttcgaaagatcccaacg
aaaagcgtgaccacatggtccttcttgagtttgtaactgctgctgggattacacatggcatgga
tgagctctacaaataa 
eGFP6 atggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcg
acgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagct
gaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccacc
ctgacctacggcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttca
agtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaacta
caagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggc
atcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccaca
acgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaa
catcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggc
cccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacg
agaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatcactctcggcatgga
cgagctgtacaagtaa 
mCherry7 atggtgagcaagggcgaggaggataacatggccatcatcaaggagttcatgcgcttcaaggtgc
acatggagggctccgtgaacggccacgagttcgagatcgagggcgagggcgagggccgccccta
cgagggcacccagaccgccaagctgaaggtgaccaagggtggccccctgcccttcgcctgggac
atcctgtcccctcagttcatgtacggctccaaggcctacgtgaagcaccccgccgacatccccg
actacttgaagctgtccttccccgagggcttcaagtgggagcgcgtgatgaacttcgaggacgg
cggcgtggtgaccgtgacccaggactcctccctgcaggacggcgagttcatctacaaggtgaag
ctgcgcggcaccaacttcccctccgacggccccgtaatgcagaagaagaccatgggctgggagg
cctcctccgagcggatgtaccccgaggacggcgccctgaagggcgagatcaagcagaggctgaa
gctgaaggacggcggccactacgacgctgaggtcaagaccacctacaaggccaagaagcccgtg
cagctgcccggcgcctacaacgtcaacatcaagttggacatcacctcccacaacgaggactaca
ccatcgtggaacagtacgaacgcgccgagggccgccactccaccggcggcatggacgagctgta
caagtaa 
pLPD06575 (pPhenol) + 
RBS5 
cgcaaagcggatcacctccgcgctcagcggatcgacgcgccgttcccacggtcgtactttcgtc
cgtacctcatcagcgccccggacaggaagggaggctccgacc 
pTet promoter + RBS8 tctgaccagggaaaatagccctctgacctggggatttgacttccctatcagtgatagagataat
ctgggagtccctatcagtgatagagaaggcggtatcgat 
R. opacus optimized tetR 
expression cassette5 
gtgatagattgcgatgcgtgtgctcggttgaacctctctgtcagatcaggaggacttcgcatgt
cgcggttggataagtccaaggtcatcaactcggcgctggagctgctgaacgaggtcggtatcga
gggactgaccacgcgcaagttggcccaaaagctcggcgtggaacaaccgaccctctactggcac
gtgaagaacaagcgcgcgctgctggatgcgttggccatcgagatgctggatcgccatcacacgc
acttttgccccctggagggcgagagctggcaggattttctgcggaacaacgcgaagtcgttccg
gtgcgccctcctgagccatcgggatggcgccaaagtccacttgggcacccgcccgaccgagaag
caatacgagaccctggagaaccagctggccttcctctgtcaacagggtttttcgttggagaacg
ccctgtatgccctgtccgccgtgggacacttcaccttgggctgcgtgttggaggatcaggaaca
tcaggtggcgaaagaggaacgggagacccccacgacggattcgatgcccccgttgttgcgccag
gcgatcgaactgtttgaccaccagggcgccgaacccgcctttttgttcgggctggagctgatca
tctgcgggctggaaaagcaactgaagtgcgaaagcggttcgtga 
T7 RNA polymerase6 atgaacacgattaacatcgctaagaacgacttctctgacatcgaactggctgctatcccgttca
acactctggctgaccattacggtgagcgtttagctcgcgaacagttggcccttgagcatgagtc
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ttacgagatgggtgaagcacgcttccgcaagatgtttgagcgtcaacttaaagctggtgaggtt
gcggataacgctgccgccaagcctctcatcactaccctactccctaagatgattgcacgcatca
acgactggtttgaggaagtgaaagctaagcgcggcaagcgcccgacagccttccagttcctgca
agaaatcaagccggaagccgtagcgtacatcaccattaagaccactctggcttgcctaaccagt
gctgacaatacaaccgttcaggctgtagcaagcgcaatcggtcgggccattgaggacgaggctc
gcttcggtcgtatccgtgaccttgaagctaagcacttcaagaaaaacgttgaggaacaactcaa
caagcgcgtagggcacgtctacaagaaagcatttatgcaagttgtcgaggctgacatgctctct
aagggtctactcggtggcgaggcgtggtcttcgtggcataaggaagactctattcatgtaggag
tacgctgcatcgagatgctcattgagtcaaccggaatggttagcttacaccgccaaaatgctgg
cgtagtaggtcaagactctgagactatcgaactcgcacctgaatacgctgaggctatcgcaacc
cgtgcaggtgcgctggctggcatctctccgatgttccaaccttgcgtagttcctcctaagccgt
ggactggcattactggtggtggctattgggctaacggtcgtcgtcctctggcgctggtgcgtac
tcacagtaagaaagcactgatgcgctacgaagacgtttacatgcctgaggtgtacaaagcgatt
aacattgcgcaaaacaccgcatggaaaatcaacaagaaagtcctagcggtcgccaacgtaatca
ccaagtggaagcattgtccggtcgaggacatccctgcgattgagcgtgaagaactcccgatgaa
accggaagacatcgacatgaatcctgaggctctcaccgcgtggaaacgtgctgccgctgctgtg
taccgcaaggacaaggctcgcaagtctcgccgtatcagccttgagttcatgcttgagcaagcca
ataagtttgctaaccataaggccatctggttcccttacaacatggactggcgcggtcgtgttta
cgctgtgtcaatgttcaacccgcaaggtaacgatatgaccaaaggactgcttacgctggcgaaa
ggtaaaccaatcggtaaggaaggttactactggctgaaaatccacggtgcaaactgtgcgggtg
tcgataaggttccgttccctgagcgcatcaagttcattgaggaaaaccacgagaacatcatggc
ttgcgctaagtctccactggagaacacttggtgggctgagcaagattctccgttctgcttcctt
gcgttctgctttgagtacgctggggtacagcaccacggcctgagctataactgctcccttccgc
tggcgtttgacgggtcttgctctggcatccagcacttctccgcgatgctccgagatgaggtagg
tggtcgcgcggttaacttgcttcctagtgaaaccgttcaggacatctacgggattgttgctaag
aaagtcaacgagattctacaagcagacgcaatcaatgggaccgataacgaagtagttaccgtga
ccgatgagaacactggtgaaatctctgagaaagtcaagctgggcactaaggcactggctggtca
atggctggcttacggtgttactcgcagtgtgactaagcgttcagtcatgacgctggcttacggg
tccaaagagttcggcttccgtcaacaagtgctggaagataccattcagccagctattgattccg
gcaagggtctgatgttcactcagccgaatcaggctgctggatacatggctaagctgatttggga
atctgtgagcgtgacggtggtagctgcggttgaagcaatgaactggcttaagtctgctgctaag
ctgctggctgctgaggtcaaagataagaagactggagagattcttcgcaagcgttgcgctgtgc
attgggtaactcctgatggtttccctgtgtggcaggaatacaagaagcctattcagacgcgctt
gaacctgatgttcctcggtcagttccgcttacagcctaccattaacaccaacaaagatagcgag
attgatgcacacaaacaggagtctggtatcgctcctaactttgtacacagccaagacggtagcc
accttcgtaagactgtagtgtgggcacacgagaagtacggaatcgaatcttttgcactgattca
cgactccttcggtaccattccggctgacgctgcgaacctgttcaaagcagtgcgcgaaactatg
gttgacacatatgagtcttgtgatgtactggctgatttctacgaccagttcgctgaccagttgc
acgagtctcaattggacaaaatgccagcacttccggctaaaggtaacttgaacctccgtgacat
cttagagtcggacttcgcgttcgcgtaa 
pT76 taatacgactcactataggg 
lacI expression cassette6 gacaccatcgaatggcgcaaaacctttcgcggtatggcatgatagcgcccggaagagagtcaat
tcagggtggtgaatgtgaaaccagtaacgttatacgatgtcgcagagtatgccggtgtctctta
tcagaccgtttcccgcgtggtgaaccaggccagccacgtttctgcgaaaacgcgggaaaaagtg
gaagcggcgatggcggagctgaattacattcccaaccgcgtggcacaacaactggcgggcaaac
agtcgttgctgattggcgttgccacctccagtctggccctgcacgcgccgtcgcaaattgtcgc
ggcgattaaatctcgcgccgatcaactgggtgccagcgtggtggtgtcgatggtagaacgaagc
ggcgtcgaagcctgtaaagcggcggtgcacaatcttctcgcgcaacgcgtcagtgggctgatca
ttaactatccgctggatgaccaggatgccattgctgtggaagctgcctgcactaatgttccggc
gttatttcttgatgtctctgaccagacacccatcaacagtattattttctcccatgaagacggt
acgcgactgggcgtggagcatctggtcgcattgggtcaccagcaaatcgcgctgttagcgggcc
cattaagttctgtctcggcgcgtctgcgtctggctggctggcataaatatctcactcgcaatca
aattcagccgatagcggaacgggaaggcgactggagtgccatgtccggttttcaacaaaccatg
caaatgctgaatgagggcatcgttcccactgcgatgctggttgccaacgatcagatggcgctgg
gcgcaatgcgcgccattaccgagtccgggctgcgcgttggtgcggatatctcggtagtgggata
cgacgataccgaagacagctcatgttatatcccgccgttaaccaccatcaaacaggattttcgc
ctgctggggcaaaccagcgtggaccgcttgctgcaactctctcagggccaggcggtgaagggca
atcagctgttgcccgtctcactggtgaaaagaaaaaccaccctggcgcccaatacgcaaaccgc
ctctccccgcgcgttggccgattcattaatgcagctggcacgacaggtttcccgactggaaagc
gggcagtgagcgcaacgcaattaatgtaagttagctcactcattaggcaccgggatctcgaccg
atgcccttgagagccttcaacccagtcagctccttccggt 
lacO6 ggaattgtgagcggataacaattcccctctaga 
lacOmin9 ttgtgagcggataacaa 
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RBS-14 ggtaccaagcttattggcactagtcgagcaacggaggtacggac 
RBS-210 catttcgacgccgagagattcgccgcccgaaatgagcacgatccgcatgcttaattaagaagga
gatatacat  
pRS23365 (rRNA) gtccgatgagataagctggaaaagttgccccggagcggctggcgagtgtgccagaagtgatggt
gtgtgcgtgttctttgagaactcaacagtgtgtcgatgaatgtcagtgccaaatgtttttggta
ctccgcatcacggatgatcaactggcccttgtggtttggttgtgaggtgtggtgtgggtatttg
ctggctcttctccttcttccgtcggaggggggtcagtgtttgagaatgctagtttgagtttttg
attgctagtgatttgactcgatgtctatgactgattagggaccttttggggtttcgaaatctag
agtc 
pRS28745 (Trp tRNA) gtttagggtggattgggtttgttccggggctttgaagtacactgagatttctgggattactcag
cgctgcgcgctgccctacggtgctgtacggccggcaagggtggcgcgcgtgtcatgtaatcaca
gagaggtcggtcaagagttggttcgaggctagtttcggaccaggtctcccgaccaa 
pRS28770 (Thr tRNA) cacacagaaccccggtgagcgacagctcaccggggttctgtcgttcgtggacgagacggggcgc
ccatgtatgcggtgatgccgaccggtcgtcgggtccatcgaatttcgcgtcccagtcgatgtcc
tggacggccttcttcgcgaccgcctgggcggacttcggcgtgatcctggagctcgatcgcgggt
ctcgagcatggtcgccggccgaactgtcgggtgcaccggcatgtgaaagccgctgaccaggcaa
tttggttctggacgcgaactctgtgtaatctcgtcaaggcttcagcgcgcagcgatgtgcgagc
gaagca 
pRS00085 (Ile tRNA) acgggatgggcgtgtgggaccggctgaacaacgcgttcacggatatcgtcgcggagtcgagctc
tgacgggctcgtgacggccgggcaggtcttcggatacgccgccgtcatcggtctcgcgaacatg
gtgttgttcaccgcattggcgacgatcggagccttcatctacaacctgtgttccgacctcgtcg
ggggcgtcgaagtgacgctcgccgaccgggactgaacgcggaaaacgacgagggctgagctggg
aaaagagcgtctcgccggaccggttttggtagttgccggtccggtggggtaatcttccgactcg
gttcagggaactgcgcgagatgagtttccagacttcag 
pRS06620 (Glu tRNA) gcccccttcgtctagcggcctaggacgccgccctttcaaggcggtagcgcgggttcgaatcccg
tagggggtacgtttgaccggtgtcgagcatgcggtatggttcgacgg 
pRS02495 (Ser tRNA) cttcgactggttcgacagccacctgcgataaagcgaccatcgttgcgctctgaccagccgtttt
gcctttgtggtggaaaggtgtgtaatctttcgcaccggcggtccgaagggatcggaaccacccc
agggaggcgtgccagagcggccgaatgggactcactgctaatgagttgtcccttttacgaggga
ccggaggttcaaatcctctcgcctccgcc 
pamiM11 agaacggggcttgtggccgtccctgtcgtgtggtaaaatgtccacaa 
pnhM11 acatctacacattgacatccgttccgatgtgatgtaaaaattgtcacg 
pcs11 ccctcctactgttgtcggcgccccgaacgtggttcactgacatcggtc 
pcs/pamiM ccctcctactgttgtgggcgccccgaacgtggtaaaatgacatcggtc 
pCory112 ttgacattaatttgaatctgtgttataatggttc 
pCory212 ttgacaaataaggttgtatgtgctataatggacc 
pLacRO1 + RBS-2 acatctacacattgacatccgttccgatgtgatgtaaaaattgtcacg 
ggaattgtgagcggataacaattcccctctagacatttcgacgccgagagattcgccgcccgaa
atgagcacgatccgcatgcttaattaagaaggagatatacat 
pLacRO2 + RBS-2 acatctacacattgacatccgttccgatgtgatgtaaaaattgtcacgcatttgtgagcggata
acaaagccgcccgaaatgagcacgatccgcatgcttaattaagaaggagatatacat 
pLacRO3 ccctcctactgttgtgagcggataacaagtggtaaaatgacatcggtc 
pLPD06764 (pHBA) + 
RBS 
catagctcgtctttcactcagtgaaagagggggtgttgcgatcacacgtcgggcagcacagtga
ctggtgtcacgaactacgcgaggagtctgctcat 
pLPD00563 (pVAN) + 
RBS 
gacgaaacccttccgacattcggaaaccgagtgtggtggatcacctccagtgccgcacagtggt
ggagacgacgctgacgcctcaccgagtccggcgtcacgaataacgcagcagcccagcatattcc
ggaggcactcat 
pLPD06580 (pBEN) + 
RBS 
ggagaagttcacgccagtcgtgtgaagtcggcccgcgtgcgcacgccgaggccctccgagcctc
ggcgtacgcatgccgaacacgtcctagtcagtactcggtaaatgcctagtgtgatgcagcgcac
aggctgcaagagtggaatccattgccggacccgggcgccctcgcagggcgcaagccccccggag
atcttggaggatcccat 
pLPD06578 (pGUA) + 
RBS 
ctgcctcactgaagaatcgttccgacctcattgaaaccgtgtcgtcacgcccagtcgaggataa
ctgagaccgcgatcacaagtagtcgcgcagatggtccagagaccgcgcagagtggctagaccac
cctcctgcgacggcctacgttcttcctcaccccgctcacacaacgaaagttgtttccgagcagt
tgctttgaatgaggagattcag 
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Supplementary Table B.2. Summary of plasmids.   
Plasmid 
Name 
Functional Insert Backbone Antibiotic 
Resistance 
Length 
(bp) 
Source 
pTara:500 pBAD-T7 RNAP p15a Chloramphenicol 8022 Shis et al. 20136 
pET28:GFP pT7(LacO)-eGFP + lacI pBR322 Kanamycin 5993 Shis et al. 20136 
pRH036 pLPD06575-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4861 DeLorenzo et al. 20175 
pDD57 pConstitutive.RBS-2-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4776 DeLorenzo et al. 
201810 
pDD65 Empty backbone pAL5000(S) + 
pMB1 
Kanamycin 3659 DeLorenzo et al. 
201810 
pDD131 pTet-mCherry + tetR pAL5000(S) + 
pMB1 
Kanamycin 6225 DeLorenzo et al. 20175 
pDD132 ROCI-3 (LPD3763/3764)  
Integrative vector 
Integrative into R. 
opacus + p15a 
Hygromycin B 4238 DeLorenzo et al. 
201810 
pDD159 pConstitutive.RBS-1-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4749 This study; derived 
from pDD57 
pDD166 pRS23365-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4988 This study; derived 
from pDD57 
pDD167 pRS28745-GFP+  pAL5000(S) + 
pMB1 
Kanamycin 4751 This study; derived 
from pDD57 
pDD168 pRS28770-GFP+  pAL5000(S) + 
pMB1 
Kanamycin 4912 This study; derived 
from pDD57 
pDD169 pRS00085-GFP+  pAL5000(S) + 
pMB1 
Kanamycin 4928 This study; derived 
from pDD57 
pDD170 pRS02495-GFP+  pAL5000(S) + 
pMB1 
Kanamycin 4791 This study; derived 
from pDD57 
pDD172 pRS06620-GFP+  pAL5000(S) + 
pMB1 
Kanamycin 4802 This study; derived 
from pDD57 
pDD181 pT7(LacO)-eGFP + lacI pAL5000(S) + 
pMB1 
Kanamycin 6373 This study; derived 
from pET28:GFP and 
pDD65 
pDD183 pTet-T7 RNAP.ROCI3 Integrative into R. 
opacus + p15a 
Hygromycin B 6996 This study; derived 
from pTara:500, 
pDD131, and pDD132 
pDD184 pLPD06575-T7 RNAP.ROCI3 or 
pPhenol-T7 RNAP.ROCI3 
Integrative into R. 
opacus + p15a 
Hygromycin B 5846 This study; derived 
from pTara:500, 
pRH036 and pDD132 
pDD188 pamiM-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4478 This study; derived 
from pDD57 
pDD189 pnhM-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4479 This study; derived 
from pDD57 
pDD190 pcs-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4479 This study; derived 
from pDD57 
pDD191 pcs/pamiM-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4479 This study; derived 
from pDD57 
pDD192 pCory1-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4465 This study; derived 
from pDD57 
pDD193 pCory2-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 4465 This study; derived 
from pDD57 
pDD203 pLacRO1-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 6003 This study; derived 
from pDD57 
pDD219 pT7-lacI + pLacRO1-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 5926 This study; derived 
pDD203   
pDD229 pLacRO3-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 5970 This study; derived 
from pDD57 and 
pET28:GFP 
pDD232 pLacRO2-GFP+ pAL5000(S) + 
pMB1 
Kanamycin 5970 This study; derived 
from pDD57  
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pDD272 pT7(LacO)-tetR + lacI +  
pTet-mCherry 
pAL5000(S) + 
pMB1 
Kanamycin 7027 This study; derived 
from pDD131 and 
pET28:GFP 
pDD299 pT7-eGFP pAL5000(S) + 
pMB1 
Kanamycin 6373 This study; derived 
from pDD181 
pDD300 pLPD06764-GFP+  
or pHBA-GFP+ 
pAL5000(S) + 
pMB1 
Kanamycin 4761 This study; derived 
from pDD57 
pDD301 pLPD00563-GFP+  
or pVAN-GFP+ 
pAL5000(S) + 
pMB1 
Kanamycin 4803 This study; derived 
from pDD57 
pDD302 pLPD06580-GFP+  
or pBEN-GFP+ 
pAL5000(S) + 
pMB1 
Kanamycin 4872 This study; derived 
from pDD57 
pDD303 pLPD06578-GFP+  
or pGUA-GFP+ 
pAL5000(S) + 
pMB1 
Kanamycin 4877 This study; derived 
from pDD57 
 
Supplementary Table B.3. Summary of strains.    
Strain 
Name 
Genus Species Strain Plasmid Contained Relevant Figure 
WRH082 Escherichia coli DH10B pRH036 N/A 
DMD056 Escherichia coli DH10B pDD65 N/A 
DMD057 Escherichia coli DH10B pDD57 N/A 
DMD081 Rhodococcus opacus PD630 pDD65 4, 6, S1, S2, and 
S6 
DMD146 Rhodococcus opacus PD630 pDD57 S1 and S2 
DMD199 Escherichia coli DH10B pDD132 N/A 
DMD220 Escherichia coli DH10B pDD131 N/A 
DMD234 Escherichia coli DH10B pDD159 N/A 
DMD237 Rhodococcus opacus PD630 pDD159 S1 and S2 
DMD241 Escherichia coli DH10B pDD167 N/A 
DMD242 Escherichia coli DH10B pDD168 N/A 
DMD243 Escherichia coli DH10B pDD169 N/A 
DMD246 Rhodococcus opacus PD630 pDD167 S1 
DMD247 Rhodococcus opacus PD630 pDD168 S1 
DMD248 Rhodococcus opacus PD630 pDD169 S1 
DMD252 Escherichia coli DH10B pDD170 N/A 
DMD253 Escherichia coli DH10B pDD172 N/A 
DMD255 Escherichia coli DH10B pDD166 N/A 
DMD259 Escherichia coli DH10B pTara:500 N/A 
DMD260 Escherichia coli DH10B pET28:GFP N/A 
DMD264 Escherichia coli DH10B pDD183 N/A 
DMD265 Escherichia coli DH10B pDD184 N/A 
DMD268 Escherichia coli DH10B pDD181 N/A 
DMD276 Rhodococcus opacus PD630 ΦpTet-T7 
RNAP.ROCI3 
pDD183 N/A 
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DMD277 Rhodococcus opacus PD630 ΦpLPD06575-T7 
RNAP.ROCI3 
pDD184 N/A 
DMD293 Rhodococcus opacus PD630 ΦpTet-T7 
RNAP.ROCI3 
pDD181 2 
DMD294 Rhodococcus opacus PD630 ΦpLPD06575-T7 
RNAP.ROCI3 
pDD181 2 
DMD287 Escherichia coli DH10B pDD188 N/A 
DMD288 Escherichia coli DH10B pDD189 N/A 
DMD289 Escherichia coli DH10B pDD190 N/A 
DMD290 Escherichia coli DH10B pDD191 N/A 
DMD291 Escherichia coli DH10B pDD192 N/A 
DMD292 Escherichia coli DH10B pDD193 N/A 
DMD299 Rhodococcus opacus PD630 pDD189 S1 
DMD300 Rhodococcus opacus PD630 pDD190 S1 
DMD301 Rhodococcus opacus PD630 pDD191 S1 
DMD302 Rhodococcus opacus PD630 pDD192 S1 
DMD303 Rhodococcus opacus PD630 pDD193 S1 
DMD306 Rhodococcus opacus PD630 ΦpTet-T7 
RNAP.ROCI3 
pDD65 1 and 2 
DMD307 Rhodococcus opacus PD630 ΦpLPD06575-T7 
RNAP.ROCI3 
pDD65 1, 2, 3, 5, S3, and 
S5 
DMD309 Escherichia coli DH10B pDD203 N/A 
DMD319 Rhodococcus opacus PD630 pDD203 4 
DMD326 Escherichia coli DH10B pDD219 N/A 
DMD356 Escherichia coli DH10B pDD229 N/A 
DMD359 Escherichia coli DH10B pDD232 N/A 
DMD362 Rhodococcus opacus PD630 pDD229 4 
DMD363 Rhodococcus opacus PD630 pDD232 4 and S6 
DMD364 Rhodococcus opacus PD630 ΦpLPD06575-T7 
RNAP.ROCI3 
pDD219 5 and S5 
DMD375 Escherichia coli DH10B pDD272 N/A 
DMD377 Rhodococcus opacus PD630 ΦpLPD06575-T7 
RNAP.ROCI3 
pDD272 3 and S3 
DMD492 Rhodococcus opacus PD630 pDD166 S1 
DMD493 Rhodococcus opacus PD630 pDD170 S1 
DMD494 Rhodococcus opacus PD630 pDD172 S1 
DMD495 Escherichia coli DH10B pDD299 N/A 
DMD496 Escherichia coli DH10B pDD300 N/A 
DMD497 Escherichia coli DH10B pDD301 N/A 
DMD498 Escherichia coli DH10B pDD302 N/A 
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Supplementary Table B.4. Fitted Hill equation parameters for Figures 3.1, 3.4, 3.6, and 
Supplementary Figure B.5. The modified Hill equation, described below in Supplementary 
Methods, was fit to each set of normalized fluorescence (au) data by minimizing the root mean 
square error (RMSE). Fmax and Fmin represent the fitted maximum and minimum normalized 
fluorescence (au), respectively. The fitted Hill coefficient (n), half-maximal constant (K), and 
RMSE are also reported. Data fitting was done to provide a guide to the eye, rather than to obtain 
biologically meaningful parameters (especially for Figure 6 in which sensor output saturation was 
not reached, giving unrealistic parameter values). 
Figure Strain Fmax Fmin n K RMSE 
3.1B pPhenol-T7 RNAP + pT7-eGFP 15334 au 827 au 1.49 0.07 g/L 802 
3.1C pTet-T7 RNAP + pT7-eGFP 4025 au 880 au 2.69 0.03 ng/mL 116 
3.4A pLacRO1.GFP+ 1247 au 64 au 1.92 0.05 mM 23.2 
3.4B pLacRO2.GFP+ 2143 au 161 au 1.65 0.02 mM 45.3 
3.4C pLacRO3.GFP+ 933 au 80 au 1.55 0.03 mM 13.3 
3.6A pHBA-GFP+ 380 au 26 au 0.57 2.45 g/L 2.9 
3.6B pVAN-GFP+ 326 au 9 au 1.69 0.26 g/L 9.4 
3.6C pBEN-GFP+ 956 au 27 au 1.45 2.80 g/L 15.1 
3.6D pGUA-GFP+ 3950 au 7 au 1.24 1.49 g/L 66.7 
B.S5 pPhenol-T7 RNAP + pT7-lacI + 
pLacRO1.GFP+ 
776 au 0 au 1.63 0.10 g/L 21.7 
 
DMD499 Escherichia coli DH10B pDD303 N/A 
DMD500 Rhodococcus opacus PD630 ΦpTet-T7 
RNAP.ROCI3 
pDD299 1 
DMD501 Rhodococcus opacus PD630 ΦpLPD06575-T7 
RNAP.ROCI3 
pDD299 1 
DMD502 Rhodococcus opacus PD630 pDD300 6 and S6 
DMD503 Rhodococcus opacus PD630 pDD301 6 and S6 
DMD504 Rhodococcus opacus PD630 pDD302 6 and S6 
DMD505 Rhodococcus opacus PD630 pDD303 6 and S6 
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B.2 Supplementary figures 
 
Supplementary Figure B.1. Screen for strong constitutive promoters in R. opacus. A) Six tRNA 
and rRNA promoters from the R. opacus genome and a previously published constitutive promoter 
(pConstitutive) were placed upstream of RBS-1 and GFP+.10 B) Two native promoters from the 
Rhodococcus ruber genome (pnhM and pcs), a novel hybrid of two R. ruber promoters 
(pcs/pamiM), two synthetic promoters designed for C. glutamicum (pCory1 and pCory2), and 
pConstitutive were placed upstream of RBS-2 and GFP+.11, 12 Values are averages of three 
replicates, and error bars represent one standard deviation. A star (*) indicates that expression from 
pConstitutive is significantly lower than expression from the compared promoter (p < 0.05, 
unpaired t-test with equal variance). See Supplementary Table 1 for genetic part sequences. The 
strengths of RBS-1 and RBS-2 are compared in Supplementary Figure B.2. 
 
 
Supplementary Figure B.2. Comparison of RBS sequences in R. opacus. Two RBS sequences 
from literature (see Supplementary Table B.1 for sequences) were placed downstream of 
pConstitutive and upstream of GFP+. Bars are averages of three replicates and error bars represent 
one standard deviation. 
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Supplementary Figure B.3. NAND logic gate in R. opacus using 0.5 g/L phenol. Normalized 
fluorescence of the NAND genetic circuit in response to phenol and IPTG inducers, as appropriate, 
at concentrations of 0.5 g/L and 1 mM, respectively. aTc was not provided during the main 
experimental culture (see Methods B for details). A) Linear y-axis. B) Log y-axis. An initial OD600 
of 0.1 was used, and cultures were grown in minimal media B with 10 g/L glucose as a carbon 
source. The decrease in normalized fluorescence between uninduced [0 0] (the highest ON) and 
phenol- and IPTG-induced [1 1] (OFF) was 31-fold. The decrease in normalized fluorescence 
between when either phenol [1 0] or IPTG [0 1] was individually provided and when both were 
provided [1 1] was 9- and 22-fold, respectively. Values are averages of three replicates, and error 
bars represent one standard deviation. 
 
 
 
Supplementary Figure B.4. Bolded nucleotides (nt) represent changes from the original 
constitutive promoter or RBS sequence. Underlined nucleotides represent the core lacO 
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recognition site, referred to as LacOMin. Blue nucleotides represent -10 promoter sites. Red 
nucleotides represent -35 promoter sites. A) To create pLacRO1, an insulated 33 nt lacO site was 
placed between pnhM and RBS-2 as shown in the figure. B) To create LacRO2, a 17 nt minimal 
lacO site (LacOMin) was overlaid with RBS-2 by changing several nucleotides as shown in the 
figure. C) To create pLacRO3, LacOMin was overlaid with the -35 site (and its immediate 
downstream region) of pcs/pamiM by changing several nucleotides as shown in the figure. Only 
the relevant sections of each promoter or RBS are shown due to space limitations. See 
Supplementary Table B.1 for complete part sequences. 
 
 
Supplementary Figure B.5. Normalized fluorescence of the IMPLY circuit in response to phenol 
in the absence of IPTG. Values are averages of three replicates at 0, 0.005, 0.01, 0.05, 0.1, 0.25, 
and 0.4 g/L phenol, and error bars represent one standard deviation. The solid black line represents 
a fitted curve (see Supplementary Methods B and Supplementary Table B.4). 
 
Supplementary Figure B.6. Comparison of inducible systems using GFP+. The normalized 
fluorescence of pPhenol, pHBA, pVAN, pBEN, pGUA, and pLacRO2 was measured when cultures 
were grown on 1 g/L glucose and with inducer concentration of 0.6 g/L PHE, 1 g/L HBA, 1.5 g/L 
VAN, 5 g/L BEN, 1.5 g/L GUA, or 1 mM IPTG as appropriate. Values are averages of three 
replicates, and error bars represent one standard deviation. 
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B.3 Hill equation fitting 
The Hill equation was adapted from DeLorenzo et al. (2017), to fit a line to the normalized 
fluorescence data.5 The model was fit to the experimentally collected data, such that the root mean 
square error (RMSE) was minimized. Fitted values are listed in Supplementary Table B.4.  
  
 For Figures 3.1, 3.4, and 3.6: 
 
𝐹 =
(𝐹𝑚𝑎𝑥 − 𝐹𝑚𝑖𝑛) ∗ 𝐼𝑛𝑑𝑢𝑐𝑒𝑟
𝑛
𝐼𝑛𝑑𝑢𝑐𝑒𝑟𝑛 + 𝐾𝑛
+ 𝐹𝑚𝑖𝑛 
𝐹 = 𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐹𝑚𝑎𝑥 = 𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐹𝑚𝑖𝑛 = 𝑀𝑖𝑛𝑖𝑚𝑢𝑚 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐾 = 𝐻𝑎𝑙𝑓 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 
𝑛 = 𝐻𝑖𝑙𝑙 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
Inducer = phenol (g/L), aTc (ng/mL), IPTG (mM), 4-hydroxybenzoic acid (g/L), vanillic 
acid (g/L), sodium benzoate (g/L), or guaiacol (g/L) 
 
Root mean square error (RMSE): 
√
∑ (𝐹 − 𝐹𝑜𝑏𝑠)2
𝑛
𝑖=1
𝑛 − 2
  
𝐹𝑜𝑏𝑠 = 𝑂𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝑛 = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑡𝑎 𝑝𝑜𝑖𝑛𝑡𝑠 
 
 
For Supplementary Figure B.5: 
 
𝐹 =  
(𝐹𝑚𝑎𝑥 − 𝐹𝑚𝑖𝑛) ∗ 𝐾
𝑛
𝐼𝑛𝑑𝑢𝑐𝑒𝑟𝑛 + 𝐾𝑛
+  𝐹𝑚𝑖𝑛 
 
𝐹 = 𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐹𝑚𝑎𝑥 = 𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐹𝑚𝑖𝑛 = 𝑀𝑖𝑛𝑖𝑚𝑢𝑚 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐾 = 𝐻𝑎𝑙𝑓 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 
𝑛 = 𝐻𝑖𝑙𝑙 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
𝐼𝑛𝑑𝑢𝑐𝑒𝑟 = 𝑝ℎ𝑒𝑛𝑜𝑙 (𝑔/𝐿) 
 
Root mean square error (RMSE): 
√
∑ (𝐹 − 𝐹𝑜𝑏𝑠)2
𝑛
𝑖=1
𝑛 − 2
  
𝐹𝑜𝑏𝑠 = 𝑂𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝑛 = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑡𝑎 𝑝𝑜𝑖𝑛𝑡𝑠 
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Appendix C: Supporting information for molecular 
toolkit for gene expression control and genome 
modification in Rhodococcus opacus PD630 
 
 
C.1 Supplementary tables 
 
Supplementary Table C.1. Constitutive promoter library. Promoters were generated by saturation 
mutagenesis of -35 (4 of 6 base pairs) and -10 (6 base pairs) sites of a strong constitutive promoter 
from Streptomyces lividans TK24, as annotated in Siegl et al. (2013), driving GFP+.1 Promoters 
are listed in the order of weakest to strongest based on normalized fluorescence. The mutagenized 
sites are italicized and underlined. Mutations differing from the original sequence are in bold. A 
gap in the sequence signifies deletion. See Figure 4.1 for normalized fluorescence produced by 
each promoter.  
 
Promoter Name Promoter Nucleotide Sequence 
1 tgtgcgcacactaacacgtcctagtatggcaatcagagcaa 
2 tgtgcggaagctaacacgtcctagtatggatatgtgagcaa 
3 tgtgcgcaagctaacacgtcctagtatggaatagagagcaa 
4 tgtgcgttcactaacacgtcctagtatggcgtggagagcaa 
5 tgtgcgatgcctaacacgtcctagtatggaagatcgagcaa 
6 tgtgcgggctctaacacgtcctagtatggtgagtggagcaa 
7 tgtgcgtagtctaacacgtcctagtatgggtttcggagcaa 
8 tgtgcgggctctaacacgtcctagtatggggtatggagcaa 
9 tgtgcgattgctaacacgtcctagtatggtatcccgagcaa 
10 tgtgcgggggctaacacgtcctagtatggtaggatgagcaa 
11 tgtgcggttactaacacgtcctagtatggtaggatgagcaa 
12 tgtgcgacaactaacacgtcctagtatggtctacagagcaa 
13 tgtgcgcctgctaacacgtcctagtatggtaggatgagcaa 
14 tgtgcgggctctaacacgtcctagtatggtatgatgagcaa 
15 tgtgcggcccctaacacgtcctagtatggttctaagagcaa 
16 tgtgcgggctctaacacgtcctagtatggagacatgagcaa 
17 tgtgcgcgccctaacacgtcctagtatggtaggatgagcaa 
18 tgtgcgctccctaacacgtcctagtatggtaggatgagcaa 
19 tgtgcgggctctaacacgtcctagtatggtacgaagagcaa 
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20 tgtgcgcgggctaacacgtcctagtatggtaggatgagcaa 
21 tgtgcgatggctaacacgtcctagtatggtaggatgagcaa 
22 tgtgcgcctgctaacacgtcctagtatggtaggatgagcaa 
23 tgtgcggatcctaacacgtcctagtatggtaggatgagcaa 
24 tgtgcgatgactaacacgtcctagtatggtaggatgagcaa 
Original or pConstitutive (Siegl et al.)1 tgtgcgggctctaacacgtcctagtatggtaggatgagcaa 
25 tgtgcgggctctaacacgtcctagtatggtggg__gagcaa 
 
Supplementary Table C.2. List of genetic parts. 
      
Part Nucleotide Sequence 
BbaJ23104 + UTR  ttgacagctagctcagtcctaggtattgtgctagccttctctgctgttaaggtttgcttagaag
cggataacaatttcacacatactagagaaagaggagaaatactag 
R. opacus/E. coli  
origin of replication 
on pNG22 
atggtaaatctgcgcagacagccctgtgcagctgaaacgcggttacgtatagcttgccatatgt
ctagccatacgtaaccgcaggtaaaaggcatatttttcgcgtgtcatggctagtaaataacacc
ggtgtcatttagagtcagggaaagacaatgaaaaacgaagaaagccaccgggcggcaacccgat
gactttcgcttatcacccagcacacacctgggagaaatcacggtcatgagtttacagactcatg
cgcagaatgcgcacactaaaacacctacccgcgtcgagcgcgaccgtggtggactggacaacac
cccagcatctgccagtgaccgcgaccttttacgcgatcatctaggccgcgatgtactccacggt
tcagtcacacgagactttaaaaaggcctatcgacgcaacgctgacggcacgaactcgccgcgta
tgtatcgcttcgagactgatgctttaggacggtgcgagtacgccatgctcaccaccaagcagta
cgccgccgtcctggtcgtagacgttgaccaagtaggtaccgcaggcggtgaccccgcagactta
aacccgtacgtccgcgacgtggtgcgctcactgattactcatagcgtcgggccagcctgggtgg
gtattaacccaactaacggcaaagcccagttcatatggcttattgaccctgtctacgctgaccg
taacggtaaatctgcgcagatgaagcttcttgcagcaaccacgcgtgtgctgggtgagctttta
gaccatgacccgcacttttcccaccgctttagccgcaacccgttctacacaggcaaagccccta
ccgcttatcgttggtataggcagcacaaccgggtgatgcgccttggagacttgataaagcaggt
aagggatatggcaggacacgaccagttcaaccccaccccacgccagcaattcagctctggccgc
gaacttatcaacgcggtcaagacccgccgtgaagaagcccaagcattcaaagcactcgcccagg
acgtagacgcggaaatcgccggtggtctcgaccagtatgacccggaacttatcgacggtgtgcg
tgtgctctggattgtccaaggaaccgcagcacgcgacgaaacagcctttagacatgcgcttaag
actggccaccgcttgcgccagcaaggccaacgcctgacagacgcagcaatcatcgacgcctatg
agcacgcctacaacgtcgcacacacccacggcggtgcaggccgcgacaacgagatgccacccat
gcgcgaccgccaaaccatggcaaggcgcgtgcgcgggtatgtcgcccaatccaagagcgagacc
tacagcggctctaacgcaccaggtaaagccaccagcagcgagcggaaagccttggccacgatgg
gacgcagaggcggacaaaaagccgcacaacgctggaaaacagaccccgagggcaaatatgcgca
agcacaaaggtcgaagcttgaaaagacgcaccgtaagaaaaaggctcaaggacgatctacgaag
tcccgtattagccaaatggtgaacgatcagtatttccagacagggacagttcccacgtgggctg
aaataggggcagaggtaggagtctctcgcgccacggttgctaggcatgtcgcggagctaaagaa
gagcggtgactatccggacgtttaaggggtctcataccgtaagcaatatacggttcccctgccg
ttaggcagttagataaaacctcacttgaagaaaaccttgaggggcagggcagcttatatgcttc
aaagcatgacttcctctgttctcctagacctcgcaaccctccgccataacctcacc 
Kanamycin resistance 
gene cassette3 
tcagaagaactcgtcaagaaggcgatagaaggcgatgcgctgcgaatcgggagcggcgataccg
taaagcacgaggaagcggtcagcccattcgccgccaagctcttcagcaatatcacgggtagcca
acgctatgtcctgatagcggtccgccacacccagccggccacagtcgatgaatccagaaaagcg
gccattttccaccatgatattcggcaagcaggcatcgccatgggtcacgacgagatcctcgccg
tcgggcatccgcgccttgagcctggcgaacagttcggctggcgcgagcccctgatgctcttcgt
ccagatcatcctgatcgacaagaccggcttccatccgagtacgtgctcgctcgatgcgatgttt
cgcttggtggtcgaatgggcaggtagccggatcaagcgtatgcagccgccgcattgcatcagcc
atgatggatactttctcggcaggagcaaggtgagatgacaggagatcctgccccggcacttcgc
ccaatagcagccagtcccttcccgcttcagtgacaacgtcgagcacagctgcgcaaggaacgcc
cgtcgtggccagccacgatagccgcgctgcctcgtcttggagttcattcagggcaccggacagg
tcggtcttgacaaaaagaaccgggcgcccctgcgctgacagccggaacacggcggcatcagagc
agccgattgtctgttgtgcccagtcatagccgaatagcctctccacccaagcggccggagaacc
tgcgtgcaatccatcttgttcaatcatgcgaaacgatcctcatcctgtctcttgatcagatctt
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gatcccctgcgccatcagatccttggcggcaagaaagccatccagtttactttgcagggcttcc
caaccttaccagagggcgccccagctggcaattccggttcgcttgctgtccataaaaccgccca
gtctagctatcgccatgtaagcccactgcaagctacctg 
Gentamicin resistance 
gene cassette2 
ctgcccaaggttgccgggtgacgcacaccgtggaaacggatgaaggcacgaacccagttgacat
aagcctgttcggttcgtaaactgtaatgcaagtagcgtatgcgctcacgcaactggtccagaac
cttgaccgaacgcagcggtggtaacggcgcagtggcggttttcatggcttgttatgactgtttt
tttgtacagtctatgcctcgggcatccaagcagcaagcgcgttacgccgtgggtcgatgtttga
tgttatggagcagcaacgatgttacgcagcagggcagtcgccctaaaacaaagttaggtggctc
aagtatgggcatcattcgcacatgtaggctcggccctgaccaagtcaaatccatgcgggctgct
cttgatcttttcggtcgtgagttcggagacgtagccacctactcccaacatcagccggactccg
attacctcgggaacttgctccgtagtaagacattcatcgcgcttgctgccttcgaccaagaagc
ggttgttggcgctctcgcggcttacgttctgcccaagtttgagcagccgcgtagtgagatctat
atctatgatctcgcagtctccggcgagcaccggaggcagggcattgccaccgcgctcatcaatc
tcctcaagcatgaggccaacgcgcttggtgcttatgtgatctacgtgcaagcagattacggtga
cgatcccgcagtggctctctatacaaagttgggcatacgggaagaagtgatgcactttgatatc
gacccaagtaccgccacctaacaattcgttcaagccgagatcggcttcccggccgcggcttggt
ttcatcagccatccgcttgccctcatctgttacgccggcggtagccggccagcctcgcagagca
ggattcccgttgagcaccgccaggtgcgaataagggacagtgaagaaggaacacccgctcgcgg
gtgggcctacttcacctatcctgcccggctgacgccgttggatacaccaaggaaagtctacacg
aaccctttggcaaaatcctgtatatcgtgcgaaaaaggatggatataccgaaaaaatcgctata
atgaccccgaagcagggttatgcagcggaaaagcgct 
Hygromycin B 
resistance gene 
cassette4 
atgagccggatgaccggcaccacctggcggtccgcgatggacggcacgaccgaccggaacgcgc
tgctcgccctggcccgcgaactcggccgggtgctcggccggctgcacagggtgccgctgaccgg
gaacaccgtgctcaccccccattccgaggtcttcccggaactgctgcgggaacgccgcgcggcg
accgtcgaggaccaccgcgggtggggctacctctcgccccggctgctggaccgcctggaggact
ggctgccggacgtggacacgctgctggccggccgcgaaccccggttcgtccacggcgacctgca
cgggaccaacatcttcgtggacctggccgcgaccgaggtcaccgggatcgtcgacttcaccgac
gtctatgcgggagactcccgctacagcctggtgcaactgcatctcaacgccttccggggcgacc
gcgagatcctggccgcgctgctcgacggggcgcagtggaagcggaccgaggacttcgcccgcga
actgctcgccttcaccttcctgcacgacttcgaggtgttcgaggagaccccgctggatctctcc
ggcttcaccgatccggaggaactggcgcagttcctctgggggccgccggacaccgcccccggcg
cctgacgccccgggccgcccggcgccgcccccggcccccggcggccgcaaaataaaaaagggga
cctctagggtccccaa 
Chloramphenicol 
resistance gene 
cassette (with a codon 
optimized gene for R. 
opacus) 
tgtgcgggctctaacacgtcctagtatggtaggatgagcaacatttcgacgccgagagattcgc
cgcccgaaatgagcacgatccgcatgcttaattaagaaggagatatacatatggagaaaaagat
cacggggtacaccaccgtggacatcagccagtggcaccgtaaggaacatttcgaagcgttccag
tccgtcgcgcaatgtacgtacaatcagaccgtccaactcgatattacggcgtttctgaagaccg
tgaagaagaataagcacaaattttaccccgcctttattcatatcctggcgcggctgatgaacgc
ccatccagaatttcgcatggccatgaaagatggcgagttggtcatctgggatagcgtccatcca
tgttatacggtgttccacgagcagaccgaaaccttttcgagcttgtggagcgagtatcacgatg
atttccggcagttcttgcacatttatagccaagatgtggcctgctatggtgagaatctggccta
ctttccgaaaggtttcattgagaacatgttttttgtgtccgccaatccgtgggtctcgttcacg
agcttcgacctcaacgtcgcgaatatggataacttttttgcgccggtctttaccatggggaaat
attatacgcagggcgataaggtgctgatgccactcgcgatccaagtgcatcatgccgtctgcga
tggcttccacgtcggtcggatgttgaacgaactccaacaatattgcgatgagtggcaaggtggt
gcgtaagctatgccaaataaaacgaaaggctcagtcgaaagactgggcctttcgttttatctgt
tgtttgtcggtgaacgctctctgag 
R. opacus origin of 
replication on 
pAL5000 (short 
variant;  S)3  
ttagaacagcggtggattgtcggcttcgttgtgggccttttgagccgcttcctgttctgccgca
cgctctttcctcgcccgatagccgagtcgcttaacggtgtccagatgcagcccgaaatgtttgg
ccgtttgcggccaagagtggccctcgtcgtcgtgataggcgcggatgcgttcgcggcgtgcagc
ctgctcggcgagccactcgctgcgttcctgcgccacgagccggacgacgtggcgttcggatagt
ccggtgattcgagcgccttcggcggcggtcacgcgccgctttttgcggacagtcggctgccggt
tgtagccgtcgctgtagccgtcgctcatagcaatgcctccatggctgacgcggactttgcgcgc
cgcgcaactgtgctcgccgccgtgcgcgctgctgcgcccttccgcgagatggccgactggcgcg
cactgagtgtggcctcgtagaccacgatcccgtccgcccaaatgcgcgacttggttgtgatcca
acgccaaatgctgttggcgatggcgcggacctcgctgtccggtagcggtccgggacacacgtcg
ttgcacgggaactcggcgtttcgcgcgtggcactcggcatagatcgcgcggccgagtccgtcca
cgttccgggtcggcaggtagatccgcatgagggcgggacgataggcccacaacctgacggaatc
gaacagtgcgcaattccgccctagcggcgtcggagccgctttgtacgtggtctgctgacgccag
cgcggcggtggcatgttcgcgccgagctcggcctcgatgtggctgagtgtgtagagatctgagt
ggagccattccgtttcccaggcgatgtggccggggtttttggtcatgaggcctgagtaactgcg
gtcgccgtccacggcgcgccgaaggccttcggcgcacgccgccatgtatgcgagcggcttacgc
cgcgcgtattcggtgcgtggaacaggggcgttgagtgcccacactgcgtgtgcgtggccgttgg
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cgcgattgcccacgatcgcgttgggcagcggatgggacccccgggcgctgagcgctcggagcgc
tgcgtctggatggtctacgtccacgaccagcaggtttgccagcgctgttgggttcgcctcgatg
taccggcggcctagggccgacgcgcggctttggcggtagatcccctcgagcagatcgtcgcttg
ccagcggccagtacggcagccagagctgctcaaattcgtcggcgacgtggctca 
R. opacus origin of 
replication on 
pAL5000 (long 
variant;  L)4 
atcgagccgagaacgttatcgaagttggtcatgtgtaatcccctcgtttgaactttggattaag
cgtagatacacccttggacaagccagttggattcggagacaagcaaattcagccttaaaaaggg
cgaggcctgcggtggtggaacaccgcagggcctctaaccgctcgacgcgctgcaccaaccagcc
cgcgaacggctggcagccagcgtaaggcgcggctcatcgggcggcgttcgccacgatgtcctgc
acttcgagccaagcctcgaacacctgctggtgtgcacgactcacccggttgttgacaccgcgcg
cggccgtgcgggctcggtggggcggctgtgtcgcccttgccagcgtgagtagcgcgtacctcac
ctcgcccaacaggtcgcacacagccgattcgtacgccataaagccaggtgagcccaccagctcc
gtaagttcgggcgctgtgtggctcgtacccgcgcattcaggcggcagggggtctaacgggtcta
aggcggcgtgtacggccgccacagcggctctcagcggcccggaaacgtcctcgaaacgacgcat
gtgttcctcctggttggtacaggtggttgggggtgctcggctgtcgctggtgttccaccaccag
ggctcgacgggagagcgggggagtgtgcagttgtggggtggcccctcagcgaaatatctgactt
ggagctcgtgtcggaccatacaccggtgattaatcgtggtctactaccaagcgtgagccacgtc
gccgacgaatttgagcagctctggctgccgtactggccgctggcaagcgacgatctgctcgagg
ggatctaccgccaaagccgcgcgtcggccctaggccgccggtacatcgaggcgaacccaacagc
gctggcaaacctgctggtcgtggacgtagaccatccagacgcagcgctccgagcgctcagcgcc
cgggggtcccatccgctgcccaacgcgatcgtgggcaatcgcgccaacggccacgcacacgcag
tgtgggcactcaacgcccctgttccacgcaccgaatacgcgcggcgtaagccgctcgcatacat
ggcggcgtgcgccgaaggccttcggcgcgccgtcgacggcgaccgcagttactcaggcctcatg
accaaaaaccccggccacatcgcctgggaaacggaatggctccactcagatctctacacactca
gccacatcgaggccgagctcggcgcgaacatgccaccgccgcgctggcgtcagcagaccacgta
caaagcggctccgacgccgctagggcggaattgcgcactgttcgattccgtcaggttgtgggcc
tatcgtcccgccctcatgcggatctacctgccgacccggaacgtggacggactcggccgcgcga
tctatgccgagtgccacgcgcgaaacgccgaattcccgtgcaacgacgtgtgtcccggaccgct
accggacagcgaggtccgcgccatcgccaacagcatttggcgttggatcacaaccaagtcgcgc
atttgggcggacgggatcgtggtctacgaggccacactcagtgcgcgccagtcggccatctcgc
ggaagggcgcagcagcgcgcacggcggcgagcacagttgcgcggcgcgcaaagtccgcgtcagc
catggaggcattgctatgagcgacggctacagcgacggctacagcgacggctacaaccggcagc
cgactgtccgcaaaaagcggcgcgtgaccgccgccgaaggcgctcgaatcaccggactatccga
acgccacgtcgtccggctcgtggcgcaggaacgcagcgagtggctcgccgagcaggctgcacgc
cgcgaacgcatccgcgcctatcacgacgacgagggccactcttggccgcaaacggccaaacatt
tcgggctgcatctggacaccgttaagcgactcggctatcgggcgaggaaagagcgtgcggcaga
acaggaagcggctcaaaaggcccacaacgaagccgacaatccaccgctgttctaacgcaattgg
ggagcgggtgtcgcgggggttccgtggggggttccgttgcaacgggtcggacaggtaaaagtcc
tggtagacgctagttttctggtttgggccatgcctgtctcgttgcgtgtttcgttgcgcccgtt
ttgaataccagccagacgagacggggttctacgaatcttggtcgataccaagccatttccgctg
aatatcggggagctcaccgccagaatcggtggttgtggtgatgtacgtggcgaactccgttgta
gtgcctgtggtggcatccgtggccactctcgttgcacggttcgttgtgccgttacaggccccgt
tgacagctcaccgaacgtagttaaaacatgctggtcaaactaggtttaccaacgatacgagtca
gctcatctagggccagttctaggcgttgttcgttgcgcggttcgttgcgcatgtttcgtgtggt
tgctagatggctccgcaaccacacgcttcgaggttgagtgcttccagcacgggcgcgatccaga
agaacttcgtcgtgcgactgtcctcgtt 
R. opacus origin of 
replication on pB2645 
cacacagctcttcagaggaacgtcgggcggtcgagcgcggcgtcgtcgcgtgtggagttgcgcg
agcgggtggtcgaggtcgagaaggtggtgcatcggccggccacgacggccattgctcgtttgaa
caggtctcacagaccatcagggtgcaacgcacccgcacggcagggctgtcccaagggggacggg
ctggtagtggacgtcatcgcagctgatactcatcgctcgattcctgccagggcgtgatggacag
tgccgaccgagcatcccagctcattggcgatagctctcatggacatgccagtaccgcgtagctc
ccgtatcttctcgcgccgttgctgtgcccgggacaggtaggcctctcgcggctctgatgtccac
cggatgatgctggccgtcgatacgcctgtgcgttcggcgagctcccgcactgttatcccgttgc
gaggcagacgctcagtcatgtgtggcctcctcaattgccagtcgcacctgatccagtttggtgc
tgcgtgcacgccgggcctggccgctggcgacgccgcctttgcggccacgggcggattggatggt
cgagagtgtggcttcgtagacggcgataccgtctttccagatgcgggatcgcgtggtgatccat
cggtgaatgctggcggcgatggcgcgggcttcagagggtgggagttcctcggtgtagctggcgt
tgagggcggtgacttcgcggtggagggcgagttcgaggccggcgctgtcatgagtgggcaggta
gttgcgcatgaggccggggcgggtggcccaggtgcgagcggcgtggaagattgcgcagttgcgg
ccgagtcctatgggggcgtcacggtgggccttggtgtgctgccagcgcggggagggcatgtgtg
tgccgagttcggcctcgagctcggcgaggctgcgcggttcggtgtggatccagtgcgtgtccca
gcctgagtgtgtggggttcttggtcatcaggcctgagtagccgatgtccccttcgacggcccgg
cgtagcccttcggtaacggcggcggcgtacgcgaggggcttccgtcgggcgtactcggtgcggg
tgaacggctcgcgcagccaccagtgcaggtgcgcatgcccgttgctgctgttttcgatcacggc
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gttcggcatagggtgattgcctgccgctgacagtgcgcgcagggcggagtcggggtggtcgacg
tcgacgacgagcagattgctcagtgtctgcgggttggcctcgatgtagcgccgctcaagtgcgg
cagggcggcgcattcgatagaccccctcaaggaagtcgtttgttgccaaaggccagaacggtag
ccacatttgctcccagtccccaccttcccgcaccccgtgtgtgtccatgctggtgaccgtcgca
tgctctcgaacgaaacctgggcatttccctcggtgtgttcaaagttaatcgtgaagccaagtca
gatgtttcggtctttgaagagcacacac 
E. coli origin of 
replication pMB12 
cgcgttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctca
agtcagaggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaagctccc
tcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcggg
aagcgtggcgctttctcaatgctcacgctgtaggtatctcagttcggtgtaggtcgttcgctcc
aagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatc
gtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggat
tagcagagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctac
actagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttg
gtagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagca
gattacgcgcagaaaaaaaggatctcaagaagatcctttgatct 
E. coli origin of 
replication pBR3226 
agatcaaaggatcttcttgagatcctttttttctgcgcgtaatctgctgcttgcaaacaaaaaa
accaccgctaccagcggtggtttgtttgccggatcaagagctaccaactctttttccgaaggta
actggcttcagcagagcgcagataccaaatactgtccttctagtgtagccgtagttaggccacc
acttcaagaactctgtagcaccgcctacatacctcgctctgctaatcctgttaccagtggctgc
tgccagtggcgataagtcgtgtcttaccgggttggactcaagacgatagttaccggataaggcg
cagcggtcgggctgaacggggggttcgtgcacacagcccagcttggagcgaacgacctacaccg
aactgagatacctacagcgtgagcattgagaaagcgccacgcttcccgaagggagaaaggcgga
caggtatccggtaagcggcagggtcggaacaggagagcgcacgagggagcttccagggggaaac
gcctggtatctttatagtcctgtcgggtttcgccacctctgacttgagcgtcgatttttgtgat
gctcgtcaggggggcggagcctatggaaaaacgccagcaacgcg 
Che9c60 and Che9c61 
genes (polycistronic)6 
atgagtgtgcccacacaggacggaatgcaccggttcgtcgacgaggacgtctaccacgctgacc
ggggctcgctgtcggtatccggcgcgaagctgctgttgccgccgtcgtgtcccgcgaaattccg
ctgggagatggacaacacccggaagccgaaaaaggtctgggacttcggacatgtcgcgcacaaa
ctggtgctcggcaagggtgccgagttcgagatcctcgaccccgaggtgcacgggctgaaggcgg
acggtacgccgtcggagaagccgaccgcgacgggcatgtggcgcaaggccgaggctgaggctcg
caaacagggcaaggtgccgattcacgtcgacctgttcacgaaggcgtacgacatggccgaaaag
gtgcgtcagcacccgacagccggcccgatcttcgccaatcctgacggcgaggccgaggtcgcgc
tgtactacaccgaccccgagaccggcgtgcggctgcgtggccggatcgactggctcactgacga
tatcgatgattacaagacgtcgatgaccgcgaacccggccgagctgaaaaccaagttctacaag
ctcggctatttcatgcaggcggcctggtacatcgatctactggtcgccctcgggctcgccgaga
acccgcgattccggttcatcacgcaggagaaagaaccgccctacgtcgtgactccgatccagta
cgacgacgaggcgatcgaagaggggcggcgccgcaaccgccaggcgatccggctctacgccgac
tgcatggaatcgggcaagtggcctgactacagcgacgacgtggtcacgatcagcctgccctcgt
gggggctgccgcgaccgcagaccgtcggcgacgtcgtcaccgacagctatatctacgacaccga
cccgctcgaagaggccgacccgattgaaggggattacatctatggctgaaaatgctgtcaccaa
gcaggattcgcccaaggcacccgagacgatctcgcaagtgctgcaggtgctcgtgccgcagctg
gcgcgtgcagtgcccaagggtatggaccccgaccgcatcgcgcggatcgtgcaaaccgagatcc
gcaagtcgcgcaacgcgaaagctgctggcatcgctaagcagtccctcgacgactgcacgcaaga
gtcatttgccggtgcgctgctgacctcggccgcgctcggtctcgagcccggtgtcaacggcgag
tgctacctcgtgccctaccgcgacacccggcgcggcgtggtcgagtgccagctgatcatcggct
accagggcatcgtcaaactgttctggcagcacccgcgcgcctcccggatcgacgcgcagtgggt
cggcgcgaacgacgaattccattacaccatgggcctcaatccgacgctgaaacacgtgaaggcc
aagggtgatcggggtaatccggtctacttctacgcgatcgtcgaggtgaccggcgctgagccgc
tgtgggacgtgttcaccgccgacgagatcagggaattgcgtcgcggcaaggtcggatcctcggg
cgacatcaaggacccgcagcgctggatggagcggaagaccgcgctcaaacaggtgctgaagctg
gcaccgaagacgacgcggctcgacgcggcgatccgcgccgacgatcgcccgggcaccgacctgt
cacagtcgcaggcgctcgcgctgccgtcgaccgtcaagccgacggccgactacatcgacggcga
gatcgccgagccgcacgaggtcgatacgccaccgaagtcgtcgcgcgcacaacgcgcgcagcgc
gccaccgcgccggcgcccgacgtgcagatggccaatcccgatcagctgaagcgcctcggcgaga
tccagaaggccgaaaagtacaacgacgccgattggttcaagttcctcgccgattcggccggcgt
caaagccacgcgcgccgccgacctcacgttcgacgaggcgaaggctgtcatcgacatgttcgac
gggcccaacgcatga 
pConstitutive from 
Streptomyces lividans 
TK24 + UTR1  
tgtgcgggctctaacacgtcctagtatggtaggatgagcaacatttcgacgccgagagattcgc
cgcccgaaatgagcacgatccgcatgcttaattaagaaggagatatacat 
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Gene encoding EYFP7, 
8 
atggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcg
acgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagct
gaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccacc
ttcggctacggcctgcaatgcttcgcccgctaccccgaccacatgaagctgcacgacttcttca
agtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaacta
caagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggc
atcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccaca
acgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaa
catcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggc
cccgtgctgctgcccgacaaccactacctgagctaccagtccgccctgagcaaagaccccaacg
agaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatcactctcggcatgga
cgagctgtacaaggctgcgaattga  
Gene encoding GFP+4, 
8 
atggctagcaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtg
atgttaatgggcacaaattttctgtcagtggagagggtgaaggtgatgctacatacggaaagct
tacccttaaatttatttgcactactggaaaactacctgttccatggccaacacttgtcactact
ttgacctatggtgttcaatgcttttcccgttatccggatcatatgaaacggcatgactttttca
agagtgccatgcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggaacta
caagacgcgtgctgaagtcaagtttgaaggtgatacccttgttaatcgtatcgagttaaaaggt
attgattttaaagaagatggaaacattctcggacacaaactcgagtacaactataactcacaca
atgtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgccacaa
cattgaagatggctccgttcaactagcagaccattatcaacaaaatactccaattggcgatggc
cctgtccttttaccagacaaccattacctgtcgacacaatctgccctttcgaaagatcccaacg
aaaagcgtgaccacatggtccttcttgagtttgtaactgctgctgggattacacatggcatgga
tgagctctacaaataa 
araC cassette + pBAD 
promoter + UTR7, 8 
ttatgacaacttgacggctacatcattcactttttcttcacaaccggcacggaactcgctcggg
ctggccccggtgcattttttaaatacccgcgagaaatagagttgatcgtcaaaaccaacattgc
gaccgacggtggcgataggcatccgggtggtgctcaaaagcagcttcgcctggctgatacgttg
gtcctcgcgccagcttaagacgctaatccctaactgctggcggaaaagatgtgacagacgcgac
ggcgacaagcaaacatgctgtgcgacgctggcgatatcaaaattgctgtctgccaggtgatcgc
tgatgtactgacaagcctcgcgtacccgattatccatcggtggatggagcgactcgttaatcgc
ttccatgcgccgcagtaacaattgctcaagcagatttatcgccagcagctccgaatagcgccct
tccccttgcccggcgttaatgatttgcccaaacaggtcgctgaaatgcggctggtgcgcttcat
ccgggcgaaagaaccccgtattggcaaatattgacggccagttaagccattcatgccagtaggc
gcgcggacgaaagtaaacccactggtgataccattcgcgagcctccggatgacgaccgtagtga
tgaatctctcctggcgggaacagcaaaatatcacccggtcggcaaacaaattctcgtccctgat
ttttcaccaccccctgaccgcgaatggtgagattgagaatataacctttcattcccagcggtcg
gtcgataaaaaaatcgagataaccgttggcctcaatcggcgttaaacccgccaccagatgggca
ttaaacgagtatcccggcagcaggggatcattttgcgcttcagccatacttttcatactcccgc
cattcagagaagaaaccaattgtccatattgcatcagacattgccgtcactgcgtcttttactg
gctcttctcgctaaccaaaccggtaaccccgcttattaaaagcattctgtaacaaagcgggacc
aaagccatgacaaaaacgcgtaacaaaagtgtctataatcacggcagaaaagtccacattgatt
atttgcacggcgtcacactttgctatgccatagcatttttatccataagattagcggatcctac
ctgacgctttttatcgcaactctctactgtttctccatacagcggataaagtagcaaagagaag
gaggttagga 
Gene encoding S. 
thermophilus dCas99 
atgtcggacctggtgctgggcctggccatcggcatcggctcggtgggcgtgggcatcctgaaca
aggtgaccggcgagatcatccacaagaactcgcgcatcttcccggccgcccaggccgagaacaa
cctggtgcgccgcaccaaccgccagggccgccgcctggcccgccgcaagaagcaccgccgcgtg
cgcctgaaccgcctgttcgaggagtcgggcctgatcaccgacttcaccaagatctcgatcaacc
tgaacccgtaccagctgcgcgtgaagggcctgaccgacgagctgtcgaacgaggagctgttcat
cgccctgaagaacatggtgaagcaccgcggcatctcgtacctggacgacgcctcggacgacggc
aactcgtcggtgggcgactacgcccagatcgtgaaggagaactcgaagcagctggagaccaaga
ccccgggccagatccagctggagcgctaccagacctacggccagctgcgcggcgacttcaccgt
ggagaaggacggcaagaagcaccgcctgatcaacgtgttcccgacctcggcctaccgctcggag
gccctgcgcatcctgcagacccagcaggagttcaacccgcagatcaccgacgagttcatcaacc
gctacctggagatcctgaccggcaagcgcaagtactaccacggcccgggcaacgagaagtcgcg
caccgactacggccgctaccgcacctcgggcgagaccctggacaacatcttcggcatcctgatc
ggcaagtgcaccttctacccggacgagttccgcgccgccaaggcctcgtacaccgcccaggagt
tcaacctgctgaacgacctgaacaacctgaccgtgccgaccgagaccaagaagctgtcgaagga
gcagaagaaccagatcatcaactacgtgaagaacgagaaggccatgggcccggccaagctgttc
aagtacatcgccaagctgctgtcgtgcgacgtggccgacatcaagggctaccgcatcgacaagt
cgggcaaggccgagatccacaccttcgaggcctaccgcaagatgaagaccctggagaccctgga
catcgagcagatggaccgcgagaccctggacaagctggcctacgtgctgaccctgaacaccgag
cgcgagggcatccaggaggccctggagcacgagttcgccgacggctcgttctcgcagaagcagg
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tggacgagctggtgcagttccgcaaggccaactcgtcgatcttcggcaagggctggcacaactt
ctcggtgaagctgatgatggagctgatcccggagctgtacgagacctcggaggagcagatgacc
atcctgacccgcctgggcaagcagaagaccacctcgtcgtcgaacaagaccaagtacatcgacg
agaagctgctgaccgaggagatctacaacccggtggtggccaagtcggtgcgccaggccatcaa
gatcgtgaacgccgccatcaaggagtacggcgacttcgacaacatcgtgatcgagatggcccgc
gagaccaacgaggacgacgagaagaaggccatccagaagatccagaaggccaacaaggacgaga
aggacgccgccatgctgaaggccgccaaccagtacaacggcaaggccgagctgccgcactcggt
gttccacggccacaagcagctggccaccaagatccgcctgtggcaccagcagggcgagcgctgc
ctgtacaccggcaagaccatctcgatccacgacctgatcaacaactcgaaccagttcgaggtgg
acgccatcctgccgctgtcgatcaccttcgacgactcgctggccaacaaggtgctggtgtacgc
caccgccaaccaggagaagggccagcgcaccccgtaccaggccctggactcgatggacgacgcc
tggtcgttccgcgagctgaaggccttcgtgcgcgagtcgaagaccctgtcgaacaagaagaagg
agtacctgctgaccgaggaggacatctcgaagttcgacgtgcgcaagaagttcatcgagcgcaa
cctggtggacacccgctacgcctcgcgcgtggtgctgaacgccctgcaggagcacttccgcgcc
cacaagatcgacaccaaggtgtcggtggtgcgcggccagttcacctcgcagctgcgccgccact
ggggcatcgagaagacccgcgacacctaccaccaccacgccgtggacgccctgatcatcgccgc
ctcgtcgcagctgaacctgtggaagaagcagaagaacaccctggtgtcgtactcggaggaccag
ctgctggacatcgagaccggcgagctgatctcggacgacgagtacaaggagtcggtgttcaagg
ccccgtaccagcacttcgtggacaccctgaagtcgaaggagttcgaggactcgatcctgttctc
gtaccaggtggactcgaagttcaaccgcaagatctcggacgccaccatctacgccacccgccag
gccaaggtgggcaaggacaaggccgacgagacctacgtgctgggcaagatcaaggacatctaca
cccaggacggctacgacgccttcatgaagatctacaagaaggacaagtcgaagttcctgatgta
ccgccacgacccgcagaccttcgagaaggtgatcgagccgatcctggagaactacccgaacaag
cagatcaacgacaagggcaaggaggtgccgtgcaacccgttcctgaagtacaaggaggagcacg
gctacatccgcaagtactcgaagaagggcaacggcccggagatcaagtcgctgaagtactacga
ctcgaagctgggcaaccacatcgacatcaccccgaaggactcgaacaacaaggtggtgctgcag
tcggtgtcgccgtggcgcgccgacgtgtacttcaacaagaccaccggcaagtacgagatcctgg
gcctgaagtacgccgacctgcagttcgacaagggcaccggcacctacaagatctcgcaggagaa
gtacaacgacatcaagaagaaggagggcgtggactcggactcggagttcaagttcaccctgtac
aagaacgacctgctgctggtgaaggacaccgagaccaaggagcagcagctgttccgcttcctgt
cgcgcaccatgccgaagcagaagcactacgtggagctgaagccgtacgacaagcagaagttcga
gggcggcgaggccctgatcaaggtgctgggcaacgtggccaactcgggccagtgcaagaagggc
ctgggcaagtcgaacatctcgatctacaaggtgcgcaccgacgtgctgggcaaccagcacatca
tcaagaacgagggcgacaagccgaagctggacttctaa 
sgRNA cassette  tgtgcgggctctaacacgtcctagtatggtaggatgagcaacaNNNNNNNNNNNNNNNNNNNNg
tttttgtactcgaaagaagctacaaagataaggcttcatgccgaaatcaacaccctgtcatttt
atggcagggtgttttttttttgtcgacttggggaccctagaggtccccttttttatttttttgg
atgaagagcattatcaatggctcttcacaggaagcttaaaaaaaaaagccccgcgattgcgggg
ctttttttttt 
E. coli origin of 
replication p15a10 
cctagggatatattccgcttcctcgctcactgactcgctacgctcggtcgttcgactgcggcga
gcggaaatggcttacgaacggggcggagatttcctggaagatgccaggaagatacttaacaggg
aagtgagagggccgcggcaaagccgtttttccataggctccgcccccctgacaagcatcacgaa
atctgacgctcaaatcagtggtggcgaaacccgacaggactataaagataccaggcgtttcccc
ctggcggctccctcgtgcgctctcctgttcctgcctttcggtttaccggtgtcattccgctgtt
atggccgcgtttgtctcattccacgcctgacactcagttccgggtaggcagttcgctccaagct
ggactgtatgcacgaaccccccgttcagtccgaccgctgcgccttatccggtaactatcgtctt
gagtccaacccggaaagacatgcaaaagcaccactggcagcagccactggtaattgatttagag
gagttagtcttgaagtcatgcgccggttaaggctaaactgaaaggacaagttttggtgactgcg
ctcctccaagccagttacctcggttcaaagagttggtagctcagagaaccttcgaaaaaccgcc
ctgcaaggcggttttttcgttttcagagcaagagattacgcgcagaccaaaacgatctcaagaa
gatcatcttattaa 
Tandem rrnB T1 and 
T7Te terminator for 
EYFP10 
accaggcatcaaataaaacgaaaggctcagtcgaaagactgggcctttcgttttatctgttgtt
tgtcggtgaacgctctctactagagtcacactggctcaccttcgggtgggcctttctgcgttta
ta 
Tandem rrnB T2 and 
TsynB terminator for 
dCas9Sth9 
agaaggccatcctgacggatggcctttttctagaaaaaaaaaaagcgccgcaactgcggcgctt
tttttttt 
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Supplementary Table C.3. qPCR primers used for plasmid copy number analysis. The “expected 
value of amplicon” or E-value refers to the likelihood that the amplicon sequence will match or 
align with the examined genome, excluding the target sequence. As the E-value approaches zero, 
the likelihood of an off-target match decreases, leading to a higher degree of specificity. E-values 
were determined using NCBI’s blastn. PCR reaction efficiency was calculated using the slope of 
a dilution series of known PCR amplicon quantity conducted in duplicate (see Materials and 
Methods C; Supplementary Figure C.1). 
 
Primer 
Name 
Target Nucleotide Sequence 
(5’ to 3’) 
Expected 
Value of 
Amplicon 
Efficiency 
% 
Amplicon 
Length 
(nt) 
PD630P1F Plasmid 1 F: CGTACAACAGCTACCAGTTCACG 9e-86 97 164 
PD630P1R R: GCGGTGTTACTGAACGTGTCC 
PD630P2F Plasmid 2 F: GACGATGAATCTGCTGTCCTCC 2e-72 95 140 
PD630P2R R: AGGTTCGGGTGAGCTTTCAGG 
PD630P3F Plasmid 3 F: GCCATCAGTCCTCGTCTTCC 3e-101 92 192 
PD630P3R R: ACTCCTGGGTGTACCTGCTG 
PD630P4F Plasmid 4 F: GGTTCGTTCTTCCCATACAGGG 3e-96 90 183 
PD630P4R R: GGTGCTCAATCATTTGGTGGTCG 
PD630P5F Plasmid 5 F: TGGGACATGGCGATGCTACC 5e-109 96 206 
PD630P5R R: CGTTTGCGTTGGTCGTTCGG 
PD630P6F Plasmid 6 F: CCACCCACACACTTGAGACG 9e-81 96 155 
PD630P6R R: GCGAGTCACGAGGTTAAGGC 
PD630P7F Plasmid 7 F: GCTCGGTCCCACTGACATATTCG 2e-113 95 214 
PD630P7R R: CGGCAGCGGAATTTAGTCGG 
PD630P8F Plasmid 8 F: AAGCACAGTTTGTCGTGTATGTCG 1e-74 96 144 
PD630P8R R: GTATGGGTACTGTCAAGATGGTGC 
PD630P9F Plasmid 9 F: CACCGCATCACAACCGTTTTCC 6e-119 93 224 
PD630P9R R: CCATCACCCGTGTCCTGATCG 
PD630PCF Chromosome F: GAAAGCGTTCGAGCACGTCG 2e-77 88 149 
PD630PCR R: CCAGGTCAAACATATTCTCGGAGC 
DKanF pAL5000 (S) 
and pB264 
F: GCTCTTCGTCCAGATCATCC No 
significant 
similarity 
90 175 
DKanR R: TCATCTCACCTTGCTCCTGC 
DGentF pNG2 F: CTATGATCTCGCAGTCTCCG No 
significant 
similarity 
91 128 
DGentR R: CGTCACCGTAATCTGCTTGC 
DHygF pAL5000 (L) F: GTCCACGAAGATGTTGGTCC No 
significant 
similarity 
89 188 
DHygR R: AGGTCTTCCCGGAACTGCTG 
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Supplementary Table C.4. Summary of candidate R. opacus chromosomal integration sites 
(ROCI-#) and endogenous plasmid integration sites (ROP#I-#). Neutral integration sites were 
identified as discussed in Figure 2.4. The replaced location and LPD gene annotation (NCBI 
database Refseq NZ_CP003949.1) are reported. Among >200 bp of each site, the replaced region 
with the integration cassette is shown in the “Location (nucleotide)” column. Annotations were 
confirmed by NCBI blastp to examine if genes had homologs with differing annotations in related 
species. “Up” refers to the gene upstream of the integration site. “Down” refers to the gene 
downstream of the integration site. 
 
Integration 
Site Name 
Location 
(nucleotide) 
Location  
(LPD annotation) 
Gene Annotations 
ROCI-1 4,222,959 to 
4,223,163 
Between LPD04028 
& LPD04029 
Up: Hypothetical protein 
Down: Putative thiamine biosynthesis lipoprotein ApbE 
ROCI-2 4,896,351 to 
4,896,498 
Between LPD04690 
& LPD04691 
Up: Hypothetical protein 
Down: Hypothetical protein 
ROCI-3 3,978,043 to 
3,978,140 
Between LPD03763 
& LPD03764 
Up: Hypothetical protein 
Down: Hypothetical protein 
ROP8I-1 147,710 to 
147,711 
Between LPD16184 
& LPD16185 
Up: Hypothetical protein 
Down: Hypothetical protein 
 
 
 
 
Supplementary Table C.5. Explanation of gel lane labels in Supplementary Figure C.5. The gel 
lane labels correspond to the following. A: cell lysis control; B: internal integration cassette 
control; C: genome/integration cassette upstream junction; and D: integration cassette/genome 
downstream junction (see Supplementary Figure C.5A for a schematic of primer locations). The 
numbers associated with lanes C and D correspond to the primer pairs for individual integration 
sites.  
 
Strain Gel Lane Labels (A-D) Nucleotide Sequences (5’ to 3’) Length (bp) 
All A F: GACGAGATCAGAGTCCGACAACTCG 1402 
R: CCGAAAATGTTACGCAGAGTGCG 
All B F: GAAGAAGTCGTGCAGCTTCATGTGG 568 
R: TTCTAATCCGCATATGATCAATTCAAGG 
ROCI-1 C1 F: TCTGCTGTAGATCGTGATGGTCATGG 1051 
R: CTGTACAAGGCTGCGAATTGAGACC 
ROCI-2 C2 F: CTGCTGCTGATACTCGAGCACATCC 1138 
R: CTGTACAAGGCTGCGAATTGAGACC 
ROCI-3 C3 F: CCTAAGTCGATCGACGATCACCAGG 779 
R: CTGTACAAGGCTGCGAATTGAGACC 
ROP8I-1 C4 F: CAACCGCACTAATCTAAGCGAAACG 1160 
R: CTGTACAAGGCTGCGAATTGAGACC 
ROCI-1 D1 F: CGAATCAATACGGTCGAGAAGTAACAGG 1078 
R: AATTCGAAGGACCAGCAGATCAATTCC 
ROCI-2 D2 F: CGAATCAATACGGTCGAGAAGTAACAGG 788 
R: TCGATGCTGATGGTGATGGTCTGAC 
ROCI-3 D3 F: CGAATCAATACGGTCGAGAAGTAACAGG 637 
R: GCGAACTCCGCTTCGAATACTGC 
ROP8I-1 D4 F: CGAATCAATACGGTCGAGAAGTAACAGG 644 
R: AGCCAAGGAACAGCACATCACCAC 
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Supplementary Table C.6. Growth rates of neutral site integration strains. An integration cassette 
containing constitutively expressed EYFP and HygR genes was integrated into one of three 
chromosomal candidate neutral sites (ROCI 1, 2, and 3) and one endogenous plasmid candidate 
neutral site (ROP8I-1). The growth rates (hr-1) were calculated by taking a linear regression of 
natural log transformed absorbance (600 nm) across at least four 1-hour interval time points. The 
growth rates of ROCI-2, ROCI-3, and ROP8I-1 were indistinguishable from the wild type (WT) 
growth rate, as determined by a Students t-test (two tail, equal variance). The growth rate for 
ROCI-1 exhibited an 18% reduction (p = 0.001). Values represent the average of three replicates 
with one standard deviation. 
 
Strain Growth rate (hr-1) Significant difference 
compared to WT? 
Wild type (WT) 0.20 ± 0.01 N/A 
ROCI-1 0.16 ± 0.01 Yes (p = 0.001) 
ROCI-2 0.18 ± 0.01 No 
ROCI-3 0.19 ± 0.01 No 
ROP8I-1 0.19 ± 0.01 No 
 
 
 
Supplementary Table C.7. CRISPRi sgRNA sequences. sgRNA PAM sites and target sequences 
were chosen and designed as described by Rock et al.9  
 
sgRNA PAM Target sequence 
A NNAGAAG ATGTGGTCGGGGTAGCGGGC 
B NNAGCAT CCGCTTCTAAGCAAACCTTA 
C NNAGCAG GCTTCTAAGCAAACCTTAACAGC 
 
 
Supplementary Table C.8. Plasmids used in this work.   
 
Plasmid name Functional insert Backbone Antibiotic 
resistance 
Length 
(bp) 
Source 
pUV15tetORm pTet.GFP+ pAL5000 (L) Hygromycin B 8026 Ehrt et al. 
20054 
pXYLA pTac.xylA pAL5000 (S) Kanamycin 5823 Xiong et al. 
20123 
pAL358 LacZ pNG2 Gentamicin 4344 Kurosawa et 
al. 20132 
pCI078 BbaJ23104-EYFP pBR322 Kanamycin 4636 Immethun et 
al. 201510 
pDD26/pJV53 pAcetamide. 
Che9c60.Che9c61 
pAL5000 Kanamycin 8812 Van Kessel & 
Hatfull 20076 
pDD42 ROCI-1 (LPD04028/04029) 
EYFP integrative vector 
Integrative Hygromycin B 4881 This study; 
derived from 
pCI078 and 
pUV15tetORm  
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pDD43 pConstitutive.GFP+ -35 
saturation mutagenesis 
library 
pAL5000 (S) Kanamycin 4776 This study; 
derived from 
pDD57 
pDD44 pConstitutive.GFP+ -10 
saturation mutagenesis 
library 
pAL5000 (S) Kanamycin 4776 This study; 
derived from 
pDD57 
pDD45 pConstitutive.GFP+ -35 &    
 -10 simultaneous saturation 
mutagenesis library 
pAL5000 (S) Kanamycin 4776 This study; 
derived from 
pDD57   
pDD56 pBAD.EYFP pAL5000 (S) Kanamycin 6013 DeLorenzo et 
al. 20178 
pDD57 pConstitutive.GFP+ pAL5000 (S) Kanamycin 4776 This study; 
derived from 
pDD65 and 
pUV15tetORm 
pDD65 Empty backbone pAL5000 (S) Kanamycin 3659 This study; 
derived from 
pXYLA  
pDD67 Empty backbone pNG2 Gentamicin 6209 This study; 
derived from 
pAL358  
pDD82 Empty backbone pB264 Kanamycin 3611 This study; 
derived from 
pDD65 
pDD99 Empty backbone pAL5000 (L) Hygromycin B 6057 This study; 
derived from 
pUV15tetORm  
pDD107 ROP8I-1 
(LPD16184/16185) EYFP 
integrative vector 
Integrative Hygromycin B 4547 This study; 
derived from 
pCI078 and 
pUV15tetORm  
pDD108 ROCI-2 (LPD04690/04691) 
EYFP integrative vector 
Integrative Hygromycin B 4290 This study; 
derived from 
pCI078 and 
pUV15tetORm  
PLJR965 pTet.dCas9Sth Mycobacteria 
integrative 
Kanamycin 8631 Rock et al. 
20179 
pDD112 Chloramphenicol cassette 
(optimized) 
pNG2 Chloramphenicol 5021 This study; 
derived from 
pDD67 
pDD119 pAcetamide. 
Che9c60.Che9c61 
pB264 Kanamycin 8585 This study; 
derived from 
pJV53 and 
pDD82  
pDD120 pConstitutive. 
Che9c60.Che9c61 
pB264 Kanamycin 6247 This study; 
derived from 
pDD57 and 
pDD119 
pDD132 ROCI-3 (LPD03763/03764) 
EYFP integrative vector 
Integrative Hygromycin B 4238 This study; 
derived from 
pCI078 and 
pUV15tetORm  
pDD143 pBAD.dCas9Sth. 
pCon.sgRNA.A 
pAL5000 (S) Gentamicin 9551 This study; 
derived from 
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PLJR965 and 
pDD56  
pDD145 pBAD.dCas9Sth. 
pCon.sgRNA.B 
pAL5000 (S) Gentamicin 9551 This study; 
derived from 
PLJR965 and 
pDD56 
pDD147 pBAD.dCas9Sth. 
pCon.sgRNA.C 
pAL5000 (S) Gentamicin 9554 This study; 
derived from 
PLJR965 and 
pDD56 
 
Supplementary Table C.9. Strains used in this work.    
 
Strain 
name 
Genus Species Strain Plasmid contained Corresponding 
figure 
DMD012 Escherichia coli DH10B pCI078 N/A 
DMD022 Rhodococcus opacus PD630 Wild type 3 and 5 
DMD026 Escherichia coli DH10B pDD67 N/A 
DMD052 Escherichia coli DH10B pDD42 N/A 
DMD056 Escherichia coli DH10B pDD65 N/A 
DMD057 Escherichia coli DH10B pDD56 N/A 
DMD061 Escherichia coli DH10B pDD26/pJV53 N/A 
DMD080 Rhodococcus opacus PD630 pDD26/pJV53 N/A 
DMD081 Rhodococcus opacus PD630 pDD65 2 
DMD093 Escherichia coli DH10B pDD82 N/A 
DMD095 Escherichia coli DH10B pUV15tetORm N/A 
DMD096 Escherichia coli DH10B pAL358 N/A 
DMD097 Escherichia coli DH10B pDD57 N/A 
DMD098 Escherichia coli DH10B pDD119 N/A 
DMD101 Rhodococcus opacus PD630 pDD67 2 
DMD102 Rhodococcus opacus PD630 pDD119 N/A 
DMD132 Escherichia coli DH10B pDD99 N/A 
DMD133 Rhodococcus opacus PD630 pDD99 2 and 3 
DMD143 Escherichia coli DH10B pDD108 N/A 
DMD144 Escherichia coli DH10B pDD107 N/A 
DMD146 Rhodococcus opacus PD630 pDD57 1 
DMD153 Escherichia coli DH10B PLJR965 N/A 
DMD155 Escherichia coli DH10B pDD120 N/A 
DMD157 Rhodococcus opacus PD630 pDD120 4 
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DMD160 Escherichia coli DH10B pDD112 N/A 
DMD161 Rhodococcus opacus PD630 pDD112 3 
DMD175 Rhodococcus opacus PD630 pDD82 2 
DMD179 Rhodococcus opacus PD630 Integrated pDD42 5 
DMD180 Rhodococcus opacus PD630 Integrated pDD107 5 
DMD181 Rhodococcus opacus PD630 Integrated pDD108 5 and 6 
DMD199 Escherichia coli DH10B pDD132 N/A 
DMD207 Rhodococcus opacus PD630 Integrated pDD132 5 
DMD221 Escherichia coli DH10B pDD143 N/A 
DMD223 Escherichia coli DH10B pDD145 N/A 
DMD225 Escherichia coli DH10B pDD147 N/A 
DMD227 Rhodococcus opacus PD630 pDD143 + 
 integrated pDD108 
6 
DMD228 Rhodococcus opacus PD630 pDD145 +  
integrated pDD108 
6 
DMD229 Rhodococcus opacus PD630 pDD147 + 
 integrated pDD108 
6 
DMD233 Escherichia coli DH10B pXYLA N/A 
EPC1 Escherichia coli DH10B pDD43 N/A 
EPC2 Escherichia coli DH10B pDD44 N/A 
EPC3 Escherichia coli DH10B pDD45 N/A 
RPC1 
through 
RPC25 
Rhodococcus opacus PD630 Selected constitutive 
promoter-GFP+ 
constructs 
1 
 
 
Supplementary Table C.10. Fitted Hill equation parameters for Figure 2.6. The modified Hill 
equation, described below in C.3 Supplementary Methods, was fit to each set of normalized 
fluorescence (au) or percent repression data by minimizing the root mean square error (RMSE). 
Fmax and Fmin represent the fitted maximum and minimum normalized fluorescence (au), 
respectively. PRmax and PRmin represent the fitted maximum and minimum percent repression, 
respectively. The fitted Hill coefficient (n), half-maximal constant (K), and RMSE are also 
reported. 
 
Figure Strain Fmax or 
PRmax 
Fmin or 
PRmin 
n K RMSE 
2.6A pBAD.dCas9Sth.pCon.sgRNA.A 988 (au) 564 (au) 1.163 2.460 7.237 
 
2.6A pBAD.dCas9Sth.pCon.sgRNA.B 1301 (au) 772 (au) 1.658 2.895 11.778 
 
2.6A pBAD.dCas9Sth.pCon.sgRNA.C 957 (au) 624 (au) 1.413 6.358 13.962 
 
2.6B pBAD.dCas9Sth.pCon.sgRNA.A 58.4 27.1 1.163 2.460 0.534 
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2.6B pBAD.dCas9Sth.pCon.sgRNA.B 43.1 4.1 1.658 2.895 0.869 
 
2.6B pBAD.dCas9Sth.pCon.sgRNA.C 54.0 29.4 1.413 6.358 1.030 
 
 
 
 
C.2 Supplementary figures 
 
 
Supplementary Figure C.1. Representative qPCR standard curve. Data for endogenous plasmid 
1 is shown as an example. The calculated PCR efficiency was 97% (see Materials and Methods 
for the corresponding equation). Experiment was conducted in duplicate (black and grey points). 
The dashed line represents a linear regression of the combined data set. The efficiency values for 
all primer pairs and targets are listed in Supplementary Table C.3. 
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Supplementary Figure C.2. Representative integration cassette. A) A plasmid containing E. coli origin 
of replication (p15A), upstream and downstream homologous arms of ~500 base pairs, a 
constitutively expressed EYFP gene, and a HygR gene. B) The integration vector was linearized 
via PCR to better facilitate double homologous recombination.6 All parts sequences are listed in 
Supplementary Table C.2. 
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Supplementary Figure C.3. Vector map of the curable recombinase plasmid (pDD120). The 
bacteriophage recombinases Che9c60 and Che9c61 were constitutively expressed on the pB264 
backbone. All parts sequences are listed in Supplementary Table C.2. The plasmid can be cured 
by removal of selection pressure and a round of colony purification.  
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Supplementary Figure C.4. Curing of pDD120 during recombination experiments. The electro-
competent cells containing the recombinases Che9c60 and Che9c61 on the pB264 backbone 
(pDD120) were electroporated with a linearized DNA integration cassette (see Materials and 
Methods). The cells were plated on a TSB agar plate containing only hygromycin B (selection for 
the integration cassette). Thus, there was no antibiotic selection for the recombinase vector 
(kanamycin), which led to curing of the plasmid after a round of colony purification. The electro-
competent cell strain and HygR integrated cell strain were both grown in minimal media B with 
either kanamycin or hygromycin B as designated. The dashed line represents the initial OD600 of 
0.2. Bars represent the average of three replicates and error bars represent one standard deviation.  
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Supplementary Figure C.5. Confirmation of a successful integration event. A) A schematic of 
primer binding locations for primer sets A through D. Primer set A binds at a location external to 
the integration site and was used to confirm successful cell lysis and that an adequate amount of 
DNA was present in the PCR reaction. Primer set B binds within the core region of the integration 
cassette and determines if the cassette was integrated, although it does not confirm whether 
integration at the correct site occurred. Primer set C spans the upstream junction of the integration 
site. Primer set D spans the downstream junction of the integration site. Primer sets A and B are 
universal for all tested strains, while sets C and D are for specific integration sites as designated 
by number (1-4). All expected band sizes are listed in Supplementary Table C.5. B) Images of 
electrophoresis gels confirming successful integration. Gel image colors were inversed for 
enhanced readability. All images include that of a wild type strain (WT) control. See 
Supplementary Table C.5 for full explanation of gel lane labels and correct PCR band sizes.  
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Supplementary Figure C.6. Illegitimate homologous recombination. The ROCI-1 integration 
cassette was transformed into wild type cells (no Che9c recombinases present). The cassette 
successfully recombines with the genome, but not in the correct location. The integration cassette 
is present (B), but it failed to integrate at site ROCI-1 (C1 and D1 bands which should be inside 
the red box are missing [see Supplementary Table C.5 for band sizes]). Gel image colors were 
inversed for enhanced readability. 
 
 
 
 
 
 
Supplementary Figure C.7. CRISPRi culture absorbance at 600 nm. The cell density of each 
culture was estimated using the absorbance at 600 nm. The absorbance data for sgRNAs A, B, and 
C across all arabinose induction concentrations are reported. The positive control had a comparable 
absorbance at 600 nm of 1.19 ± 0.01. Values represent the average of three replicates grown in 
minimal media B, and error bars represent one standard deviation. The dashed line represents a 
logarithmic regression and the equation of each respective line is reported. Induction of dCas9Sth 
with arabinose had no impact on growth of any of the strains (|logarithmic coefficient| < 0.01).  
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C.3 Supplementary methods 
 
C.3.1 Propagated standard deviation calculation for plasmid copy number 
The propagated standard deviation for each plasmid copy number ratio was calculated according 
to the following equation to account for the respective standard deviations of both the chromosome 
and plasmid copy numbers, which were measured in triplicate. 
𝑃𝑟𝑜𝑝𝑎𝑔𝑎𝑡𝑒𝑑 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 𝑟𝑎𝑡𝑖𝑜 =
𝜇𝑃
𝜇𝐶
∗ √(
𝜎𝑃
𝜇𝑃
)
2
+ (
𝜎𝐶
𝜇𝐶
)
2
 
𝜇𝑃 = 𝑚𝑒𝑎𝑛 𝑜𝑓 𝑎𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑝𝑙𝑎𝑠𝑚𝑖𝑑 𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 
𝜇𝐶 =  𝑚𝑒𝑎𝑛 𝑜𝑓 𝑎𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑐ℎ𝑟𝑜𝑚𝑜𝑠𝑜𝑚𝑒 𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 
𝜎𝑃 = 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑎𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑝𝑙𝑎𝑠𝑚𝑖𝑑 𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 
𝜎𝐶 = 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑎𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑐ℎ𝑟𝑜𝑚𝑜𝑠𝑜𝑚𝑒 𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 
 
 
C.3.2 Propagated standard deviation for percent repression  
The propagated standard deviation for percent repression was calculated according to the 
following equation to account for the respective standard deviations of both the CRISPRi and 
positive control (EYFP only) culture fluorescence values, which were measured in triplicate. 
𝑃𝑟𝑜𝑝𝑎𝑔𝑎𝑡𝑒𝑑 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑟𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 = 100 ∗
𝜇𝐼
𝜇𝑈
∗ √(
𝜎𝐼
𝜇𝐼
)
2
+ (
𝜎𝑈
𝜇𝑈
)
2
 
𝜇𝐼 = 𝑚𝑒𝑎𝑛 𝑜𝑓 𝐶𝑅𝐼𝑆𝑃𝑅𝑖 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝜇𝑈 =  𝑚𝑒𝑎𝑛 𝑜𝑓 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝜎𝐼 = 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝐶𝑅𝐼𝑆𝑃𝑅𝑖 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝜎𝑈 = 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
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C.3.3 Hill equation fitting 
 
The Hill equation was adapted from DeLorenzo et al. (2017), to fit a line to both the normalized 
fluorescence and percent repression data.8 The model was fit to the experimentally collected data 
such that the RMSE was minimized (Microsoft Excel Solver GRG Nonlinear). Fitted values are 
listed in Supplementary Table 10.  
  
 For CRISPRi normalized fluorescence plots: 
 
𝐹 =
(𝐹𝑚𝑎𝑥 − 𝐹𝑚𝑖𝑛) ∗ 𝐾
𝑛
𝐼𝑛𝑑𝑢𝑐𝑒𝑟𝑛 + 𝐾𝑛
+ 𝐹𝑚𝑖𝑛 
𝐹 = 𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐹𝑚𝑎𝑥 = 𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐹𝑚𝑖𝑛 = 𝑀𝑖𝑛𝑖𝑚𝑢𝑚 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝐾 = 𝐻𝑎𝑙𝑓 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 
𝑛 = 𝐻𝑖𝑙𝑙 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
𝐼𝑛𝑑𝑢𝑐𝑒𝑟 = 𝐴𝑟𝑎𝑏𝑖𝑛𝑜𝑠𝑒 𝑖𝑛𝑑𝑢𝑐𝑒𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑚𝑀) 
 
 
Root mean square error (RMSE): 
√
∑ (𝐹 − 𝐹𝑜𝑏𝑠)2
𝑛
𝑖=1
𝑛 − 2
  
𝐹𝑜𝑏𝑠 = 𝑂𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝑛 = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑡𝑎 𝑝𝑜𝑖𝑛𝑡𝑠 
 
 
 
For CRISPRi percent repression plots: 
 
𝑃𝑅 =  
(𝑃𝑅𝑚𝑎𝑥 − 𝑃𝑅𝑚𝑖𝑛) ∗ 𝐼𝑛𝑑𝑢𝑐𝑒𝑟
𝑛
𝐼𝑛𝑑𝑢𝑐𝑒𝑟𝑛 + 𝐾𝑛
+  𝑃𝑅𝑚𝑖𝑛 
𝑃𝑅 = 𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑟𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 
𝑃𝑅𝑚𝑎𝑥 = 𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑟𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 
𝑃𝑅𝑚𝑖𝑛 = 𝑀𝑖𝑛𝑖𝑚𝑢𝑚 𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑟𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 
𝐾 = 𝐻𝑎𝑙𝑓 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 
𝑛 = 𝐻𝑖𝑙𝑙 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
𝐼𝑛𝑑𝑢𝑐𝑒𝑟 = 𝐴𝑟𝑎𝑏𝑖𝑛𝑜𝑠𝑒 𝑖𝑛𝑑𝑢𝑐𝑒𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑚𝑀) 
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Root mean square error (RMSE): 
√
∑ (𝑃𝑅 − 𝑃𝑅𝑜𝑏𝑠)2
𝑛
𝑖=1
𝑛 − 2
  
𝑃𝑅𝑜𝑏𝑠 = 𝑂𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
𝑛 = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑡𝑎 𝑝𝑜𝑖𝑛𝑡𝑠 
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Appendix D: Supplementary materials for selection  
of stable reference genes for RT-qPCR in  
Rhodococcus opacus PD630 
 
D.1 Supplementary tables 
Supplementary Table D.1. Candidate reference gene (RG) primer sequences. The forward and 
reverse oligonucleotide sequences used for RT-qPCR for each respective RG candidate. Also listed 
are the predicted melting temperature (TM) for each respective oligonucleotide and the annealing 
temperature (TA) for each oligonucleotide pair as predicted by the ThermoFisher’s Tm calculator 
(https://www.thermofisher.com/us/en/home/brands/thermo-scientific/molecular-
biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-scientific-
web-tools/tm-calculator.html). See “RT-qPCR primer design criteria” for how oligonucleotide 
sequences were selected. 
 
Reference gene (RG) Primer sequence TM TA 
RG1 
F:  CCCGCCGAGTCCGTGTTGTTCTTG 
R:  CGACAGCCGAGTGCGACAACCTCATC 
65 OC 
67 OC 
60 OC 
RG2 
F:  CCTGACCTGTCGGCACGAATGAGC 
R:  CCTTCACGGCATCCCCAACGC 
65 OC 
65 OC 
60 OC 
RG3 F:  ATTCCGTGAGTAGTGGCGAGCGAAAGC 
R:  CCACAACCCCACGAATGCAACACCTG 
66 OC 
65 OC 
60 OC 
RG4 
F:  GCTGTCGGCTGAGGTCGCCATC 
R:  CTGCTGCGCCATCTTCACCATGTCG 
66 OC 
65 OC 
60 OC 
RG5 F:  CTCACCTTCCGACGTGACGCTGTC 
R:  GCGACGATTGTGGCGGCATCACTC 
65 OC 
66 OC 
60 OC 
RG6 
F:  GCCCACGCACCTCGTCGTCG 
R:  GACCTTGACGCCCATCTCGGTGTAGG 
67 OC 
66 OC 
61 OC 
RG7 
F:  GCGTCCGTGGTGAACTCCAACTCC 
R:  TCCAGATCCTCTCCGAGCCGAAGAAC 
65 OC 
65 OC 
60 OC 
RG8 
F:  CTCGGAGGAAGGTGGGGACGACG 
R:  CCTCACGGTATCGCAGCCCTCTG 
65 OC 
65 OC 
60 OC 
RG9 
F:  TGGATAAGCGGCAGCGACCACTTGG 
R:  GGAGTCGGGTGTGGTGAAGGAAGC 
66 OC 
65 OC 
60 OC 
RG10 F:  CGTCGTCGGTGGGTGTTGCATGTC 
R:  TCAGGATGCCGTAGCACCTCGACTG 
65 OC 
65 OC 
60 OC 
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Supplementary Table D.2. Ranking of candidate reference genes (RGs) by CT standard 
deviation. The ten candidate RGs were ranked by the standard deviation of their CT values as 
calculated by Bestkeeper. Analysis was performed on the pooled data set containing all four 
growth conditions. A standard deviation greater than 1 is considered unstable. The minimum and 
maximum CT values for each RG are also provided.  
 
Rank 10 9 8 7 6 5 4 3 2 1 
 RG4 RG6 RG2 RG10 RG9 RG1 RG5 RG3 RG8 RG7 
min [CT] 22.93 25.47 25.86 28.34 28.32 23.44 24.56 8.74 10.48 24.93 
max [CT] 27.41 29.01 28.20 30.61 30.33 25.23 25.96 10.16 11.74 25.77 
std dev [± CT] 1.37 1.13 0.67 0.61 0.46 0.40 0.37 0.33 0.29 0.21 
 
 
Supplementary Table D.3. Bestkeeper ranking with significance value. The ten candidate RGs 
were ranked by their Bestkeeper r-value calculated on the pooled data set containing the results 
from all four growth conditions in biological triplicates. Three technical replicates for each 
biological replicate were averaged prior to input into Bestkeeper. Bolded values represent a p-
value < 0.05. 
 
Rank 10 9 8 7 6 5 4 3 2 1 
Gene RG10 RG1 RG5 RG2 RG4 RG9 RG6 RG8 RG7 RG3 
r-value -0.192 -0.046 -0.006 0.326 0.609 0.634 0.731 0.814 0.847 0.895 
 
 
 
Supplementary Table D.4. Bestkeeper ranking with significance value with rRNA candidates 
removed. The eight candidate RGs were ranked by their Bestkeeper r-value calculated on the 
pooled data set containing the results from all four growth conditions in biological triplicates. 
Three technical replicates for each biological replicate were averaged prior to input into 
Bestkeeper. Bolded values represent a p-value < 0.05. 
 
Rank 8 7 6 5 4 3 2 1 
Gene RG10 RG1 RG5 RG2 RG4 RG9 RG7 RG6 
r-value -0.122 -0.043 -0.001 0.418 0.532 0.624 0.716 0.845 
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D.2 Supplementary figures 
 
Supplementary Figure D.1. Standard curves for RT-qPCR primers. A five-round 10-fold serial 
dilution was performed on purified PCR product for each RT-qPCR primer pair. Each data point 
represents the average of duplicate values. A linear regression (dashed line) was performed for 
each data set, and the equation of the line and R2 value are listed on each respective plot.  
205 
 
 
Supplementary Figure D.2. Melt curves for candidate reference gene amplicons. A melting curve 
analysis was performed on samples using the BioRad CFX96 after RT-qPCR to confirm a single 
amplicon was produced. The cDNA condition (black line) had cDNA added to the PCR reaction, 
while the NTC (no template control; orange line) condition had H2O added instead.  
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Supplementary Figure D.3. Minimum number of reference genes (RGs) with rRNA removed. 
The pair-wise variation Vn/Vn+1, where n represents the number of RGs used in the normalization 
factor (NF), was calculated by geNorm to determine the minimum number of RGs required for 
normalization. A geNorm V value below 0.15 signifies that no additional benefit is gained from 
increasing the number of reference genes from n to n+1. The dashed line represents a V value of 
0.15. 
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Supplementary Figure D.4. Effect of reference gene choice on RT-qPCR normalization with 
rRNA candidates removed. A) Box plots of averaged PD630_RS15810 expression data (CT) for 
all four growth conditions (HN, LN, TSB, and PHE). Each gray box represents the first through 
third quartiles, the solid black line represents the median, and the whiskers represent the minimum 
and maximum values. B-D) The normalized relative expression ratio of PD630_LPD05540 going 
from HN to either LN (B), TSB (C), or PHE (D). The expression data was normalized with either 
RG5/RG7, RG5/RG9, RG7/RG9, RG5/RG7/RG9, or RG7/RG8 using REST 2009. Error bars 
represent the 95% confidence interval (CI) as calculated by REST 2009. Stars indicate that a 95% 
CI range falls outside of the 95% CI range of the RG7/RG8 normalized ratio.  
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Supplementary Figure D.5. The original version of electrophoresis gel images. A) The original 
non-edited, full length electrophoresis gel image showing single amplicon bands after RT-qPCR 
for each reference gene candidate (RG 1 to RG 10; left to right). B) The original non-edited, full 
length electrophoresis gel image confirming no bands for the negative template controls (NTCs) 
after RT-qPCR for each gene candidate (RG 1 to RG 10; left to right). The sizes for the nucleotide 
ladder are indicated to left of bands (50 to 200 bp). The size of each amplicon is denoted in Table 
5.1. 
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D.3 RT-qPCR primer design criteria 
Primer annealing temperature = ~60 oC when using 125 nM primer (ThermoFisher Tm calculator) 
Amplicon length = 70-160 bp 
Try to have only one G/C at 3’ end. No more than 2 G/Cs 
Two or fewer consecutive G/C pairs in predicted hairpin structure (IDT OligoAnalyzer 3.1; 
https://www.idtdna.com/calc/analyzer); avoid binding on 3’ end  
Primer hairpin = ΔG > -2 kcal/mol  
Primer homodimer = ΔG > -7 kcal/mol 
Primer heterodimer = ΔG > -7 kcal/mol 
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